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°C degree Celsius 
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EOM ethoxymethyl 
Et ethyl 
h hours 
IC inhibitory concentration 
KHMDS potassium bis(trimethylsilyl)amide 
LiHMDS lithium bis(trimethylsilyl)amide 
Me methyl 
min minutes 
Ms methylsulfonyl 
MS molecular sieve 
N normality 
NBS N-bromosuccinimide 
nM nanomolar 
Ph phenyl 
PMB para-methoxybenzyl 
PPA polyphosphoric acid 
rt room temperature 
SEM 2-(trimethylsilyl)ethoxymethyl 
TFA trifluoroacetic acid 
THF tetrahydrofurane 
M micromolar 
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1. Introduction
The search for new pharmaceuticals requires intensive collaboration in different research 
areas including pharmacology, clinical sciences, chemistry, bioinformatics, molecular 
biology and in particular genomic sciences.1 In billion-years of evolution, living organisms 
have advanced their internal signaling, communication and defense by utilizing small 
molecules. These pre-validated small-molecule natural products provide the fruitful 
resources for the pharmaceutical industry. However, in the development of novel drug 
candidates, the isolation, identification and synthesis of natural products remain an 
ongoing big challenge for organic chemists.2 Consequently a number of drugs are natural 
products, such as erythromycin,3 taxol4 and lovastatin,5 or their derivatives, like aspirin. 
In many cases interesting pharmacological properties guided the synthesis of novel natural 
product hybrid structures as lead compounds.6,7 The pharmacological activity of 
compounds from nature and their derivatives are especially promising, since those 
structures or substructures thereof have been selected by evolution and are therefore 
privileged structures.8 Interestingly statistical studies indicated that structural complexity 
and diversity of drug molecules is much closer to natural products, than to compounds 
obtained by random combinatorial library synthesis.9 Therefore complexity and diversity 
are key-factors for success in navigating the vast chemical space to identify regions 
containing relevant bioactive compounds.10 Although marketed drugs have addressed only 
a limited number of biological targets, which are usually proteins like enzymes, ion 
channels or receptors, researchers from genomics are identifying more and more 
previously unknown targets simultaneously.11 Today the time consuming hit and lead 
finding efforts progress with modern high-throughput techniques, which are able to screen 
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thousands of small molecules within days. Medicinal chemists thus face the challenge of 
the tremendous demand for more new compounds to address novel targets.  
In order to increase the efficiency for identification of novel drug candidates, different 
synthetic strategies have been developed to compose small molecule libraries.12 On the one 
hand target-oriented synthesis can be used to synthesize natural product derivatives with 
common structural features for pre-selected protein targets. Organic chemists usually 
perform a retro-synthetic analysis as a problem-solving method to discover key structural 
elements in the initial stage.13 Thereby fragment-coupling reactions are identified as crucial 
steps to connect building blocks to the structural complex molecule. Derived from this 
synthetic analysis, these chemical transformations might lead to a synthetic diversification 
strategy to gain structurally related target molecules for focused libraries. Depending on 
their specific efficiency, standard solution phase protocols, solid phase synthesis and their 
combinations have been applied to create small molecule libraries based on natural product 
scaffolds, e.g. vancomycin14 and sarcodictyin.15  
On the other hand diversity-oriented synthesis does not aim on a certain target. This 
concept emphasizes on the generation of structural diversity and complexity for a 
compound library aiming on a successful genetic-like screening against various targets.16 
Solid phase synthesis combined with a split-and-pool synthesis strategy and the spatial 
segregation of polymer beads is very often employed. In practice diversity-oriented 
synthesis for drug discovery is embedded in a three step process: combinatorial generation 
of diverse small molecules, followed by various biological screenings, and finally 
structural characterization of the small molecules, which gave positive hits in the 
corresponding assays. Typically only very small quantities of complex molecules are 
synthesized. For the difficult backwards analysis of the active structure, encoded one-bead-
one-stock systems with high capacities per bead have been developed. The encoding 
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information supports the independent chemical synthesis of the active compound and its 
derivatives.17 
In the last decade crossovers of methods and tools described above have been 
implemented. Recently Shair and co-workers demonstrated the application of diversity-
oriented synthesis as a strategy to produce a diverse natural-product based library to 
identify molecules with totally new biological functions.18 In their one-bead-one-stock 
approach, the split-and-pool synthesis was designed analogous to a natural product 
synthesis. Subsequent phenotype screening led to the identification of novel biological 
functions of natural product derivatives. Merging the concept of target-oriented synthesis 
and privileged structures, Nicolaou et al. applied a two step approach: first statistical 
identification of the privileged structural motif (e.g. benzopyrane), followed by a 
combination of this structural feature with six different natural product scaffolds to obtain 
focused natural-product like compound libraries for their screenings against certain 
targets.19  
In general the design and diversity of the compound library is intrinsically more important 
than the library size to find relevant biological activity.20 In recent years small collections 
of smart library molecules appear more valuable than a large mindlessly assembled one. It 
increases the hit rate during the search for improved or novel bioactivities.21 The success of 
drug development from natural product origins has been proofed by the large number of 
pharmaceuticals in the last 25 years.22 Structural and statistical analysis guided the design, 
synthesis and selection of compounds for the setup of focused chemical libraries. This 
development was supported by experimental and computational approaches towards the 
helpful concepts of drug-like properties23 and privileged structures of potential drug 
candidates.24  
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The natural product hymenialdisine and its analogues exhibit a variety of interesting 
biological activities. A detailed analysis of reported syntheses of hymenialdisine and 
related natural products as well as their non-natural derivatives guided the way to the 
development of a focused library of novel bioactive compounds.  
 
 
1.1. Synthesis of natural products from the hymenialdisine 
family
 
In the last decades a broad variety of pyrrole alkaloids has been isolated, synthesized and 
studied in detail as potential pharmaceuticals.25,26 Among them natural products containing 
a pyrrolo[2,3-c]azepinone motif like hymenialdisine (1),27,28,29 hymenin (2),30 stevensine 
(3),31,32 latonduine A (4) and B,33 (E)-anxinohydantoin (5)34,35 (the corresponding 
(Z)-isomers of the anxinohydantoins are also named as spongiacidins C and D),36 aldisine37 
and other derivatives of the related oroidin family38 have been isolated and characterized 
(Figure 1).39 Due to their interesting pharmacological properties, significant efforts have 
been made to achieve independent synthesis of these natural products. All compounds 
related to the hymenialdisine family share the structural element of the fused bicyclic 
pyrrolo[2,3-c]azepinone. Additionally, the majority of these complex molecules possess a 
third heterocycle connected to the pyrrolylic carbon.  
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Figure 1. Natural products with a pyrrolo[2,3-c]azepinon core structure: (Z)-hymenial-
disine (1), hymenin (2), stevensine (3), lantonduine A (4) and (E)-axinohydantoin (5). 
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Among natural products with a pyrrolo[2,3-c]azepinone core structure, hymenialdisine (1) 
was studied extensively. In the early 1980s (Z)-hymenialdisine (1),27,28 (Z)-2-debromo-
hymenialdisine40 and 3-bromohymenialdisine41 were isolated from different marine 
sponges like Acanthella aurantiaca,27 Hymeniacidon aldis,28 Axinella verrucosa (syn. 
Stylissa)34 and Pseudoaxinyssa cantharella.42 The molecular structure of (Z)-hymenial-
disine (1) was confirmed by X-ray crystallographic analysis. Later (E)-hymenialdisine was 
also found in nature by extraction of Stylotella aurantium from Palau.29 The (Z)-isomer (1) 
appeared to be more thermodynamically stable than the corresponding (E)-hymenial-
disine.43 (Z)-Debromohymenialdisine was first isolated in 1980 out of the sponge Phakellia 
flabellata from the Great Barrier Reef44 and was structurally confirmed during the 
discovery of hymenialdisine (1) two years later.27 Analogous to its brominated derivative 
1, the (E)-isomer of debromohymenialdisine has been also isolated and characterized.29 In 
1990 the isolation and characterization of hymenialdisine (1) by Pettit et al. was driven by 
the discovery of antiproliferative properties of a hymenialdisine-containing natural product 
extract on cultured lymphocytic leukemia cells.34 Later hymenialdisine (1) was identified 
to inhibit various protein kinases such as cyclin-dependent kinases CDK1, CDK2 and 
CDK5, glycogen synthase kinase GSK3, casein kinase CK1,45 mitogen-activated protein 
kinases MEK1 and MAPK1,46 checkpoint kinases Chk1 and Chk2,47,48 p90 ribosomal S6 
kinase p90RSK, kinase domain-containing receptor KDR, tyrosine kinases Fes and c-KIT, 
p21-activated kinase PAK2, pyruvate dehydrogenase kinase PDK1, protein kinase PKC, 
protein kinase PKD2, ribosomal kinase Rsk1, and serum- and glucocorticoid-inducible 
kinase SGK.49 The kinase inhibiting properties are of great potential for the development 
of novel pharmaceuticals e.g. in the area of cancer,50 Alzheimer’s disease,49 arthritis,51 etc. 
Further hymenialdisine (1) inhibits the interleukin-1-induced proteoglycan degradation,52 
the production of cytokine53 and was identified to be active against NFB-mediated gene 
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transcription and the IL-8 production in U937 cells resulting in anti-inflammatory 
effects.54,55,56  
The close related derivative hymenin (2) was isolated by Kobayashi and coworkers in 1986 
from the marine sponge Hymeniacidon and found to be an -adrenoceptor blocking 
agent.30,57 Meanwhile stevensine (3) was isolated from an unidentified Micronesian 
sponge31 and a Pseudaxinyssa Cantharella sponge simultaniously.42 Recently, the novel 
marine alkaloids latonduine A and B have been isolated from the sponge Stylissa cateri 
and were subsequently synthesized since an extract of this sponge showed significant in 
vitro cytotoxicity against human cancer cell lines.33 Additionally, in 1990 the natural 
product (E)-axinohydantoin (5) was obtained from the marine sponge Axinella and its 
structure was determined by X-ray crystallography.34 In 1997 two other isomers, 
(Z)-axinohydantoin and (Z)-debromoaxinohydantoin have been isolated from the sponge 
Stylotella aurantium and were found to inhibit protein kinase C (PKC) in micro molar 
concentrations with IC50 values of 9.0 and 22 M respectively.35 Subsequent to the 
isolation of four new natural products from the sponge Hymeinacidon Kobayashi and 
coworkers renamed the corresponding (Z)-axinohydantoin and (Z)-debromoaxinohydantoin 
in their series as spongiacidins C and D.36 
The first total synthesis of hymenialdisine (1) was established by Annoura et al.58 In their 
synthesis the fused pyrrolo[2,3-c]azepinone motif was introduced via a 2-bromoaldisine42 
synthon 8a, which was synthesized starting from commercially available pyrrole-2-
carboxylic acid (6). Via the transformation to an acid chloride, 6 was reacted with 
-alanine methyl ester to obtain intermediate 7 in 35 % yield after bromination. 
Saponification and acidic cyclization yielded 2-bromoaldisine (8a) in a 1:1 mixture with 
3-bromoaldisine (8b) (combined yield: 65 %). Separation of both isomers succeeded via 
column chromatography after the introduction of 2-(trimethylsilyl)ethoxymethyl (SEM) 
protecting groups (yields: 9a: 35 %, 9b: 23 %) (Scheme 1).  
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N
H
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    PhMe, 60 °C, 1 h
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H
H
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Br N
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6
8a, X1= Br, X2 = H   
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N
O
O
Br
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SEM N
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OSEM
SEM+
Br
9a, 35 % 9b, 23 %  
Scheme 1. Synthesis of SEM-protected 2-bromoaldisine (9a).  
 
Aldisine derivative 9a was subsequently converted into (Z)-hymenialdisine (1) in six 
additional steps to install the third heterocycle and remove the SEM-protecting groups 
(Scheme 2). First 9a was reacted in a Horner-Emmons reaction yielding intermediate 10, 
followed by deprotonation and treatment with 2-benzenesulfonyl-3-phenyloxaziridine (11) 
to give pyrrole[2,3-c]azepinone 12. Introduction of a leaving group and reaction with 
guanidine led to cyclization of hydantoin derivative 13 in 42 % yield. Finally, deprotection 
of the SEM groups with hydrochloric acid in methanol yielded the natural product 
(Z)-hymenialdisine (1).  
DME, 50 °C, 24 h N
N
O
Br
SEM
SEM
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10, 83 % 12, 78 %
KHMDS, THF, 
-78 °C, 2 h
O
N
SO2Ph
COOEt
N
N
O
Br
SEM
SEM
COOEt
HO
1. MsCl, NEt3, DCM, 0 °C,
2. guanidine, DMF, 
    50 °C, 5 h
N
N
O
N
HN
OH2N
Br
SEM
SEM N
H
NH
O
N
HN
OH2N
Br
5 % HClaq:MeOH 1:1
80 °C, 2 h
13, 42 % 1, 70 %
(EtO)2POCH2COOEt, NaH
11
 
Scheme 2. First total synthesis of (Z)-hymenialdisine (1).  
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The same procedure was employed to prepare the natural product (Z)-debromohymeni-
aldisine. Thereby the SEM-protected aldisine derivative was synthesized in very similar 
overall yield.  
One year later new cyclization conditions implemented for the indolo-derivatives using 
polyphosphoric acid in the absence of phosphorus pentoxide resulted in 77 % yield of an 
annulated aldisine derivative.59 In the same year Cho et al. reported the application of a 9:1 
mixture of methanesulfonic acid and phosphorus pentoxide as a more efficient (up to 90 % 
yield) and easy to handle method.60 A novel synthesis of the pyrrole-2-carboxylic acid 
derivatives starting from pyrrole (14) and phosgene analogues in the presence of a base 
was developed to obtain the substrate 15 in a cheap and large scale manner. In subsequent 
cyclization with P2O5/MsOH the natural product aldisine (16) was obtained (Scheme 3).61 
Similar synthetic strategies have often applied in the total synthesis of aldisine derivatives 
later on. 
 
N
H
O
HN
COOH
MsOH, P2O5
100-120 °C, 1 h
16, 44 %
N
H
N
H
O
O
15, 68 %
N
H
1. Cl3C-CO-Cl, Me2NPh,          
    PhMe, 2 h, rt
2. -alanine methyl ester,        
    Me2NPh, PhMe, reflux, 1 h
3. NaOH, EtOH, rt, 18 h
14  
Scheme 3. Cyclization to aldisine (16) with P2O5 and MsOH. 
 
Recently, the total synthesis of (Z)-hymenialdisine (1) was completed by Papeo et al. 
employing a new glycociamidine ring precoursor (Scheme 4).62 During their studies a 
Friedel-Crafts type cyclization to access 2-bromoaldisine (8a) motif was introduced. The 
reaction conditions reported for the synthetically challenging 2-bromoaldisine (8a) are 
advantageous due to the low reaction temperature, but this route required one more step to 
obtain the acid chloride intermediate from 19. Followed by a three-step one-pot 
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methodology involving a titanium-mediated Aldol-reaction, (Z)-hymenialdisine (1) was 
obtained in 25 % yield. Surprisingly, the main product in the final step of the 
hymenialdisine formation was endo-debromohymenialdisine (21) (30 % yield).  
 
N
H
1. H2NCH2CH2COOEt,   
    NEt3, MeCN, rt, 48 h
17
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O
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O
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19, 92 %
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    DCM, -10 °C - rt
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3. 7 N NH3 in MeOH, 
    rt, 3 h
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O
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O
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+
20
Scheme 4. Papeo´s total synthesis of (Z)-hymenialdisine (1). 
 
In the past twenty years Horne and coworkers accomplished the total synthesis of a series 
of the pyrrolo[2,3-c]azepinone based natural products such as hymenialdisine (1), hymenin 
(2),63 stevensine (3) and debromohymenialdisine.64,65 A novel synthesis to access the core 
structure of hymenin (2) was developed. Starting from 2, other previously isolated marine 
alkaloids have been synthesized for the first time. 
As a starting point for the synthesis of hymenin (2), a novel cyclization from aldehyde 
derivatives 22a and 22b was established. Acidic cyclization to the olefins 23a and 23b was 
employed instead of previously described ring closure of acid intermediates to aldisin (16) 
or derivatives 9a and 9b. Thereby the introduction of two bromine substituents into the 
pyrrole moiety was crucial to avoid dimerization of olefin 23a (59 % isolated yield for 
dimerized product). Subsequent treatment of intermediate 23b with 2-aminoimidazole (24) 
under acidic conditions yielded hymenin (2) in 65 % yield (Scheme 5). Reductive 
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debromination of hymenin (2) with hydrogen in the presence of palladium on charcoal and 
NaOAc led to debromohymenin (25) in quantitative yield.  
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22b, X = Br
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X N
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(from 23b)
H2, Pd/C, NaOAc
MeOH, rt, 5 h
25, > 99 %
N
H
NH
O
N
HN
H2N
24
 
Scheme 5. Horne´s synthesis of hymenin (2) and debromohymenin (25).
 
Further chemical transformation of the previously synthesized hymenin (2) allowed the 
total synthesis of stevensine (3) in two additional steps (scheme 6).32 Bromination of the 
imidazole heterocycle in substrate 2 yielded 4´-bromohymenin (26) followed by a proto-
debromination/trans-bromination event to yield stevensine (3) in 20 % yield. In the final 
step hymenin (2) was re-obtained in 40 % isolated yield.  
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Scheme 6. Total synthesis of stevensine (3) starting from hymenin (2). 
 
A debromination procedure applied to intermediate 26 employing aqueous hydrobromic 
acid led to (Z)-debromohymenialdisine (27) (40 % yield) and debromostevensine (28) 
(21 % yield) in one step (Scheme 7). 
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Scheme 7. Synthesis of (Z)-debromohymenialdisine (27) and debromostevensine (28).
 
In the last decade more practical protocols for the synthesis of hymenin (2) and (Z)-de-
bromohymenialdisine (27) have been developed. Combining short and high yielding 
reactions, the acidic cyclization to the core structure and the attachment of the 2-amino-
imidazole heterocycle (24) onto the pyrrole[2,3-c]azepinone structure within a one-pot-
two-steps reaction as key transformation yielded hymenin (2) in excellent yields (overall 
54 %) (Scheme 8).64 A two-fold oxidation of hymenin (2) and subsequent treatment with 
hydrogen in the presence of palladium on charcoal yielded the target compound 27 in 34 % 
allover yield. 
 
N
H
H
N
O
Br
Br
MsOH, 45 °C, 4 d
O
O
1. Br2, NaOAc,            
    HOAc, rt, 1 h
2. H2, Pd/C, NaOAc, 
    MeOH, 10 h
31, 90 %
N
H
NH
O
N
HN
H2N
27, 64 %
O
N
H
NH
O
N
HN
H2N
2, 60 %
NH2
O
O
MeCN, rt, 16 h
N
H
Br
Br
O
CCl3
then 24, 45 °C, 4 d
Br
Br
29
30
 
Scheme 8. Practical synthesis of hymenin (2) and (Z)-debromohymenialdisine (27). 
 
In their multigram preparation of (Z)-debromohymenialdisine (27), Portevin et al. 
employed the synthetic strategy of Cho and coworkers (see above, Scheme 3) to obtain 
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aldisine (16) in four steps starting from pyrrole.66 Further transformation of 16 (Scheme 9) 
with 2-thiohydantoin (32) in the presence of BF3·Et2O to intermediate 33, followed by 
treatment of aqueous ammonia in the presence of tert-butyl peroxide yielded the natural 
product (Z)-debromohymenialsine (27) in six steps and overall 6.6 % yield starting from 
pyrrole.  
 
NH4OH, tBuOOH
N
H
NH
O
N
HN
H2N
27, 74 %
O
BF3· Et2O, NEt3
N
H
NH
O
H
N
HN
S
33, 31 %
O
N
H
NH
O
16
O HN
H
NS
O
THF EtOH
32
 
Scheme 9. Preparation of (Z)-debromohymenialdisine (27) from aldisine (16). 
 
Synthetic efforts to synthesize hymenialdisine (1) were also successful starting from the 
olefinic intermediate 23b using cascades of bromine-chemistry (Scheme 10).65 Reaction of 
olefin 23b with bromine in methanol at room temperature led to the functionalized lactam 
34 in 95 % yield. Intermediate 34 reacted with 2-aminoimidazole (24) under acidic 
conditions to give the carbon-carbon coupling product 35 in 46 % yield. The subsequent 
formation of olefin 36 involved an elimination of hydrobromic acid, followed by a 
protodebromination of the -pyrrolic position. Simultaneous production of bromine 
resulted in a reaction to 5-bromo-3-debromostevensine (36). Finally, olefin 36 was treated 
with aqueous acetic acid under reflux conditions to give hymenialdisine (1) in 65 % as the 
major product. 
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Scheme 10. Synthesis of hymenialdisine (1) from olefin 23b.
 
Inspired by the strategy of cyclization to olefin 23b, Linington et al. developed a synthesis 
of lantonduine A (4) and B.33 First protected aldehyde 31 was cyclized to olefin 23b. The 
attachment of the fused pyrimidine heterocycle to the seven membered ring system was 
achieved via hydroboration of olefin 23b in the presence of catecholborane and lithium 
borohydride and subsequent hydrolysis with base to yield alcohol 37 in 84 % over two 
steps. This intermediate 37 was further oxidized with Dess-Martin periodinane to give the 
cyclic ketone 38 in almost quantitative yield (Scheme 11). Treatment with ethyl 
orthoformate resulted in functionalization in -position to the pyrrole ring system and 
further reaction of 39 with guanidine led to lantonduine A (4) in 17 % overall yield.  
N
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H
N
O
Br N
H
NH
O
Br
BrBr
35 °C, 7 d NH
NH
O
Br
Br
O
O
MsOH
23b, 69 %
1. catecholborane, 
    LiBH4, THF, rt, 1 h
2. 1 N NaOHaq,
    5 min
OH
37, 84 %
Dess-Martin 
periodinane
THF, rt, 2 h NH
NH
O
Br
Br
O
38, 98 %
TFA, reflux, 18 h NH
NH
O
Br
Br
O
39, 35 %
OEt
H
guanidine, 
K2CO3
THF/H2O 6:1, 
reflux, 1 h
N
H
NH
O
Br
Br
N
N
NH2
4, 85 %
31
HC(OEt)3
 
Scheme 11. Synthesis of lantonduine A (4). 
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Another class of natural products containing the pyrollo[2,3-c]azepinone core structure is 
the group of anxinohydantoins. In 2002 Horne and coworkers completed the synthesis of 
debromo- and bromoaxinohydantoin in both (E)- and (Z)-forms.67 Starting from -func-
tionalized imidazolones 42, the route might reflect a possible biosynthetic pathway 
analogous to a cyclization of the natural product oroidin. The synthesis follows the concept 
of amide bond formation previous to the acidic cyclization as already described above. But 
in contrast to earlier protocols the third heterocycle of the natural product was already 
connected in the synthon 44 before cyclization to intermediate 45 occurs (Scheme 12). 
Bromination with three equivalents bromine gave the (E)- and (Z)-isomers 46 and 47 of 
bromoaxinohydantoin in 35 % and 45 % isolated yield, respectively.  
 
CO2MeH2N
H2N
1. Na/Hg, 0-5 °C,  
    HClaq, H2O, 
    pH = 1.2-1.5, 1 h
2. KOCN, NaOHaq,      
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HN
N
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NCS
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N
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NH2MeO
42, 70 %
DMF, rt, 16 h
N
H
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O
H
N
HN
O NH
OMe O H
N
44, 85-90 %
TFA, rt, 24 h
45, 30 %
N
H
NH
O
H
N
HN
O
Br
Br
Br
3 equiv. Br2,
NaOAc
AcOH, rt, 16 h NH
NH
O
H
N
HN
O
Br
O
N
H
NH
O
Br
NH
HN
Br Br
O
O
46, 35 % 47, 45 %
+
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Scheme 12. Synthesis of (E)-bromoaxinohydantoin (46), (Z)-bromoaxinohydantoin (47). 
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Both isomers 46 and 47 were separately debrominated in a hydrogenation reaction with 
hydrogen gas in the presence of palladium on charcoal at room temperature in methanol to 
give (E)-debromoaxinohydantoin and its (Z)-isomer 40 % and 80 % respectively. 
 
In summary different syntheses of pyrrolo[2,3-c]azepinone derived natural products from 
the hymenialdisine family have been analyzed in detail. A significant number of 
preparation protocols are based on the preformation of the pyrrolo[2,3-c]azepinone core 
structure in form of an aldisine derivative or an olefinic intermediate. Usually the third 
heterocycle is connected or created subsequently. These methods commonly provide 
robust reactions with respect to stable yields and isolatable intermediates for further 
synthetic procedures. Additionally, a number of biological studies with natural products 
from the hymenialdisine family have been reported. In combination of the chemistry and 
biology, hymenialdisine (1) and analogues are attractive synthetic targets for further 
derivatisation. A compound library derived from these structures is a valuable tool for the 
improvement of existing biological properties and discovery of novel pharmacological 
activities.  
 
1.2. Preparation and biological activities of hymenialdisine 
derivatives 
Attracted by the biological properties of the hymenialdisine family, different research 
groups revisited the synthesis for the development of novel hymenialdisine-derived 
indolo[2,3-c]azepines aiming on investigation of novel biological functions of these small 
molecules. The synthesis of direct indolo-analogues of hymenialdisine (1) has been 
reported.  
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Starting from indole-2-carboxylic acid, Tepe and coworkers synthesized an annulated 
aldisine derivative 48 via amide bond formation with -alanine ethyl ester, subsequent 
saponification and acidic cyclization based on known procedures in the total synthesis of 
hymenialdisine (1). A titanium-mediated Aldol-condensation with 5-phenyloxazolone (49) 
as a precursor resulted in intermediate 50 in 55 % yield (Scheme 13). Treatment of the 
oxazolone derivative 50 with S-benzylthiourea (51) and lithium hydride led to the direct 
annulated hymenialdisine analog 52 in 12 % overall yield.53 
 
N
H
NH
O
O
N
OPh
O
TiCl4, pyridine
THF, 0 °C, 2.5 h, 
then rt, overnight
N
H
NH
O
O
N
O
Ph
EtOH, reflux, 48 h
LiH
H2N NH
SBn
x HCl
N
H
NH
O
H
N
N
O
H2N
48 50, 55 % 52, 28 %
49
51
 
Scheme 13. Synthesis of annulated hymenialdisine derivative 52. 
 
In biological screenings the non-natural product 52 inhibited interleukin-2 (IC50 = 3.5 M) 
and the tumor necrosis factor  (IC50 = 8.2 M). Additionally, it was identified as a potent 
inhibitor of the cell cycle checkpoint kinase Chk2 in nanomolar concentrations 
(IC50 = 8 nM).48 Interestingly annulated compound 52 led to significantly increased 
selectivities towards the inhibition of kinases Chk1 and Chk2 compared to hymenialdisine 
(1) or debromohymenialdisine (27).  
In another study, the synthesis and novel target identification of direct hymenialdisine 
analogs and annulated derivatives were accomplished.49 Beside the intense efforts to 
synthesize close related derivatives with pyrrolo- and indolo[2,3-c]azepinone core 
structures, a novel library of hydrazones 54 (Scheme 14) was generated starting from 
various aldisine derivatives 53 in order to modify the heterocycle at -position to the 
pyrrole moiety. 
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Scheme 14. Derivatisation of pyrrolo[2,3-c]azepinones 53 via hydrazone formation to 54. 
 
Screening of the focused library against a panel of 60 recombinant enzymes resulted in the 
discovery of eleven new targets including the kinases p90RSK, KDR, c-Kit, Fes, MAPK1, 
PAK2, PDK1, PKC, PKD2, Rsk1 and SGK. The novel natural product analogs 54 turned 
out to possess dramatically increased or changed selectivities compared to hymenialdisine 
(1) itself; e.g. the annulated hydrazone derivative 55 exhibits 30-fold higher anti-
proliferative activities than hymenialdisine (1). 
Inspired by these studies, the modification of substituents on the azepinone-ring system 
turned out to be another attractive goal for synthetic chemists. Recently two further 
research groups published their synthetic progress in the preparation of latonduine 
derivatives carrying a fused benzene moiety instead of a pyrimidine ring system in the 
natural product 4. In 2005 Joseph and coworkers developed a synthesis of indolo[2,3-c]-
azepinones as a part of their novel strategy to obtain the natural product derivatives 58
(Scheme 15).68 Condensation of protected indole-2-carboxylic acid derivatives to 
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2-iodobenzamine and subsequent intramolecular palladium-catalyzed Heck-reactions 
yielded the corresponding indolo[2,3-c]benzazepinones 57. Recently the synthetic protocol 
was extended by a variation with removable protecting groups. After deprotection of the 
tert-butyloxycarbonyl (boc) and ethoxymethyl (EOM) groups the desired target com-
pounds 58 were obtained.69 
 
N
EOM
N
O
Boc
I
Pd(OAc)2, PPh3,
Ag2CO3
DMF, 100 °C, 1 h N
N
O
Boc
EOM
1N  HCl
1,4-dioxane, 
80 °C, 5 h
N
H
NH
O
R R R
56 57 58
N
H
NH
O
59
N
H
NH
O
60
MeO
 
Scheme 15. Synthesis of latonduine derivatives 58 via intramolecular Heck-reaction. 
 
In an additional diversification the indole moiety was exchanged to pyrrole and 
benzothiofurane to obtain modified structures and gain novel non-natural derivatives. But 
in contrast to the indole derivatives 58, these structures remained all mono-methylated on 
the lactam nitrogen atom, which might be unfavorable in biological screenings. 
Nevertheless, the compounds have been tested in vitro on MCF-7 breast adenocarcinoma 
cell lines. The best antiproliferative activity was found as expected for close derivatives 59 
(IC50 = 1.2 M) and 60 (IC50 = 0.6 M), which do not carry any N-protecting group. 
Very recently an inverted synthetic sequence was applied in a study about inhibitors of 
tubulin polymerization resulting in antitumor and cytotoxic activities (Scheme 16).70 The 
synthetic strategy started with Suzuki-couplings of arylboronic acids 63 to a 3-iodoindole 
derivative 62, followed by the deprotection of the boc-protecting group. Subsequent 
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removal of the sulfonyl-protecting group and formation of a ring-closing amide-bond was 
achieved in one-step to obtain the alkylated latonduine derivatives 65. 
 
1. TFA, DCM,
    rt, 16 h
N
H
NH
O2. Na/EtOH,
    reflux, 10 h
N
H
COOH
R1
R2
R1
1. EtOH, cat. H2SO4,
    reflux, 16 h
2. KOH, I2, DMF, rt, 
    45 min
3. PhSO2Cl, NaH,   
    THF, rt, 16 h
N
COOEt
R1
I
SO2Ph
10 mol% Pd(PPh3)4,
Na2CO3
PhMe:EtOH 1:1, 
relfux, 20 h
B(OH)2
R2
NHBoc
N
COOEt
R1
SO2Ph
NHBoc
R2
61 62 64
65
63
R1 = H, OMe, F; R2 = H, Me, (R)-Me, (S)-Me, (R)-Et, (S)-Et, nPr, nBu, iPr.  
Scheme 16. Synthesis of a small library of alkylated latonduine analogues 65.  
 
This novel synthetic concept led to a small compound library of structures with the general 
core structure 65, which were identified as potent antiproliferative agents in a variety of 
cancer cell lines.  
 
Since the X-ray structure of the CDK2-hymenialdisine complex indicates that some 
lipophilic effects of the bromine atom in hymenialdisine (1) might play a crucial role for its 
protein kinase inhibition potency,45 the synthesis of novel 2-substituted hymenialdisine 
derivatives has been developed.71 According to the preparation of different the 
corresponding pyrrole-5-carboxylic acid derivatives, amide bond formation with -alanine 
esters was carried out followed by a sequence of saponification and acidic cyclization to 
give 2-substituted aldisine derivatives 67. Adoption of the synthetic strategy from Papeo et 
al.62 led to four different hymenialdisine derivatives 68; surprisingly the compounds were 
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obtained in the non-natural endo-form (Scheme 17). Isomerisation of endo-analogues 68 
into the corresponding exo-compounds by irradiation was unsuccessful. 
N
HR
HN
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O
N
H
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OR
N
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O
H2N
66 67 68
1. 1 N NaOHaq
2. PPA/P2O5, 120 °C
N
N
MeS
OO
Ph
TiCl4, pyridine
DCM, -10 °C
1. NH3 in dioxane
2. NH3 in MeOH
R = Me, Bn, Ph, tBu
20
 
Scheme 17. Synthesis of 2-substituted endo-hymenialdisine derivatives 68.  
 
Moreover, a couple of research groups applied modern catalytic methods in the synthesis 
and modification of pyrrolo[2,3-c]azepinones. Mérour and coworkers were interested to 
find new catalytic pathways to fused bicyclic indolo-lactam derivatives as innovative 
scaffolds in drug development. Thereby olefin metathesis was introduced for the first time 
to prepare the pyrrolo[2,3-c]azepinone motif (Scheme 18).72 Suitable substrates like vinyl-
indole 71 were obtained starting from indole-2-carboxylic acid 69, coupling to allylamine, 
followed by the installation a vinyl group at 3-position of the indole. Protection of the NH-
functionalities with boc-groups gave intermediates 71. Subsequent ring-closing alkene 
methathesis with a Grubbs I catalyst yielded the seven-membered olefin 72 in 60 % yield. 
The non-protected olefin 73 was obtained by acidic deprotection in high yields at room 
temperature.  
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OH
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    DMAP, DCM, 
    0 °C - rt, 24 h
2. (COCl)2, DMF,                  
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H
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O
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N
N
O2. Boc2O, DMAP,    
    MeCN, rt, 16 h
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DCM, rt, 48 h
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N
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Scheme 18. Synthesis of olefin 73 via ring-closing metathesis. 
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Another catalytic diversification approach has been reported for the synthesis of 
derivatives 78 (Scheme 19). Palladium-catalyzed cross-coupling reactions have been 
employed to link various arylboronic acids or arylstannates with the brominated synthon 
76.73 In the fist step protected aldisine-derivatives 74 were synthesized and subsequently 
double-brominated to give intermediate 75 in 93 % yield. Subsequent formal elimination 
of hydrobromic acid under basic reaction conditions yielded the vinyl bromide derivative 
76 in high yields (93 %). Cross-coupling reactions with either arylboronic acids or aryl 
stannates were used to create a focused chemical library of natural-product derived 
structures 78. 
 
1. LiHMDS, THF,  
   -78 °C, 1 h
2. Br2, -78 °C, 15 min or      
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Scheme 19. Synthesis of natural product derivatives 78.  
 
The careful analysis of the chemistry and biology of natural products derived from the 
hymenialdisine family showed the great potential of these privileged structures as a starting 
point for navigating chemical space for improved or novel biological activities. Beside the 
synthesis of the fused-bicyclic lactam the attachment of the third heterocycle to the 
pyrrolo[2,3-c]azepinone moiety was identified as the crucial fragment-coupling key step. 
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Additionally, in the majority of the described syntheses and diversifications of the bicyclic 
pyrrolo[2,3-c]azepinones, the syntheses were preformed with aldisine-derived or olefinic 
intermediates. These two building blocks are beneficial with respect to the short synthesis, 
good yields, high product stability and short reaction time. On this basis a novel concept 
employing oxidation chemistry has been investigated in the diversification of 
indolo[2,3-c]azepinones.74 A linear synthesis of aziridines, epoxides and hydroxyl 
precursors containing the natural product derived core structure has been developed to 
obtain building blocks for rapid diversification with various reagents. These key 
intermediates were then attacked by a variety of different nucleophiles, mostly indoles, to 
prepare a focused library of novel functionalized annulated hymenialdisine derivatives.  
The linear synthesis to the key building blocks benefited from the advantages of high 
yielding and robust reactions such as the amide bond formation, saponification and acidic 
cyclization to annulated aldisine 48 and could be performed on multigram scale. Reduction 
of aldisine derivative 48 with sodium borohydride to the racemic alcohol 79 and a one-pot 
elimination-protection sequence yielded olefin 72 in 50 % yield over five steps (Scheme 
20). The introduction of boc-protecting groups was necessary to obtain a more stable and 
storable alkene from the acidic elimination reaction. 
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O N
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79, 99 % 72, 85 %
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O
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1. -alanine ethylester,       
    DCC, BTA, NEt3,
    dioxane:DCM:DMF 
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2. KOH, dioxane:H2O
    1:1, rt, 20 h
3. P2O5, MsOH, 
    80 °C, 2 h
NaBH4
abs. EtOH, 
rt, 14 h
1. MsOH,         
    DCM, rt, 1 h
2. (Boc)2O, 
    DMAP, rt, 2 h
69 48, 60 % 
(3 steps)
Scheme 20. Linear synthesis of protected olefin 72 for further derivatisation. 
 
Subsequent oxidation of the protected olefin 72 led to the desired aziridines 80 and 
epoxides 82 as building blocks for diversification.75,76 The key intermediates 80 and 82
were exposed to various indoles in solvent-free ring-opening reactions on solid support 
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(Scheme 21). In situ deprotection reactions in case of aziridines 80 and a separated second 
deprotection step for epoxides 82 led to a focused library containing novel bisindole-type 
hymenialdisine derivatives 81 and 83. 
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Scheme 21. Preparation of a focused library of bisindoles 81 and 83.  
 
Further transformations of aziridines with H-, N-, and O-nucleophiles demonstrated their 
versatility as useful intermediates in library synthesis. For direct comparison in biological 
studies the corresponding bisindoles without a side chain at the seven-membered ring were 
also desired synthetic targets. Surprisingly, alcohol intermediate 79 reacted 
regioselectively with indoles at 3-position of the nucleophile under the same reaction 
conditions (Scheme 22). The desired hymenialdisine-type bisindoles 84 were obtained in 
only five steps.  
 
1. Introduction 
 
24
R = H, 5-Me, 5-F, 5-Cl, 5-Br, 5-OMe, 5-OBn, N-Me, 2-Me, 4-Br, 6-Cl, 7-Me
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R
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Scheme 22. Synthesis of bisindole-type hymenialdisine derivatives 84 from alcohol 79.  
 
As described above much attention has been paid to several biological activities of natural 
products from the hymenialdisine family and its non-natural derivatives. Among them the 
relatively general protein kinase inhibiting properties have been widely recognized and 
make the core structure of hymenialdisine a suitable starting point in chemical space for 
the search of novel biological targets or for improved properties on known targets.  
 
During the last two decades, protein kinases were found to be involved in essential 
regulatory cellular functions such as gene expression, cellular proliferation, differentiation, 
membrane transport, and apoptosis.77 Since a number of small molecule kinase inhibitors 
entered clinical trials,78 there is an ongoing academic and industrial interest for the 
development of new kinase inhibitors and the identification of novel targets.79 The most 
protein kinases phosphorylate serine, threonine, tryosine, arginine or histidine side chains 
of proteins and are of great interest in current drug research.80 Meijer and coworkers were 
able to show on molecular level by X-ray crystallography of a hymenialdisine (1) complex 
in the ATP (adenosine triphosphate) binding pocket of the protein kinase CDK2 (Figure 2). 
Hymenialdisine blocks this pocket in a competitive manner45 and the binding structural 
elements of the molecule were identified.  
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Figure 2. Schematic representation of the ATP binding pocket of CDK2 in complexes with 
ATP (left) and hymenialdisine (1) (right).81  
 
On the one hand the NH-CO-C-NH sequence on the lower part of the molecule (Figure 2) 
is crucial for the binding affinity to the protein. On the other hand the heterocycle 
connected at -position is also required for coordination on the upper part. This complex 
binding mode might be the reason for the relatively general kinase inhibiting action of 
hymenialdisine as a privileged structure. At the same time its molecular complexity could 
be the key factor for positive results in other unrelated screenings since the molecule might 
allow a number of different binding modes.  
 
A screening of our focused chemical library of around 80 hymenialdisine-derivatives of 
81, 83 and 84 and of their synthetic intermediates and fragments was performed to identify 
novel inhibitors for the protein kinases DYRK1A, CDK1, CDK5, CK1 and GSK3.82 
Thereby the annulated bisindole-type hymenialdisine analogue 85 (Figure 3) exhibited 
significant activities in the inhibition of DYRK1A (IC50 = 1.8 M) and GSK3 (IC50 = 44 
M) in low micromolar concentrations.  
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Figure 3. Novel kinase inhibitor 85 for the kinases DYRK1A and GSK3. 
 
Due to the 4-bromine substitution pattern on the attached indole moiety other 4-substituted 
and various halogenated indole derivatives are currently being synthesized in our 
laboratories. In this iterative screening program, we are aiming on getting more 
information about the structural-activity relationship on molecular level to improve activity 
and selectivity of the novel kinase inhibiting structure. 
 
In contrast to the most synthetic programs for target-oriented synthesis, we employed our 
focused library also for diverse screenings of biological targets. With the help of the high-
throughput devices at the Center for Life Science Automation at the University of Rostock, 
a very similar compound library of our hymenialdisine derivatives was screened in various 
assays. Among them the compounds were tested in a cell-based assay in the area of 
genome (de)activation by zinc finger proteins.  
Zinc finger proteins are the most studied DNA-binding proteins.83 Around one third of all 
zinc finger DNA-binding proteins possess a so called Krüppel-associated box (KRAB) 
domain.84 These KRAB zinc finger proteins are further assumed to build the largest family 
of transcription factors within the human genome.85 When such a zinc finger protein binds 
to DNA, the KRAB domain acts as a potent transcriptional repressor for a certain gene 
function.86 In 1995 Thiesen and coworkers have successfully linked a KRAB repressor 
domain of the human Kox1 zinc finger protein to a tetracycline-depending repressor 
protein (TetR) and incorporated them into HeLA A12 cells.87 Transfection of the same 
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cells with a luciferase reporter gene bearing seven tetracycline operator (tetO) sequences 
yielded stable cells for further studies. Inside the transfected cell system, the TetR protein 
of the TetR-KRAB protein binds to the tetO sequences of the reporter gene. Thereby the 
KRAB domain represses the function of a certain part of the reporter gene (luciferase). In 
the presence of tetracycline the TetR domain competitively coordinates to tetracycline 
molecule and the connection to the tetO sequences of the reporter gene gets lost. Since the 
KRAB domain is not linked to the reporter gene furthermore, its repression function is 
deactivated. This consequence leads to an activation of the artificial reporter gene and 
results in luminescence. For future application, the binding selectivity of zinc finger 
proteins and the mechanisms of repression and activation of a certain gene function need to 
be identified. Small molecules which bind to the KRAB domain of zinc finger proteins 
undoubtedly alter the function of signaling. This concept is of great potential for the direct 
activation and/or repression of discrete DNA functions. So far no molecule has been 
identified to bind to the KRAB domain. This fundamental concept of controlling signaling 
domains might be applied for the search of novel drugs in the future. 
During the establishment of an automated cell-based assay with those transfected HeLa 
cells from the Thiesen research laboratories, the novel hymenialdisine-type bisindole 86 
(Figure 4) was identified to show around 90 % activity compared to the tetracycline 
positive control in low micromolar concentrations.88  
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Figure 4. Hymenialdisine-type bisindole 86. 
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In this study compound 86 was already proven to possess the ability to enter the cell 
nucleus and act under given physiological conditions without significant influence on the 
vitality and metabolism of the cells.89 Beside the function of the molecule, this implies the 
ability of our novel-designed class of compounds to pass cell membranes without affecting 
the cell-life cycle significantly. Subsequently the small molecule 86 was exposed to two 
different discrimination assays to clarify action of the activating molecule 86. Further 
biological measurements and chemical synthesis are under investigation to gain more 
information about the mode of action, which might take part on the KRAB or tetO 
domaine, and structural influences of the natural product-derived bisindole 86 to activity.  
 
In summary the necessity to navigate chemical space in order to find novel 
pharmacologically active compounds was shown. Especially natural products as privileged 
structures from nature are excellent starting points to prepare focused chemical libraries for 
subsequent biological activity screenings. In the past limited number of chemical libraries 
with hymenialdisine-derived structures were synthesized with respect to their promising 
biological functions. These investigations led to a number of novel synthetic methods for 
the preparation of promising drug candidates. Subsequently the development of novel 
diversification strategies was established during the attachment of the third heterocyclic 
moiety.  
Following the general concept of target-oriented synthesis, we started to navigate the 
chemical space starting from the hymenialdisine core structure. The lower part of the 
pyrrolo[2,3-c]azepinone structure and one further coordination part on the upper 
heterocycle connected to the lactam moiety were identified as crucial structural elements 
for bioactive new molecules. Further oxidation chemistry and subsequent diversification 
resulted in a focused library of novel hymenialdisine derivatives. In contrast to common 
target-oriented studies, we performed biological testings for already established targets and 
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extended our search to unrelated biological activities. Our collection of smart molecules 
was accessible to biologists for a diversity-oriented screening approach including test 
systems in the area of kinase inhibition and novel cell-based assays e.g. with zinc finger 
proteins. So far our efforts resulted in to two significant hits in the biological screenings, 
which actively guide our compound synthesis in further diversifiactions. More basic 
understanding of the mode of action for bisindole-type hymenialdisine derivatives 85 and 
86 is currently awaited. 
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2. Objectives of this work 
 
Natural products and their derivatives have been candidates for the development of novel 
drugs for a long time due to their important structural complexity and diversity. In the 
preparation of focused chemical libraries, target-oriented synthesis usually aims on direct 
natural product analogues for preselected biological targets. Also diversity-oriented 
synthesis has been applied to generate a large number of novel molecules, which occupy a 
lot of regions in the chemical space for the evaluation in a variety of biological activities.  
As a starting point for our development of new bioactive chemical libraries, a collection of 
unsymmetrical bisindoles based on the natural product hymenialdisine was prepared. As a 
part of this project, we investigated a solvent-free, efficient and easy to handle 
diversification strategy for annulated hymenialdisine-type bisindoles. A C-C bond-
formation reaction on activated silica under mild reaction conditions starting from 
aziridines or hydroxyl compounds is the crucial technology. The arylation reactions 
proceeded in a highly regio- and stereoselective manner at the benzylic position of the 
indolo[2,3-c]azepinone moiety and at the 3-position of the attached indole. In addition, 
boc-protecting groups can be removed in situ smoothly. The versatility of various 
aziridines as key building blocks was demonstrated with H-, O-, and N-nucleophiles in a 
diversity oriented synthesis to build up a small compound library. X-ray analysis 
confirmed the molecular structures of six important key intermediates and library 
compounds. This gives direct evidence for the trans-ring-opening reaction (see 3.1., Org. 
Lett. 2006 and 3.2., J. Org. Chem. 2007). In our ongoing synthetic efforts, we also 
implemented the application of epoxidation chemistry for the synthesis of the key building 
block. Due to the higher reactivity of the epoxide, the diversification to the corresponding 
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bisindoles was achieved in a two-step ring-opening and deprotection sequence on solid 
support under mild reaction conditions. This method can also be extended to synthesize 
enantiomerically pure bisindole-type hymenialdisine analogues (see 3.3., Tetrahedron 
2008). Subsequent biological screenings led to the identification of two bisindoles with 
inhibiting effects on protein kinases and zinc finger proteins (see 1.2., unpublished results).  
 
Parallel to our efforts in the preparation of a focused chemical library of hymenialdisine 
derivatives, we were interested in the development of novel synthetic methodologies for 
the introduction and transformation of important functional groups for the synthesis of 
potential biological active molecules. 
Following our general library concept starting from indole-2-carboxylic acids, we 
identified 7-substituted indoles as rare substrates in organic synthesis. In order to reach 
these difficult accessible substrates for our compound library, we applied iridium-catalyzed 
borylation to 2-substituted indoles. Hence, 7-borylated indoles were obtained in excellent 
regioselectiviy. In the presence of an excess of the borylation reagent 2,4,7-trisubstituted 
indoles were obtained preferentially (see 3.4., Tetrahedron Lett. 2007). Further 
investigations were guided by the idea to introduce potentially biologically relevant 
functional groups into the prefunctionalized borylated compounds. In this context a novel 
palladium-mediated fluorination of arylboronic acids was developed. The functional group 
tolerance, broad substrate scope, and regiospecificity of this reaction provide a general 
method for fluorination of structurally complex arenes, especially in the late stage (see 
3.5., Angew. Chem., 2008, accepted). Moreover we developed a general copper-catalyzed 
method for the sulfonylation of arylboronic acids with sulfinate salts. A variety of alkyl-
aryl, diaryl, and alkyl-heteroaryl sulfones were synthesized in good yield (see 3.6., Org. 
Lett. 2007). On the other hand, a self-catalyzed selective oxidation of sulfides to sulfoxides 
has been developed to access sulfur-containing functional groups in lower oxidation state. 
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Compared with previous protocols, this system has the advantage that no organic solvents 
or any additional catalyst is necessary (see 3.7., Adv. Synth. Catal. 2007).  
Attracted by our previous development of CH-functionalization via borylation and 
subsequent functional group transformation in fluorination and sulfonylation reactions, we 
sought a synthetic method for the direct functionalization of arenes without “pre-
activation” in form of arylhalides, arylboronic acids or other reagents. A novel general 
gold-catalyzed oxidative homocoupling of arenes was developed. Theoretically this double 
CH-functionalization is the most efficient process for the synthesis of biaryls, which 
constitute an important structural component in natural products, pharmaceuticals, 
agrochemicals and materials (see 4.8., Chem. Commun. 2007). Additionally, hetero-
coupling was achieved for the first time (see 4.9., J. Organomet. Chem. 2008, submitted). 
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3.1.  New synthetic protocols for the preparation of unsym-
metrical bisindoles 
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ABSTRACT
Novel unsymmetrical bisindoles were synthesized by a solvent-free C−C bond-formation reaction under mild conditions. Starting from aziridines
or hydroxyl precursors, indoles have been used as C-nucleophiles to form new pharmacologically interesting bisindoles via an electrophilic
aromatic substitution pathway in good to excellent yields.
During the last two decades, protein kinases were found to
be involved in essential regulatory cellular functions such
as gene expression, cellular proliferation, differentiation,
membrane transport, and apoptosis.1 Staurosporine (1), a
bisindole, has been found as one of the first kinase inhibitors
in nanomolar concentrations.2 In addition, various small
molecular kinase inhibitors are known.3 Among them,
Hymenialdisine (HMD) (2)4 and annulated derivatives 35
(Figure 1) have been found to inhibit a number of different
kinases very selectively. Additionally, compounds 2 and 3
prevent the production of cytokines.6
We have been interested in the application of catalytic
reactions for the synthesis of potential pharmaceuticals for
some time.7 As a starting point for the development of new
bioactive kinase inhibitors, we decided to prepare a small
† Leibniz-Institut fu¨r Katalyse e.V. an der Universita¨t Rostock.
‡ Center for Life Science Automation (CELISCA).
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Bach, S.; Mayer, T.; Fabbro, D.; Meijer, L.; Gray, N. S. Chem. Biol. 2004,
11, 247-259.
(6) Sharma, V.; Lansdell, V. A.; Jin, G.; Tepe, J. J. J. Med. Chem. 2004,
47, 3700-3703.
Figure 1. Structures of Staurosporine (1), Hymenialdisine (HMD)
(2), and HMD analogues 3.
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compound library of unsymmetrical bisindoles. As a part of
this project, we developed a solvent-free, efficient, and easy
to handle diversification strategy for annulated HMD-type
bisindoles via a C-C bond-formation reaction on activated
silica under mild reaction conditions starting from aziridines
or hydroxyl compounds.
In the past, different synthetic strategies have been
developed for the synthesis of the pyrrolo[2,3-c]azepine motif
of HMD. The first total synthesis of HMD (2) was published
by Annoura;8 later, Horne introduced another synthetic
strategy.9 Recently, a new total synthesis was introduced by
Papeo.10 Annulated HMD derivatives usually were prepared
via the azepino[3,4-b]indole-1,5-dione (5) intermediate or
the corresponding alcohol (()-6 and subsequent attachment
of the imidazole heterocycle.5 Azepino-indole 5 is usually
synthesized via intramolecular cyclization reactions with
MsOH/P2O5.11 Also, protocols employing ring-closing meta-
thesis12 and polyphosphoric acid13 were introduced so far.
It has been shown that the kinase inhibiting activities of
annulated HMDs 3 vary very much when other heterocycles
instead of imidazole are introduced.5 Hence, we aimed to
develop a general and easy manageable preparation of
unsymmetrical HMD-type bisindoles. On the basis of our
experience on oxidation methods,14 we planned to use
different oxidation reactions as a toolbox for diversity-
oriented synthesis.15 Until now, relatively little use has been
made applying oxidation methodologies for this purpose. The
starting material 7 was synthesized in a one-pot elimination-
protection procedure from (()-6 (Scheme 1).5 Boc-protecting
groups were introduced to obtain a more stable and storable
alkene, which smoothly reacts in the subsequent aziridination
reaction.
Although initial exploratory experiments employing stan-
dard epoxidation methods such as m-CPBA or MTO16 were
not successful, we turned our interest to the aziridination of
olefin 7.17 It is well documented that N-arylsulfonylaziridines
react with C, O, S, N, halogen, or hydrogen nucleophiles18
in the presence of a base, an acid, or a Lewis acid. In general,
it should be possible to perform these reactions highly regio-
and stereoselectively.19 For aziridination of olefins, a number
of different metal-catalyzed nitrene transfer methods with
copper, rhodium, ruthenium, iron, cobalt, manganese, silver,
and gold catalysts were described.20 With respect to synthetic
application, we decided to perform the bromine-catalyzed
aziridination developed by Sharpless and co-workers be-
cause this protocol does not require an excess of olefin
(Scheme 2).21
To our delight, the aziridination of 7 proceeded smoothly
to give (()-8 in good yield (78%). In contrast to the reported
literature conditions, the reaction is favorably carried out
(7) (a) Kumar, K.; Michalik, D.; Castro, I. G.; Tillack, A.; Zapf, A.;
Arlt, M.; Heinrich, T.; Bo¨ttcher, H.; Beller, M. Chem.-Eur. J. 2004, 10,
746-757. (b) Michalik, D.; Kumar, K.; Zapf, A.; Tillack, A.; Arlt, M.;
Heinrich, T.; Beller, M. Tetrahedron Lett. 2004, 45, 2057-2061. (c) Tewari,
A.; Hein, M.; Zapf, A.; Beller, M. Tetrahedron Lett. 2004, 45, 7703-7707.
(d) Khedkar, V.; Tillack, A.; Michalik, M.; Beller, M. Tetrahedron 2005,
61, 7622-7631. (e) Neumann, H.; Stru¨bing, D.; Lalk, M.; Klaus, S.; Hu¨bner,
S.; Spannenberg, A.; Lindequist, U.; Beller, M. Org. Biomol. Chem. 2006,
4, 1365-1375.
(8) Annoura, H.; Tatsuoka, T. Tetrahedron Lett. 1995, 36, 413-416.
(9) (a) Xu, Y.-Z.; Yakushijin, K.; Horne, D. A. J. Org. Chem. 1997, 62,
456-464. (b) Sosa, A. C. B.; Yakushijin, K.; Horne, D. A. J. Org. Chem.
2000, 65, 610-611.
(10) Papeo, G.; Posteri, H.; Borghi, D.; Varasi, M. Org. Lett. 2005, 7,
5641-5644.
(11) Cho, H.; Matsuki, S. Heterocycles 1996, 43, 127-131.
(12) Chacun-Lefe`vre, L.; Be´ne´teau, V.; Joseph, B.; Me´rour, J.-Y.
Tetrahedron 2002, 58, 10181-10188.
(13) Suzuki, H.; Shinpo, K.; Yamazaki, T.; Niwa, S.; Yokoyama, Y.;
Murakami, Y. Heterocycles 1996, 42, 83-86.
(14) For recent publications in this area, see: (a) Tse, M. K.; Do¨bler,
C.; Bhor, S.; Klawonn, M.; Ma¨gerlein, W.; Hugl, H.; Beller, M. Angew.
Chem., Int. Ed. 2004, 43, 5255-5260. (b) Tse, M. K.; Bhor, S.; Klawonn,
M.; Anilkumar, G.; Jiao, H.; Do¨bler, C.; Spannenberg, A.; Ma¨gerlein, W.;
Hugl, H.; Beller, M. Chem.-Eur. J. 2006, 12, 1855-1874. (c) Tse, M. K.;
Bhor, S.; Klawonn, M.; Anilkumar, G.; Jiao, H.; Spannenberg, A.; Do¨bler,
C.; Ma¨gerlein, W.; Hugl, H.; Beller, M. Chem.-Eur. J. 2006, 12, 1875-
1888. (d) Tse, M. K.; Klawonn, M.; Bhor, S.; Do¨bler, C.; Anilkumar, G.;
Hugl, H.; Ma¨gerlein, W.; Beller, M. Org. Lett. 2005, 7, 987-990.
(15) (a) Burke, M. D.; Schreiber, S. L. Angew. Chem., Int. Ed. 2004,
43, 46-58. (b) Schreiber, S. L. Science 2000, 287, 1964-1969. (c) Nicolaou,
K. C.; Pfefferkorn, J. A.; Roecker, A. J.; Cao, G.-Q.; Barluenga, S.; Mitchell,
H. J. J. Am. Chem. Soc. 2000, 122, 9939-9953.
(16) (a) Herrmann, W. A.; Fischer, R. W.; Marz, D. W. Angew. Chem.,
Int. Ed. 1991, 30, 1638-1641. (b) Rudolph, J.; Reddey, K. L.; Chiang, J.
P.; Sharpless, K. B. J. Am. Chem. Soc. 1997, 119, 6189-6190.
(17) For a review, see: Tanner, D. Angew. Chem., Int. Ed. 1994, 33,
599-619.
(18) For reviews, see: (a) Hu, X. E. Tetrahedron 2004, 60, 2701-2743.
(b) Stamm, H. J. Prakt. Chem. 1999, 341, 319-331.
(19) For a review, see: Sweeney, J. B. Chem. Soc. ReV. 2002, 31, 247-
258.
Scheme 1. Synthesis of Intermediates (()-6 and 7
Scheme 2. Bromine-Catalyzed Aziridination of 7
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employing an understoichiometric amount of chloramine-T
trihydrate (1 equiv) in the presence of only 5 mol % of
phenyltrimethylammonium tribromide (PTAB) and 2 equiv
of 7 to reduce side products such as the brominated olefin
and the ring-opening product of the formed aziridine with
the amide salt.22 Next, we attempted the direct arylation of
various indoles using (()-8 as the key building block in the
presence of acidic heterogeneous catalysts such as clay23 or
silica.24 The arylations took place highly regioselectively at
the benzylic position of (()-8 applying Hudlicky’s protocol
of solvent-free conditions on silica (Table 1).24a All reactions
ran overnight at 70 °C and yielded the ring-opening product
in good to excellent yields.
The crystal structure of product (()-9f clearly showed that
the reaction yielded a trans ring-opening product (Figure 2).25
Functional groups such as alkyl, halide, alkoxy, and ester
groups were tolerated by the mild reaction conditions.
However, nitro- and cyano-substituted indoles did not react
well in this protocol. In the case of 5,6-dimethylindole, we
obtained an unseparable 70:30 mixture of two different
(20) (a) For an overview, see: Mo¨ner, C.; Bolm, C. Catalyzed
Asymmetric Aziridinations. In Transition Metals for Organic Synthesis;
Beller, M., Bolm, C., Eds.; Wiley-VCH: Weinheim, 2004; Vol. 2, pp 389-
402. (b) For a review, see: Mu¨ller, P.; Fruit, C. Chem. ReV. 2003, 103,
2905-2919. (c) For recent developments with Au and Ag, see: Li, Z.;
Ding, X.; He, C. J. Org. Chem. 2006, 71, 5876-5880. Cui, Y.; He, C. J.
Am. Chem. Soc. 2003, 125, 16202-16203.
(21) Jeong, J. U.; Tao, B.; Sagasser, I.; Henniges, H.; Sharpless, K. B.
J. Am. Chem. Soc. 1998, 120, 6844-6845.
(22) Stewart, I. C.; Lee, C. C.; Bergmann, R. G.; Toste, F. D. J. Am.
Chem. Soc. 2005, 127, 17616-17617.
(23) Nadir, U. K.; Singh, A. Tetrahedron Lett. 2005, 46, 2083-2086.
(24) (a) Hudlicky, T.; Rinner, U.; Finn, K. J.; Ghiviriga, I. J. Org. Chem.
2005, 70, 3490-3499. (b) Minakata, S.; Hotta, T.; Oderaotoshi, Y.;
Komatsu, M. J. Org. Chem. 2006, 71, 7471-7472.
(25) X-ray crystallographic study of 9f: data were collected with a
STOE-IPDS diffractometer using graphite-monochromated Mo KR radiation.
The structure was solved by direct methods [SIR2004: Burla, M. C.;
Caliandro, R.; Camalli, M.; Carrozzini, B.; Cascarano, G. L.; De Caro, L.;
Giacovazzo, C.; Polidori, G.; Spagna, R. J. Appl. Cryst. 2005, 38, 381-
389] and refined by full-matrix least-squares techniques against F2 [Sheld-
rick, G. M. SHELXL-97; University of Go¨ttingen: Germany, 1997.] XP
(BRUKER AXS) was used for a structural representation. Space group
P21/c, monoclinic, a ) 13.641(3), b ) 16.424(3), c ) 12.005(2) Å, b )
94.29(3)°, V ) 2682.1(9) Å3, Z ) 4, rcalcd ) 1.354 g/cm-3, 28 216 reflections
measured, 4732 were independent of symmetry, of which 2669 were
observed (I > 2s(I)), R1 ) 0.042, wR2 (all data) ) 0.090, 367 parameters.
Table 1. Ring-Opening Reactions of (()-8a
a Reaction conditions: aziridine (()-8 (113 mg, 0.20 mmol), indole
derivative (2.00 mmol), activated silica (0.040-0.063 mm, 429 mg), 70
°C, Ar, overnight. b Isolated yield.
Figure 2. Molecular structure of (()-9f. The thermal ellipsoids
correspond to 30% probability.25
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regioisomers likely caused by the electron-rich aromatic
system of the substrate.
In all cases, the functionalization took place in the
3-position of the employed indoles, which is in agreement
with an electrophilic aromatic substitution mechanism.
Interestingly, both nitrogen atoms were deprotected in situ
giving products (()-9a-n directly. This desired parallel
reaction avoids any other further deprotection steps.
For direct comparison in biological screenings, we also
prepared the analogues (()-10a-e without the tosylamide
side chain. Under similar reaction conditions, the hydroxyl
compound (()-6 yielded the corresponding bisindoles (()-
10a-e in moderate to good yields (Table 2). Presumably, a
carbocation is formed in situ at the benzylic position, which
reacted afterwards in an electrophilic aromatic substitution
pathway with the various indoles. Also a reaction following
Horne’s azafulvenium ion pathway seems possible.9a To the
best of our knowledge, this is the first direct benzylation of
indoles at the 3-position with a hydroxyl precursor under
solvent-free reaction conditions.26
In summary, we have developed new synthetic protocols
for the preparation of unsymmetrical bisindoles. The ring-
opening arylation of the aziridine or the direct arylation of
the hydroxyl precursor proceeds highly regio- and stereo-
selectively with various indoles solvent free on solid support.
This reaction enables an easily manageable and fast diver-
sification pathway for a number of unsymmetrical bisindoles
and pharmaceutically interesting HMD derivatives.
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R.; Palmieri, A.; Petrini, M.; Torregiani, E. Org. Lett. 2006, 8, 4093-4096.
Table 2. Formation of Bisindoles (()-10a-e from (()-6a
a Reaction conditions: alcohol (()-6 (100 mg, 0.462 mmol), indole
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Indole aziridines and their hydroxyl derivatives have been used for the preparation of a small library of
novel functionalized bisindoles. Diversification of these building blocks by solvent-free C-C-bond
formation on solid support yielded annulated Hymenialdisine analogues under mild reaction conditions.
Indoles as C-nucleophiles form potentially pharmacologically active bisindoles through an electrophilic
aromatic substitution pathway in good to excellent yields. Further transformations of the indole aziridines
with H-, N-, and O-nucleophiles demonstrate their versatility as key intermediates in diversity oriented
synthesis. The hydroxyl precursor leads also to unsymmetrical bisindoles under similar reaction conditions.
Important intermediates and final library compounds were confirmed by X-ray analysis. Theoretical studies
on these systems show the possible cationic intermediate in the substitution pathway.
Introduction
Aziridines are versatile and highly valuable intermediates in
organic synthesis.1 In addition, natural products containing an
aziridine moiety are known; some of them like Mitomycin A
and B exhibit interesting biological activity.2 Probably most
importantly, aziridines serve as building blocks in drug research,
such as in the development of neuramidase inhibitors3 and
calcium sensing receptor ligands,4 and allow a straightforward
preparation of diversified compound libraries. Thus, during the
last decades significant attention has been paid to the racemic
and stereoselective preparation of these nitrogen-containing
three-membered-ring systems.5 N-Arylsulfonylaziridines are
especially important since they react smoothly with C-,6 O-,7
S-,8 N-,9 halogen-,10 and hydrogen-nucleophiles11 in the presence
of Brønstedt bases, Brønstedt acids, or Lewis acids.12
† Leibniz-Institut fu¨r Katalyse e.V. an der Universita¨t Rostock.
‡ Universita¨t Rostock, Center for Life Science Automation (CELISCA).
(1) Aziridines and Epoxides in Organic Synthesis; Yudin, A., Ed.; Wiley-
VCH: Weinheim, Germany, 2006.
(2) For an overview, see: Lowden, P. A. S. Aziridine Natural Productss
Discovery, Biological Acitvity and Biosynthesis. In Aziridines and Epoxides
in Organic Synthesis; Yudin, A., Ed.; Wiley-VCH: Weinheim, Germany,
2006; pp 399-442.
(3) (a) Kim, C. U.; Lew, W.; Williams, M. A.; Liu, H.; Zhang, L.;
Swaminathan, S.; Bischofberger, N.; Chen, M. S.; Mendel, D. B.; Tai, C.
Y.; Laver, W. G.; Stevens, R. C. J. Am. Chem. Soc. 1997, 119, 681-690.
(b) Kim, C. U.; Lew, W.; Williams, M. A.; Wu, H.; Zhang, L.; Chen, X.;
Escarpe, P. A.; Mendel, D. B.; Laver, W. G.; Stevens, R. C. J. Med. Chem.
1998, 41, 2451-2460.
(4) Kessler, A.; Faure, H.; Petrel, C.; Rognan, D.; Ce´sario, M.; Ruat,
M.; Dauban, P.; Dodd, R. H. J. Med. Chem. 2006, 49, 5119-5128.
(5) (a) Mu¨ller, P.; Fruit, C. Chem. ReV. 2003, 103, 2905-2920. (b)
Tanner, D. Angew. Chem., Int. Ed. 1994, 33, 599-619. (c) Osborn, H. M.
I.; Sweeney, J. Tetrahedron: Asymmetry 1997, 8, 1693-1715.
(6) For recent publications in this area see: (a) Beresford, K. J. M.;
Church, N. J.; Young, D. W. Org. Biomol. Chem. 2006, 4, 2888-2897. (b)
Pineschi, M.; Bertolini, F.; Crotti, P.; Macchia, F. Org. Lett. 2006, 8, 2627-
2630. (c) Pattenden, L. C.; Wybrow, R. A. J.; Smith, S. A.; Harrity, J. P.
A. Org. Lett. 2006, 8, 3089-3091. (d) Minakata, S.; Hotta, T.; Oderaotoshi,
Y.; Komatsu, M. J. Org. Chem. 2006, 71, 7471-7472.
(7) For recent publications in this area see: (a) Sun, X.; Ye, S.; Wu, J.
Eur. J. Org. Chem. 2006, 4787-4790. (b) Das, B.; Reddy, V. S.; Tehseen,
F. Tetrahedron Lett. 2006, 47, 6865-6868. (c) Xichun, F.; Guofu, Q.;
Shucai, L.; Hanbing, T.; Lamei, W.; Xianming, H. Tetrahedron: Asymmetry
2006, 17, 1394-1401.
10.1021/jo7016026 CCC: $37.00 © 2007 American Chemical Society
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In general, aziridines are prepared either via traditional
cyclization reactions of 1,2-aminoalcohols, 1,2-aminohalides,
or 1,2-azidoalcohols or via catalytic carbene- or nitrene-transfer
methods to double bonds (CdN or CdC). Unfortunately, most
catalytic aziridinations of olefins require a large excess of olefin,
and need metal catalysts based on copper, rhodium, ruthenium,
iron, cobalt, manganese, silver, or gold.13 Also, electrochemical
nitrene transfer methods were introduced.14 Notably, these
protocols were transferred to easily manageable protocols with
phenyliodo(III) diacetate as an oxidant later on.15 In addition,
Sharpless and co-workers introduced the bromine-catalyzed
aziridination procedure that does not necessarily require an
excess of alkene.16
Kinase inhibitors are involved in fundamental regulatory
cellular functions such as gene expression, cellular proliferation,
differentiation, membrane transport, and apoptosis.17 As one of
the first kinase inhibitors, the bisindole Staurosporine (1) was
found to be active in nanomolar concentration in the 1980s.18
Besides, some other small molecules also act as kinase inhibitors
as well.19 Among them natural products like Hymenialdisine
(HMD) (2) and its annulated derivatives 3 showed very
promising kinase inhibiting properties20 and prevent the produc-
tion of cytokines (Figure 1).21
On the basis of our experience with the application of catalytic
reactions for the synthesis of new pharmacologically interesting
compounds22 and our background in catalytic oxidation meth-
ods,23 we have been interested in the synthesis of potentially
bioactive bisindoles as kinase inhibitors employing catalytic
aziridination and epoxidation for diversity oriented synthesis24
on complex organic natural product analogues. The prior work
of Gray and co-workers20c showed that the kinase inhibiting
activities of annulated HMDs (3) vary a great deal, if other
heterocycles instead of imidazole are introduced. Therefore we
focused on the introduction of different indoles onto the structure
of annulated HMDs (3) to form new unsymmetrical bisindoles.
Here, we report the detailed studies of a solvent-free, efficient,
and easy to handle diversification strategy for annulated HMD-
type bisindoles via C-C bond formation reaction on activated
silica under mild reaction conditions, in which aziridines and
hydroxyl compounds were used as the starting materials.
Results and Discussion
Several strategies for the synthesis of the pyrrolo[2,3-c]-
azepine motif of HMD and the annulated derivatives have been
published. The first total synthesis of HMD (2) was developed
by Annoura.25 Later Horne introduced another synthetic path-
way26 and Papeo developed a new total synthesis recently.27
(8) For recent publications in this area see: (a) Krishnaveni, N. S.;
Surendra, K.; Rao, K. R. AdV. Synth. Catal. 2006, 348, 696-700. (b) Wu,
J.; Sun, X.; Sun, W. Org. Biomol. Chem. 2006, 4, 4231-4235. (c) Kamal,
A.; Reddy, D. R.; Rajendar Tetrahedron Lett. 2006, 47, 2261-2264. (d)
Wu, J.; Sun, X.; Li, Y. Eur. J. Org. Chem. 2005, 4271-4275.
(9) For recent publications in this area see: (a) Kessler, A.; Faure, H.;
Petrel, C.; Rognan, D.; Ce´sario, M.; Ruat, M.; Dauban, P.; Dodd, R. H. J.
Med. Chem. 2006, 49, 5119-5128. (b) Markov, V. I.; Polyakov, E. V.
ARKIVOC 2005, 8, 89-98. (c) Rinaudo, G.; Narizuka, S.; Askari, N.;
Crousse, B.; Bonnet-Delpon, D. Tetrahedron Lett. 2006, 47, 2065-2068.
(10) For recent publications in this area see: (a) Ding, C.-H.; Dai, L.-
X.; Hou, X.-L. Synlett 2004, 2218-2220. (b) Ghorai, M. K.; Das, K.;
Kumar, A.; Ghosh, K. Tetrahedron Lett. 2005, 46, 4103-4106. (c) Das,
B.; Krishnaiah, M.; Venkateswarlu, K. Tetrahedron Lett. 2006, 47, 4457-
4460. (d) Hanessian, S.; Del Valle, J. R.; Xue, Y.; Blomberg, N. J. Am.
Chem. Soc. 2006, 128, 10491-10495.
(11) (a) Pak, C. S.; Kim, T. H.; Ha, S. J. J. Org. Chem. 1998, 63, 10006-
10010. (b) Chandrasekhar, S.; Ahmed, M. Tetrahedron Lett. 1999, 40,
9325-9327. (c) Molander, G. A.; Stengel, P. J. Tetrahedron 1997, 53,
8887-8912.
(12) For reviews, see: (a) Hu, X. E. Tetrahedron 2004, 60, 2701-2743.
(b) Stamm, H. J. Prakt. Chem. 1999, 341, 319-331. (c) Pineschi, M. Eur.
J. Org. Chem. 2006, 4979-4988.
(13) (a) For an overview, see: Mo¨ner, C.; Bolm, C. Catalyzed
Asymmetric Aziridinations. In Transition Metals for Organic Synthesis;
Beller, M., Bolm, C., Eds.; Wiley-VCW: Weinheim, Germany, 2004; Vol.
2, pp 389-402. (b) For recent developments with Au and Ag, see: Li, Z.;
Ding, X.; He, C. J. Org. Chem. 2006, 71, 5876-5880. Cui, Y.; He, C. J.
Am. Chem. Soc. 2003, 125, 16202-16203.
(14) (a) Siu, T.; Yudin, A. K. J. Am. Chem. Soc. 2002, 124, 530-531.
(b) Watson, I. D. G.; Yu, L.; Yudin, A. K. Acc. Chem. Res. 2006, 39, 194-
206.
(15) Krasnova, L. B.; Hili, R. M.; Chernoloz, O. V.; Yudin, A. K.
ARKIVOC 2005, 4, 26-38.
(16) Jeong, J. U.; Tao, B.; Sagasser, I.; Henniges, H.; Sharpless, K. B.
J. Am. Chem. Soc. 1998, 120, 6844-6845.
(17) Bridges, A. J. Chem. ReV. 2001, 101, 2541-2572.
(18) Tamaoki, T.; Nomoto, H.; Takahashi, I.; Kato, Y.; Morimoto, M.;
Tomita, F. Biochem. Biophys. Res. Commun. 1986, 135, 397-402.
(19) Huwe, A.; Mazitschek, R.; Giannis, A. Angew. Chem., Int. Ed. 2003,
42, 2122-2138.
(20) (a) Cimino, G.; De Rosa, S.; De Stefano, S.; Mazzarella, L.; Puliti,
R.; Sodano, G. Tetrahedron Lett. 1982, 23, 767-768. (b) Kitagawa, I.;
Kobayashi, M.; Kitanaka, K.; Kido, M.; Kyoguku, Y. Chem. Pharm. Bull.
1983, 31, 2321-2328. (c) Wan, Y.; Hur, W.; Cho, C. Y.; Liu, Y.; Adrian,
F. J.; Lozach, O.; Bach, S.; Mayer, T.; Fabbro, D.; Meijer, L.; Gray, N. S.
Chem. Biol. 2004, 11, 247-259.
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(22) (a) Kaiser, H. M.; Lo, W. F.; Riahi, A. M.; Spannenberg, A.; Beller,
M.; Tse, M. K. Org. Lett. 2006, 8, 5761-5764. (b) Kumar, K.; Michalik,
D.; Castro, I. G.; Tillack, A.; Zapf, A.; Arlt, M.; Heinrich, T.; Bo¨ttcher,
H.; Beller, M. Chem. Eur. J. 2004, 10, 746-757. (c) Michalik, D.; Kumar,
K.; Zapf, A.; Tillack, A.; Arlt, M.; Heinrich, T.; Beller, M. Tetrahedron
Lett. 2004, 45, 2057-2061. (d) Tewari, A.; Hein, M.; Zapf, A.; Beller, M.
Tetrahedron Lett. 2004, 45, 7703-7707. (e) Khedkar, V.; Tillack, A.;
Michalik, M.; Beller, M. Tetrahedron 2005, 61, 7622-7631. (f) Neumann,
H.; Stru¨bing, D.; Lalk, M.; Klaus, S.; Hu¨bner, S.; Spannenberg, A.;
Lindequist, U.; Beller, M. Org. Biomol. Chem. 2006, 4, 1365-1375. (g)
Schwarz, N.; Tillack, A.; Alex, K.; Sayyed, I. A.; Jackstell, R.; Beller, M.
Tetrahedron Lett. 2007, 48, 2897-2900.
(23) For recent publications in this area see: (a) Gelalcha, F. G.;
Bitterlich, B.; Anilkumar, G.; Tse, M. K.; Beller, M. Angew. Chem., Int.
Ed. 2007, 46, 7293-7296. (b) Bitterlich, B.; Anilkumar, G.; Gelalcha, F.
G.; Spilker, B.; Grotevendt, A.; Jackstell, R.; Tse, M. K.; Beller, M. Chem.
Asian J. 2007, 2, 521-529. (c) Anilkumar, G.; Bitterlich, B.; Gelalcha, F.
G.; Tse, M. K.; Beller, M. Chem. Commun. 2007, 289-291. (d) Tse, M.
K.; Bhor, S.; Klawonn, M.; Anilkumar, G.; Jiao, H.; Do¨bler, C.; Spannen-
berg, A.; Ma¨gerlein, W.; Hugl, H.; Beller, M. Chem. Eur. J. 2006, 12, 1855-
1874. (e) Tse, M. K.; Bhor, S.; Klawonn, M.; Anilkumar, G.; Jiao, H.;
Spannenberg, A.; Do¨bler, C.; Ma¨gerlein, W.; Hugl, H.; Beller, M. Chem.
Eur. J. 2006, 12, 1875-1888. (f) Tse, M. K.; Klawonn, M.; Bhor, S.; Do¨bler,
C.; Anilkumar, G.; Hugl, H.; Ma¨gerlein, W.; Beller, M. Org. Lett. 2005, 7,
987-990. (g) Tse, M. K.; Do¨bler, C.; Bhor, S.; Klawonn, M.; Ma¨gerlein,
W.; Hugl, H.; Beller, M. Angew. Chem., Int. Ed. 2004, 43, 5255-5260.
(24) (a) Burke, M. D.; Schreiber, S. L. Angew. Chem., Int. Ed. 2004,
43, 46-58. (b) Schreiber, S. L. Science 2000, 287, 1964-1969. (c) Nicolaou,
K. C.; Pfefferkorn, J. A.; Roecker, A. J.; Cao, G.-Q.; Barluenga, S.; Mitchell,
H. J. J. Am. Chem. Soc. 2000, 122, 9939-9953.
(25) Annoura, H.; Tatsuoka, T. Tetrahedron Lett. 1995, 36, 413-416.
FIGURE 1. Structures of Staurosporine (1), Hymenialdisine (HMD)
(2), and HMD analogues 3.
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Annulated HMD derivatives (3) were usually prepared via the
ketone 5 intermediate or the corresponding alcohol (()-6 and
subsequent attachment of the imidazole heterocycle.20c Azepino-
indole 5 is usually synthesized via intramolecular cyclization
reactions with MsOH/P2O5.28 In addition, protocols employing
ring-closure metathesis29 and polyphosphoric acid30 were in-
troduced.
Starting from indole-2-carboxylic acid (4) amide-bound
formation with -alanin ethyl ester in the presence of dicyclo-
hexylcarbodiimine (DCC), triethylamine, and 4-hydroxybenzo-
triazole (BTA), subsequent ester cleavage and cyclization with
phosphorus(V) oxide in methansulfonic acid yielded azepino-
indole 5 (60%). Subsequent reduction of the keto-group with
sodium borohydride in ethanol gave (()-6 in excellent yield
(99%). The ease of isolation of (()-6 is strongly dependent on
the purity of the azepino-indole 5. Compound 5 has very low
solubility in common organic solvents and can be purified by
treatment with activated charcoal in hot acetone and subsequent
recrystallization from a concentrated acetone solution. Olefin
7 was obtained by a one-pot elimination-protection procedure
from (()-6 (Scheme 1).20c Introduction of two boc-protecting
groups was crucial to provide a more stable and storable alkene
from these acidic reaction conditions.
Next, we focused on the oxidation of olefin 7 to aziridines
(()-8a-c. As stated above, most catalytic aziridination meth-
odologies generally require an excess of olefin. As a key
building block for subsequent chemical diversification, it was
crucial to introduce applicable and high-yielding aziridination
methods. In this respect, we utilized the bromine-catalyzed
aziridination protocol developed by Sharpless and co-workers,16
because this method, in principle, does not require an excess
of olefin. In contrast to conditions reported in the literature,
we obtained our best results ((()-8a: 78%) with an under-
stoichiometric amount of the nitrogen source (chloramine-T)
in the presence of only 5 mol % of phenyltrimethylammonium
tribromide (PTAB) and 2 equiv of alkene 7 (eq 1).
Employing these reaction conditions, we were able to reduce
the degree of reaction side products such as the brominated
olefin and the ring-opening product of the product aziridine with
the amide salt.31 Applying the same procedure to compound 7
with chloramine-B, aziridine (()-8b was obtained in a reason-
able (54%) yield.
Next, we planned to introduce a heterocyclic sulfonyl group
to the aziridine motif. Once again the major drawback of most
of the synthetic methods was the large excess of olefin
required.32 Optimization of the reaction conditions of the copper-
catalyzed aziridination method introduced by Chang and co-
workers33 showed that a large excess of olefin 7 was not neces-
sary to obtain the desired product (()-8c in high yield (70%)
(Table 1). The best result with respect to conversion and yield
was obtained employing 5-10 mol % of copper(II) trifluoro-
acetylacetonate [Cu(tfac)2] with a slight excess of olefin 7 (Table
1, entries 3 and 5). Unfortunately further attempts to introduce
the 2-nitrobenezenesulfonyl group onto the aziridine via a gold-
catalyzed procedure gave only a trace amount of the product.13b
We were delighted to be able to apply all of these methods
for the preparation of aziridines (()-8a-c in multigram-scale.
With three different aziridines in hand, we looked for suitable
conditions to affect the nucleophilic ring-opening reaction of
(26) (a) Xu, Y.-Z.; Yakushijin, K.; Horne, D. A. J. Org. Chem. 1997,
62, 456-464. (b) Sosa, A. C. B.; Yakushijin, K.; Horne, D. A. J. Org.
Chem. 2000, 65, 610-611.
(27) Papeo, G.; Posteri, H.; Borghi, D.; Varasi, M. Org. Lett. 2005, 7,
5641-5644.
(28) Cho, H.; Matsuki, S. Heterocycles 1996, 43, 127-131.
(29) Chacun-Lefe`vre, L.; Be´ne´teau, V.; Joseph, B.; Me´rour, J.-Y.
Tetrahedron 2002, 58, 10181-10188.
(30) Suzuki, H.; Shinpo, K.; Yamazaki, T.; Niwa, S.; Yokoyama, Y.;
Murakami, Y. Heterocycles 1996, 42, 83-86.
(31) Stewart, I. C.; Lee, C. C.; Bergmann, R. G.; Toste, F. D. J. Am.
Chem. Soc. 2005, 127, 17616-17617.
(32) (a) Evans, D. A.; Bilodeau, M. T.; Faul, M. M.; Anderson, B. A.;
Barnes, D. M. J. Am. Chem. Soc. 1993, 115, 5328-5329. (b) Evans, D.
A.; Faul, M. M.; Bilodeau, M. T. J. Org. Chem. 1991, 56, 6744-6746. (c)
Evans, D. A.; Faul, M. M.; Bilodeau, M. T. J. Am. Chem. Soc. 1994, 116,
2742-2753.
(33) Han, H.; Bae, I.; Yoo, E. J.; Lee, J.; Do, Y.; Chang, S. Org. Lett.
2004, 6, 4109-4112.
SCHEME 1. Synthesis of Alcohol (()-6 and Olefin 7 TABLE 1. Copper-Catalyzed Aziridination of 7 to Aziridine
(()-8ca
entry
molar ratio
of 7:9:10 catalyst
conv
[%]
yieldb
[%]
1 1:0.8:0.8 5 mol % of Cu(OTf)2 45 27
2 1:0.8:0.8 5 mol % of Fe(acac)3 23 0
3 1:0.8:0.8 5 mol % of Cu(tfac)2 55 70
4 1:1.5:1.5 5 mol % of Cu(tfac)2 50 62
5 1:0.8:0.8 10 mol % of Cu(tfac)2 51 69
a Reaction conditions: olefin 7 (100 mg, 0.25 mmol), appropriate
amounts of 9, 10, catalyst, 4 Å MS (500 mg), anhydrous CH3CN (2 mL),
Ar, 13 h. b Isolated yield based on recycled precursor 7.
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these aziridines. Therefore, key intermediate (()-8a was allowed
to react with indole as C-nucleophile in the presence of different
acidic solid supports such as silica,34,6d alumina, and clay
(Montmorillonite K-10).35 Moreover, the reaction temperature
and the ratio of indole to (()-8a were varied (Table 2).
The results demonstrate that a high molar ratio of indole at
a moderate temperature of 70 °C (Table 2, entry 3) gave the
desired bisindole (()-11a in excellent yield (93%). In principle,
only a slight excess of indole is consumed and it can be recycled.
Since indole sublimes during the reaction, 10 equiv of indole
is used to ensure efficient conversion of the aziridine to our
product. All arylations proceeded with excellent regioselectivity
at the benzylic position of (()-8a and at the 3-position of the
attached indole. The best conditions were then tested with other
solid supports such as clay (Montmorillonite K-10) (Table 2,
entry 6) and alumina (Table 2, entry 7). These solid supports
exhibit significant disadvantages such as side product formation
or lower yields. For example, employing clay as the solid
support we observed both possible ring-opening products of the
aziridine by 1H NMR. In the case of neutral alumina the desired
product (()-11a was formed in lower yield. The 1H NMR
spectrum of the reaction mixture indicated also that deprotection
of both boc-groups under the employed reaction conditions on
clay or alumina was not complete. In contrast, the protecting
boc-groups could be easily removed under the reaction condi-
tions on activated silica. The isolation of the N,N-di-boc-
protected ring-opening product (()-12 in low yields at room
temperature (Table 2, entry 1) provides direct evidence that the
ring-opening reaction proceeds significantly faster than the
deprotection of the boc-protecting groups under mild conditions.
Moreover, the deprotection of the nitrogen atoms does not seem
to be required for the activation of the indole for the ring-
opening reaction. In a few attempts (Table 2, entries 1, 2, and
7), the ring-opening products with only one protecting group
were also observed (1H NMR) on the lactam moiety.
(34) Hudlicky, T.; Rinner, U.; Finn, K. J.; Ghiviriga, I. J. Org. Chem.
2005, 70, 3490-3499.
(35) Nadir, U. K.; Singh, A. Tetrahedron Lett. 2005, 46, 2083-2086.
TABLE 3. Ring-Opening Reactions of (()-8a with Various
Indolesa
a Reaction conditions: aziridine (()-8a (113 mg, 0.20 mmol), indole
derivative (2.00 mmol), activated silica (0.040-0.063 mm, 429 mg),
70 °C, Ar, overnight. b Isolated yield.
TABLE 2. Variation of Solid Support, Temperature, and Amount
of C-Nucleophile in the Ring-Opening Reaction of Aziridine (()-8a
with Indolea
entry solid support
temp
[°C]
ratio of
indole:(()-8a
yieldb
[%]
1 activated silica rt 10:1 0 (34)c
2 activated silica 40 10:1 75
3 activated silica 70 10:1 93
4 activated silica 70 3:1 81
5 activated silica 70 1:1 40
6 montmorillonite K-10 70 10:1 70
7 alumina (neutral) 70 10:1 21
a Reaction conditions: aziridine (()-8a (113 mg, 0.2 mmol), indole (234
mg, 2.00 mmol), 429 mg of solid support, Ar, 16 h. b Isolated yield of
product (()-11a. c Isolated yield of product (()-12.
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Next, we adopted the optimized protocol to the prepara-
tion of unsymmetrical bisindoles starting from aziridines (()-
8a-c. All reactions ran overnight at 70 °C and yielded the trans-
ring-opening product (see the crystal structure of (()-11f) in
good to excellent yields (Table 3).
Functional groups on the indole ring such as halides and
alkoxy and ester groups were tolerated under these mild reaction
conditions. However, under similar conditions the ring-opening
product with 5-nitro-indole was only obtained in poor (<20%)
yields. Using 5,6-dimethylindole we obtained an inseparable
70:30 mixture of two different regioisomers likely caused by
the electron-rich aromatic system of the substrate. The reaction
of (()-8a with indole (Table 3, entry 1) also can be performed
on gram-scale and provided the desired product in excellent
yield (95%). Employing the precursors (()-8b and (()-8c under
the same reaction conditions, compounds (()-13a-h (36-83%)
and (()-14a-i (47-92%) were obtained in moderate to good
yield.
To determine the structural influence of the aryl-sulfonamide
side chain in biological screenings, we also decided to prepare
the analogues (()-15a-l. For this purpose we tested the
hydroxyl-precursor (()-6 under similar reaction conditions.
Fortunately the desired bisindoles (()-15a-l were obtained in
moderate to good yields (Table 6). Direct benzylations with
alcoholic precursors were of significant interest for the prepara-
tion of diarylmethanes.36 Usually Lewis acid catalyst in
homogeneous solution is required for this reaction.37 To the best
of our knowledge this is the first direct benzylation of indoles
TABLE 4. Ring-Opening Reactions of (()-8b with Various
Indolesa
a Reaction conditions: aziridine (()-8b (111 mg, 0.20 mmol), indole
derivative (2.00 mmol), activated silica (0.040-0.063 mm, 429 mg),
70 °C, Ar, overnight. b Isolated yield.
TABLE 5. Ring-Opening Reactions of (()-8c with Various
Indolesa
a Reaction conditions: aziridine (()-8b (114 mg, 0.20 mmol), indole
derivative (2.00 mmol), activated silica (0.040-0.063 mm, 429 mg),
70 °C, Ar, overnight. b Isolated yield.
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with an alcohol precursor on solid support.22a The reaction of
alcohol (()-6 with C-nucleophiles on silica enables a convenient
access to this class of compounds. Compared with the method
employing olefin 7a and other heterocyclic C-nucleophiles under
strong acidic conditions (MsOH as solvent), our method is more
managable.20c
To demonstrate the versatility of the aziridines for further
diversification reactions, we examined aziridine (()-8a in
ring-opening reactions with H-, O-, and N-nucleophiles. First
(()-16a was prepared by reductive ring-opening reaction with
ammonium formate in the presence of palladium on charcoal.38
After deprotection with TFA, (()-16b was obtained in excel-
lent yield (73%, over two steps). This product can give
direct comparison information for the structural influence of
the indole group in products (()-11a-n. Direct deprotection
of crude (()-16a with TFA in CH2Cl2 gave (()-16b in sim-
ilar yield (68%) (Scheme 2).39 It should be noted that this
two-step aziridination-hydrogenation sequence offers a straight-
forward approach to novel sulfonylated tryptamine deriva-
tives, which may be of interest in various pharmaceutical
applications.
Next, we turned our interests to other nucleophiles such as
alcohols or amines. Initial experiments designed to react
aziridine (()-8a with n-octanol similar to the indole-ring-
opening reactions on silica led only to the decomposition of
the starting material. However, the reaction of alcohol (()-6
with n-octanol proceeded overnight with low conversion of
(()-6 on silica. After 15 h the desired substitution product
(()-17 was isolated in 15% yield (eq 2). Further we tried to
convert alcohol (()-6 on silica with tosylamide and various
amines. Unfortunately these reactions failed to produce any
conversion.
Next, aziridine (()-8a was successfully converted with
MeOH as an O-nucleophile by reaction with ceric ammonium
nitrate (CAN) (Scheme 3).40 Hence, (()-18a was synthesized
from (()-8a in MeOH with 10 mol % of CAN at room
temperature for 9 h in excellent yield (99%) based on recycled
aziridine (()-8a (52%). Further, the catalyst loading up to 40
mol % gave full conversion of (()-8a (TLC) and the subsequent
deprotection of (()-18a on silica at 70 °C yielded (()-18b in
good yield (74%).
In addition, we also explored the ring-opening reaction of
aziridine (()-8a in the presence of pyrazoles on activated silica.
To our delight, reactions employing our standard reaction
conditions (Table 2) yielded compounds (()-19a and (()-19b
in moderate yields (37% and 59%, eq 3).
TABLE 6. Formation of Bisindoles (()-15a-l from Alcohol (()-6a
a Reaction conditions: alcohol (()-6 (100 mg, 0.462 mmol), indole
derivative (4.62 mmol), activated silica (0.040-0.063 mm, 800 mg),
70 °C, overnight. b Isolated yield.
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Aziridine (()-8a could be opened smoothly with more
volatile secondary amines.41 To our surprise, (()-8a underwent
the direct amination reaction smoothly at 80 °C in homogeneous
solution without any catalyst or further activating reagent (e.g.,
organic base, etc.) to give also the in situ deprotected compounds
(()-20a-c (eq 4). Depending on the solubility of the products
during the recrystallization step, we obtained good to very good
yields (74-84).
X-ray Crystallographic Studies. Single crystals suitable for
X-ray diffraction analysis were obtained by slow evaporation
of methanol, ethyl acetate, diethyl ether, or dichlormethane
solutions. The molecular structures of 7, (()-8a, (()-8b, (()-
8c, (()-11f, and (()-15d confirmed our assignments (see the
Supporting Information). Among them, the crystal structure of
bisindole (()-11f has been reported by us previously.22a The
CdC double bond in olefin 7 exhibits a length of 1.323(2) Å.
Possibly with respect to the nonplanarity of the seven-membered
ring, the olefinic CdC bond puckered from the plane of the
indole moiety [torsion angle: 156.0(2)°]. The molecular struc-
tures of aziridines (()-8a-c showed that the angles between
the three-atom-ring plane of the aziridines and the indole plane
are almost in the same range for all aziridines [(()-8a: 57.7-
(2)°; (()-8b: 60.3(1)°; (()-8c: 61.4(1)°]. Also, the bond lengths
of the aziridine moieties of (()-8a-c showed the structural
similarities of these compounds: (a) C-C: (()-8a 1.471(4)
Å, (()-8b 1.473(2) Å, (()-8c 1.472(2) Å; (b) N-C: (()-8a
1.502(4) Å, (()-8b 1.501(2) Å, (()-8c 1.512(2) Å; (b) C-N:
(()-8a 1.490(4) Å, (()-8b 1.488(2) Å, (()-8c 1.493(2) Å. The
X-ray analysis of bisindole (()-11f gives direct evidence for
the trans configuration of the ring-opening product. The
comparison of bisindole (()-11f and its analogue (()-15d
without the tosyl-amide side chain showed significant differ-
ences in the angle between the two planes of the indole ring
systems [(()-11f: 83.37(6)°; (()-15d: 73.87(5)°] in the
crystal structures. However, in both cases the planes of the
indole systems are clearly out of the same plane from each
other.
Mechanistic Aspects. Inspired by the previous reports about
the concept of an aza-fulvenium ion as the intermediate in the
reaction mechanism,26a we became interested in the process of
the charge-stabilization of the cationic intermediate during the
bisindole formation from alcohol (()-6 and aziridines (()-
8a-c. It is well-known that the elimination of benzylic OH-
groups proceeds smoothly to afford olefins in the presence of
acids. Thus a carbocationic intermediate is formed in situ and
subsequent elimination of proton yields the corresponding olefin.
(36) (a) Iovel, I.; Mertins, K.; Kischel, J.; Zapf, A.; Beller, M. Angew.
Chem., Int. Ed. 2005, 44, 3913-3917. (b) Mertins, K.; Iovel, I.; Kischel,
J.; Zapf, A.; Beller, M. Angew. Chem., Int. Ed. 2005, 44, 238-242.
(37) (a) Brandt, S. D.; Freemanb, S.; McGagha, P.; Abdul-Halima, N.;
Alder, J. F. J. Pharm. Biomed. Anal. 2004, 36, 675-691. (b) Magesh, C.
J.; Nagarajan, R.; Karthik, M.; Perumal, P. T. Appl. Catal. A 2004, 266,
1-10. (c) El Gihani, M. T.; Heaney, H.; Shuhaibar, K. F. Synlett 1996,
871-872. (d) Crookes, D. L.; Parry, K. P.; Smith, G. F., Pol. J. Chem.
1979, 53, 73-78.
(38) Sayyed, I. A. Ph.D. Thesis, University of Pune, India, 2003.
(39) Davis, F. A.; Wu, Y.; Yan, H.; McCoull, W.; Prasad, K. R. J. Org.
Chem. 2003, 68, 2410-2419.
(40) Chandrasekhar, S.; Narsihmulu, Ch; Sultana, S. S. Tetrahedron Lett.
2002, 43, 7361-7363.
(41) Mao, J.; Wan, B.; Wang, R.; Wu, F.; Lu, S. J. Org. Chem. 2004,
69, 9123-9127.
SCHEME 2. Formation of Protected Sulfonamides (()-16a from (()-8a and Subsequent Deprotection to (()-16b
SCHEME 3. Synthesis of (()-18a and Subsequent Deprotection to (()-18b
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During initial 1H NMR experiments of alcohol (()-6 with
MsOH in CD2Cl2, only olefin 7a was observed immediately
after addition of a catalytic amount of MsOH to alcohol (()-6.
Further, the boc-protected olefin 7 did not react with indole on
silica to form the desired product (()-15a. Here, only olefin
7a was observed on TLC. In fact, olefin 7 can be deprotected
on activated silica at 70 °C overnight to yield the N,N-
deprotected olefin 7a in 98% yield. Attempts to produce
bisindole from 7a on silica or in MsOH with indole were
performed. However, no reaction was observed on silica and
no well-defined product could be isolated from the MsOH-
reaction system. This indicates that the generation of the active
cationic intermediate from 7a is significantly slower than that
from the hydroxyl precursor (()-6.
To understand the structure of the cationic intermediate (B),
we have carried out B3LYP/6-311G(d) density functional theory
calculations along with the alcohol (A) by using the Spartan
04 program package.42 As shown in Figure 2, the five-membered
ring in A has a pyrrole moiety and the exocyclic C2-C5 bond
length is 1.501 Å. In the cationic intermediate (B), however,
the C2-C5 and C1-N1 bond lengths become shorter (1.357
and 1.316 Å, respectively) and the C1-C2 bond length becomes
longer (1.453 Å). This change is due to the delocalization effect
with the formation of the butadiene moiety of N1-C1-C2-
C5. In addition to the changes of the bond lengths, it is also
interesting to compare the Mulliken charges between A and B.
Therefore it seems to be clear that the positive charge from a
theoretical perspective point of view has to be delocalized over
C1, C2, and C5 (the computed Mulliken chargessfor A: N1
) -0.701; C1 ) 0.156; C2 ) -0.021; C5 ) -0.030; for B:
N1 ) -0.632; C1 ) 0.242; C2 ) -0.018; C5 ) -0.094). This
stands in contrast to the known literature and established aza-
fulvenium ion.26a
On the basis of the DFT calculations and our observations
of the reactions of alcohol (()-6 with indoles on silica, we
believe the reaction proceeds through the attack of the indole
to the LUMO of the cationic diene species, which is stabilized
by delocalization of the positive charge on the N1-C1-C2-
C5 moiety (Scheme 4). It is also possible for the same charge
stabilization mechanism to proceed during the ring-opening and
subsequent aromatic substitution reactions of aziridines (()-
8a-c with indoles.
Conclusion
In summary, a practical and easy to handle protocol for the
synthesis of unsymmetrical bisindoles was developed. The
arylation reactions proceed in a highly regio- and stereoselctive
manner at the benzylic position of the azepino[3,4-b]indol-
1(10H)-one moiety and at the 3-position of the attached indole
on a solid support. The solvent-free synthetic protocol is easily
manageable and yields the desired bisindoles from the aziridines
or alcohols. In addition, boc-protecting groups can be removed
in situ smoothly. The versatility of these aziridines was
demonstrated with H-, O-, and N-nucleophiles in a diversity
oriented synthesis to build up a small compound library. X-ray
analysis confirmed the molecular structures of important key
intermediates and library compounds. Specifically, the molecular
structure of (()-11f gives direct evidence for the trans-ring-
opening reaction. In addition, DFT calculations indicate that
the mechanism might proceed via a charge stabilized azabuta-
diene motif, which reacts further exclusively at the benzylic
position to rebuild the aromatic ring system.
Experimental Section
5-Hydroxy-2,3,4,5-tetrahydroazepino[3,4-b]indol-1(10H)-
one ((()-6). Ketone 5 (3.31 g, 15.5 mmol) was suspended in
degassed absolute ethanol (250 mL) under argon.43 Then freshly
ground NaBH4 (2.92 g, 77.3 mmol) was added and the reaction
mixture was stirred at ambient temperature overnight (∼14 h). The
mixture was filtered over celite and washed with acetone. After
removal of the solvent under reduced pressure, purification by
column chromatography (silica gel 70-230 mesh, CH2Cl2 to
CH2Cl2:MeOH 100:7 as a gradient eluent) yielded an off-white solid
(3.30 g, 99%). Rf 0.40 (CH2Cl2:MeOH:NEt3 100:10:1). Mp 167-
169 °C (ethyl acetate). 1H NMR (300 MHz, DMSO-d6) δ (ppm)
11.29 (1H, br s), 8.15 (1H, dd, J ) 6.0, 3.2 Hz), 7.78 (1H, d, J )
7.9 Hz), 7.41 (1H, d, J ) 8.1 Hz), 7.19 (1H, ddd, J ) 8.1, 7.0, 1.1
(42) SPARTAN’04: Copyright 1991-2005 by Wavefunction Inc.; ww-
w.wavefun.com.
(43) For the synthesis of the precursors, please see the Supporting
Information.
FIGURE 2. Calculated molecular structures of alcohol (()-6 (A) and
the cationic intermediate (B).
SCHEME 4. Proposed Mechanism for the Synthesis of
Unsymmetrical Bisindoles from Alcohol (()-6
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Hz), 7.04 (1H, ddd, J ) 8.1, 7.0, 1.0 Hz), 5.23 (1H, d, J ) 6.6
Hz), 5.18-5.10 (1H, m), 3.59-3.45 (1H, m), 3.22-3.08 (1H, m),
2.22-2.10 (1H, m), 2.07-1.93 (1H, m). 13C NMR (75 MHz,
DMSO-d6) δ (ppm) 163.7, 135.8, 127.7, 126.8, 123.9, 121.5, 119.5,
119.1, 112.1, 63.5, 36.5, 35.5. IR (KBr) ν (cm-1) 3520 m, 3281 s,
3211 sh, 3051 m, 2952 m, 2917 m, 2861 sh, 1647 s, 1550 s, 1478
s, 1456 m, 1412 m, 1362 m, 1334 s, 1297 m, 1239 w, 1185 w,
1160 w, 1144 w, 1063 w, 1047 m, 1003 m, 958 m, 924 w, 881 m,
792 m, 740 s, 680 m, 606 w, 539 w, 465 w, 435 w. MS (EI) m/z
(rel. intensity) 217 (13), 216 (72), 200 (13), 199 (36), 198 (100),
197 (50), 189 (13), 186 (11), 172 (10), 171 (25), 170 (37), 169
(50), 168 (13), 159 (35), 158 (17), 155 (14), 154 (15), 149 (14),
145 (16), 144 (30), 143 (29), 142 (12), 141 (11), 140 (15), 130
(12), 129 (12), 128 (10), 117 (13), 116 (17), 114 (11), 89 (17), 83
(11), 78 (13), 77 (18), 71 (14), 69 (12), 63 (19), 57 (22), 55 (16),
44 (46), 43 (14), 41 (17). HRMS (ESI) calcd for C12H12N2O2Na
(M + Na+) 239.0791, found 239.0803. Anal. Calcd for
C12H12N2O2: C, 66.65; H, 5.59; N, 12.96. Found: C, 66.59; H,
5.33; N, 12.90.
(Z)-Di-tert-butyl 1-Oxoazepino[3,4-b]indole-2,10(1H,3H)-di-
carboxylate (7). To a solution of alcohol (()-6 (3.30 g, 15.3 mmol)
in CH2Cl2 (500 mL) was added methanesulfonic acid (0.730 g, 7.63
mmol) dropwise. The solution was stirred at room temperature for
∼40 min. After the full conversion of (()-6 as indicated by TLC
analysis, 4-dimethylaminopyridine (4.47 g, 36.6 mmol) and di-tert-
butyl dicarbonate (6.97 g, 30.5 mmol) were added. The reaction
was monitored by TLC (CH2Cl2:MeOH:NEt3 100:10:1) and portions
of di-tert-butyl dicarbonate (3 × 2.30 g, 3 × 10.2 mmol) were
added further to complete the reaction. The solvent was removed
in vacuo and the residual brown reaction mixture was purified via
column chromatography (silica gel 70-230 mesh, n-hexane:ethyl
acetate 6:1, packed with 1% NEt3) to yield a white solid (5.19 g,
85%). Crystals suitable for X-ray diffraction analysis were obtained
by slow evaporation of a solution of diethyl ether at room
temperature. Rf 0.23 (n-hexane:ethyl acetate 6:1). Mp 127-128 °C
(Et2O). 1H NMR (300 MHz, CDCl3) δ (ppm) 8.11 (1H, d, J ) 8.5
Hz), 7.67 (1H, d, J ) 7.9 Hz), 7.48 (1H, ddd, J ) 8.4, 7.2, 1.3
Hz), 7.31 (1H, ddd, J ) 8.1, 7.2, 0.9 Hz), 7.19 (1H, d, J ) 9.6
Hz), 6.57 (1H, dt, J ) 9.7, 6.5 Hz), 4.29 (2H, br s), 1.64 (9H, s),
1.55 (9H, s). 13C NMR (75 MHz, CDCl3) δ (ppm) 159.3, 151.4,
149.5, 138.3, 132.1, 131.2, 128.0, 125.9, 125.5, 123.8, 123.4, 120.4,
114.8, 84.8, 83.5, 43.6, 28.2, 27.9. IR (KBr) ν (cm-1) 3438 w,
3053 w, 2983 m, 2940 w, 1764 s, 1730 s, 1691 sh, 1670 w, 1532
w, 1448 m, 1418 m, 1373 s, 1339 s, 1326 s, 1278 m, 1264 m,
1229 s, 1141 s, 1118 s, 1027 m, 1016 m, 1011 m, 976 m, 951 w,
895 w, 862 m, 834 m, 805 m, 780 m, 767 m, 747 s, 695 w, 674 w,
607 w, 588 w, 511 w, 470 w, 442 w. MS (EI) m/z (rel. intensity)
398 (2), 242 (7), 199 (11), 198 (100), 197 (33), 170 (6), 169 (20),
157 (6), 56 (7), 44 (21), 41 (13). HRMS (ESI+) calcd for
C22H26N2O5Na (M + Na+) 421.1734, found 421.1735.
(Z)-2,3-Dihydroazepino[3,4-b]indol-1(10H)-one (7a). Olefin 7
(600 mg, 1.51 mmol) was dissolved in CH2Cl2 and activated silica
(1.0 g, 0.040-0.063 mm) was added. After removal of the solvent
the mixture was heated at 70 °C for 16 h. Purification by column
chromatography (silica gel 70-230 mesh, n-hexane:ethyl acetate
1:1 to ethyl acetate as the gradient eluent) yielded a white solid
(293 mg, yield: 98%). Rf 0.44 (ethyl acetate). Mp 198 °C (n-hexane:
ethyl acetate). 1H NMR (300 MHz, DMSO-d6) δ (ppm) 11.86 (1H,
br s), 7.91 (1H, unresolved dd), 7.76 (1H, d, J ) 8.1 Hz), 7.45
(1H, unresolved ddd), 7.28 (1H, ddd, J ) 8.1, 7.0, 1.1 Hz), 7.15
(1H, d, J ) 10.0 Hz), 7.12 (1H, ddd, J ) 7.9, 7.0, 0.9 Hz), 6.04
(1H, dt, J ) 9.9, 6.5 Hz), 3.53 (2H, unresolved dd). 13C NMR (75
MHz, DMSO-d6) δ (ppm) 163.9, 136.1, 130.6, 125.3, 125.2, 124.5,
124.0, 120.0, 119.9, 116.0, 112.3, 38.4. IR (KBr) ν (cm-1) 3209 s,
3060 sh, 2984 sh, 2924 sh, 1911 w, 1627 s, 1574 sh, 1525 s, 1500
m, 1478 s, 1438 m, 1419 m, 1394 m, 1333 s, 1301 m, 1271 m,
1246 w, 1233 w, 1156 m, 1114 w, 1071 w, 1021 w, 1007 w, 932
w, 904 m, 854 w, 810 m, 775 m, 758 s, 675 m, 620 w, 596 m, 586
w, 564 w, 515 m, 436 m, 423 m. MS (EI) m/z (rel. intensity) 199
(20), 198 (100), 170 (20), 169 (77), 168 (12), 155 (16), 154 (16),
140 (11), 115 (24), 86 (30), 84 (50), 83 (13), 71(12), 70 (11), 69
(14), 63 (11), 57 (21), 55 (18), 51 (18), 49 (62), 43 (19), 41 (18).
HRMS (EI) calcd for C12H10N2O (M+) 198.0788, found 198.0782.
Aziridiniation of (Z)-Di-tert-butyl 1-Oxoazepino[3,4-b]indole-
2,10(1H,3H)-dicarboxylate (7) with Chloramine-T, Synthesis of
(()-8a. Olefin 7 (3.10 g, 7.78 mmol) was dissolved under argon
in anhydrous acetonitrile (200 mL), then PhNMe3Br3 (146 mg,
0.390 mmol) and chloramine-T × 3H2O (1.10 g, 3.89 mmol) were
added. The mixture was stirred for 13 h and was quenched with
saturated Na2SO3(aq) (200 mL). After extraction with ethyl acetate
(3 × 200 mL), the combined organic layers were dried over MgSO4
and filtered, and the solvent was removed under reduced pressure.
The crude orange solid product was purified by column chroma-
tography (silica gel 70-230 mesh, n-hexane to n-hexane:ethyl
acetate 5:1 as the gradient eluent) to yield a white solid product
(1.74 g, 78%) and a pure fraction of starting material 7 (1.19 g,
38%). The product was recrystallized from ethyl acetate:n-heptane
(1:4) at 4 °C. Crystals suitable for X-ray diffraction analysis were
obtained by slow evaporation of a solution of ethyl acetate at room
temperature. Mp 169-170 °C (ethyl acetate). Rf 0.24 (n-hexane:
ethyl acetate 4:1). 1H NMR (300 MHz, CDCl3) δ (ppm) 8.03 (1H,
d, J ) 8.5 Hz), 7.89 (2H, d, J ) 8.3 Hz), 7.44-7.34 (3H, m),
7.17-6.95 (2H, m), 4.60 (1H, br s), 3.92 (1H, d, J ) 6.9 Hz),
3.81-3.72 (1H, m), 3.60 (1H, br s), 2.49 (3H, s), 1.59 (9H, s),
1.56 (9H, s). 13C NMR (75 MHz, CDCl3) δ (ppm) 159.9, 151.8,
148.9, 145.4, 137.9, 134.6, 130.3, 130.1, 128.5, 127.8, 126.9, 123.7,
120.2, 117.1, 114.8, 85.3, 84.5, 35.6, 28.2, 27.7, 21.9. 1H NMR
(300 MHz, 323 K, CDCl3) δ (ppm) 8.04 (1H, ddd, J ) 8.6, 1.0,
0.7 Hz), 7.89 (2H, unresolved ddd), 7.37 (1H, ddd, J ) 8.5, 6.7,
1.8 Hz), 7.21-7.12 (2H, m), 4.60-4.47 (1H, m), 3.95 (1H, d, J )
6.8 Hz), 3.76 (1H, ddd, J ) 9.0, 7.0, 4.5 Hz), 3.72-3.58 (1H, m),
2.48 (3H, s), 1.59 (9H, s), 1.57 (9H, s). 13C NMR (75 MHz, 323
K, CDCl3) δ (ppm) 159.8, 152.1, 149.0, 145.3, 138.1, 135.2, 130.5,
130.1, 128.5, 127.8, 127.1, 123.7, 120.4, 117.2, 114.8, 85.3, 84.5,
45.7 (br s), 41.9 (br s), 35.8, 28.3, 27.8, 21.8. IR (KBr) ν (cm-1)
3428 w, 2977 w, 2934 w, 1745 s, 1723 s, 1701 s, 1596 w, 1556 w,
1477 w, 1447 m, 1396 m, 1369 s, 1323 s, 1289 s, 1260 m, 1225
m, 1207 m, 1160 s, 1124 m, 1111 m, 1091 m, 1018 w, 999 w, 974
w, 951 w, 876 w, 864 w, 829 w, 811 w, 768 w, 741 m, 706 w, 679
m, 659 w, 590 w, 567 m, 548 m, 509 w. MS (EI) m/z (rel. intensity)
567 (3), 511 (2), 367 (4), 356 (7), 300 (21), 256 (24), 212 (53),
181 (26), 155 (11), 131 (31), 91 (18), 59 (56), 57 (47), 56 (100),
55 (36), 53 (12), 51 (13), 49 (13). HRMS (ESI) calcd for
C29H33N3O7SNa (M + Na+) 590.1931, found 590.1937. HPLC
(column: Reprosil 100 Chiral-NR 8 μm, solvent: n-hexane:ethanol
97:7, flow ) 0.8 mL/min) tR ) 63.37, 70.22 min. Anal. Calcd for
C29H33N3O7S: C, 61.36; H, 5.86; N, 7.40; S, 5.65. Found: C, 61.16;
H, 5.57; N, 7.16; S, 5.68.
Aziridiniation of (Z)-Di-tert-butyl 1-Oxoazepino[3,4-b]indole-
2,10(1H,3H)-dicarboxylate (7) with Chloramine-B, Synthesis of
(()-8b. Olefin 7 (1.51 g, 3.78 mmol) was dissolved under argon
in anhydrous acetonitrile (200 mL), then PhNMe3Br3 (71 mg, 0.189
mmol) and chloramine-B × 3 H2O (405 mg, 1.89 mmol) were
added. The mixture was stirred for 13 h and was quenched with
saturated Na2SO3(aq) (200 mL). After extraction with ethyl acetate
(3 × 200 mL), the combined organic layers were dried over MgSO4
and filtered, and the solvent was removed under reduced pressure.
The crude orange product was purified by column chromatography
(silica gel 70-230 mesh, n-hexane to n-hexane:ethyl acetate (8:1)
as the gradient eluent) to yield a white solid product and the starting
material (0.81 g). The product was recrystallized from CH2Cl2:n-
hexane to yield a white solid product (0.57 g, 54%). Crystals
suitable for X-ray diffraction analysis were obtained by slow
evaporation of a solution of ethyl acetate at room temperature. Rf
0.24 (n-hexane:ethyl acetate 6:1). Mp 203 °C (CH2Cl2:ethyl acetate).
1H NMR (400 MHz, CDCl3) δ (ppm) 8.05-7.99 (3H, m), 7.71
(1H, unresolved dd), 7.59 (2H, unresolved dd), 7.40 (1H, unresolved
ddd), 7.13 (1H, unresolved dd), 7.06 (1H, s), 4.60 (1H, s), 3.96
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(1H, d, J ) 6.6 Hz), 3.85-3.74 (1H, m), 3.61 (1H, s), 1.59 (9H,
s), 1.56 (9H, s). 13C NMR (100 MHz, CDCl3) δ (ppm) 159.8, 151.8,
148.9, 137.9, 137.7, 134.2, 130.3, 129.5, 128.4, 127.8, 126.9, 123.8,
120.1, 116.9, 114.8, 85.3, 84.5, 35.8, 28.2, 27.8. 1H NMR (400
MHz, 323 K, CDCl3) δ (ppm) 8.03 (3H, m), 7.69 (1H, unresolved
dddd), 7.57 (1H, unresolved dddd), 7.40 (1H, ddd, J ) 8.4, 6.7,
1.7 Hz), 7.21-7.12 (2H, m), 4.54 (1H, d, J ) 12.5 Hz), 3.90 (1H,
d, J ) 6.8 Hz), 3.83-3.76 (1H, m), 3.74-3.57 (1H, m), 1.59 (9H,
s), 1.57 (9H, s). 13C NMR (100 MHz, 323 K, CDCl3) δ (ppm)
159.8, 152.1, 149.0, 138.3, 138.1, 134.1, 130.5, 129.5, 128.4, 127.8,
127.1, 123.8, 120.3, 117.0, 114.9, 85.3, 84.5, 45.6, 42.0, 36.0, 28.3,
27.8. IR (KBr) ν (cm-1) 3423 w, 3119 w, 3070 w, 2981 m, 2932
w, 1751 s, 1720 s, 1696 s, 1607 w, 1556 w, 1474 sh, 1448 m,
1428 sh, 1395 m, 1369 s, 1338 s, 1322 s, 1290 s, 1261 s, 1222 s,
1208 s, 1170 s, 1150 s, 1125 m, 1091 s, 1020 m, 1002 m, 976 m,
954 m, 895 w, 879 m, 857 m, 811 m, 773 m, 754 m, 744 s, 726 m,
692 w, 670 w, 639 w, 594 m, 555 m, 504 w, 486 w, 442 w. MS
(EI) m/z (rel. intensity) 553 (1), 353 (18), 356 (36), 213 (81), 212
(100), 199 (10), 198 (75), 197 (25), 185 (63), 184 (60), 183 (60),
169 (31), 168 (13), 167 (17), 157 (16), 156 (26), 155 (43), 142
(11), 130 (13), 129 (22), 128 (25), 127 (15), 126 (10), 101 (14), 78
(42), 77 (63), 64 (11), 57 (68), 56 (87), 55 (43), 53 (11), 51 (29),
50 (18), 44 (69), 41 (85), 40 (16), 39 (76). HRMS (EI) calcd for
C28H31N3O7S (M+) 553.1877, found 553.1877. Anal. Calcd for
C28H31N3O7S: C, 60.74; H, 5.64; N, 7.59; S, 5.79. Found: C, 60.53;
H, 5.93; N, 7.56; S, 6.02.
Copper-Catalyzed Aziridiniation of (Z)-Di-tert-butyl 1-Oxoaze-
pino[3,4-b]indole-2,10(1H,3H)-dicarboxylate, Synthesis of (()-
8c.33 Olefin 7 (4.00 g, 10.0 mmol), PhI(OAc)2 (2.58 g, 8 mmol),
5-methylpyridine-2-sulfonamide (1.38 g, 8.00 mmol), copper(II)
trifluoroacetylacetonate [Cu(tfac)2] (148 mg, 0.40 mmol), and
activated 4 Å molecular sieve (20 g) were suspended under argon
in anhydrous acetonitrile (80 mL). The mixture was stirred for 13
h. It was then diluted with ethyl acetate (400 mL) and washed with
water (400 mL). The aqueous layer was further extracted with ethyl
acetate (3 × 10 mL). The combined organic layers were dried over
MgSO4 and filtered, and the solvent was removed under reduced
pressure. The crude solid product was purified by column chro-
matography (silica gel 70-230 mesh, n-hexane to n-hexane:ethyl
acetate 4:1 as the gradient eluent) to yield a white solid product
(2.44 g, 76%) and a pure fraction of starting material 7 (1.74 g,
43%). The product was recrystallized from diethyl ether:n-hexane.
Crystals suitable for X-ray diffraction analysis were obtained by
slow evaporation of a solution of CH2Cl2 at ambient temperature.
Rf 0.06 (n-hexane:ethyl acetate 4:1). Mp 149-150 °C (Et2O:n-
hexane). 1H NMR (300 MHz, CDCl3) δ (ppm) 8.57 (1H, s), 8.01
(1H, d, J ) 8.5 Hz), 7.99 (1H, d, J ) 8.0 Hz), 7.71 (1H, dd, J )
8.0, 1.7 Hz), 7.67 (1H, d, J ) 8.0 Hz), 7.39-7.44 (1H, m), 7.22-
7.27 (1H, m), 4.60 (1H, br s), 4.21 (1H, d, J ) 7.0 Hz), 3.93 (1H,
ddd, J ) 8.9, 7.0, 4.7 Hz), 3.63 (1H, br s), 2.44 (3H, s), 1.57 (9H,
s), 1.53 (9H, s). 13C NMR (75 MHz, CDCl3, 323 K) δ (ppm) 159.7,
153.4, 151.8, 150.8, 148.8, 138.5, 138.2, 138.0, 130.4, 127.7, 127.0,
123.6, 122.8, 120.7 117.2, 114.6, 85.1, 84.2, 45.4, 42.2, 35.8, 28.1,
27.7, 18.5. IR (KBr) ν (cm-1) 3443 s, 2981 s, 2934 m, 1770 sh,
1749 s, 1721 s, 1635 w, 1558 w, 1447 s, 1394 m, 1370 s, 1315 s,
1292 sh, 1259 s, 1227 s, 1156 s, 1104 s, 1083 s, 1024 m, 1000 m,
975 m, 952 m, 850 m, 832 m, 810 w, 767 m, 751 m, 744 m, 693
m, 679 w, 659 w, 638 w, 589 w, 569 m, 562 m, 549 m, 524 w,
495 w, 469 w, 425 w. HRMS (ESI) calcd for C28H33N4O7S+ (M +
H+) m/z 569.2064, found 569.2072 and calcd for C28H32N4O7SNa
(M+Na+) m/z 591.1884, found 591.1897. Anal. Calcd for
C28H32N4O7S: C, 59.14; H, 5.67; N, 9.85; S, 5.64. Found: C, 58.93;
H, 5.46; N, 9.54; S, 5.80.
General Procedure for the Ring-Opening Reaction of Aziri-
dines with Indoles (General Procedure A). Aziridine (()-8a-c
(0.2 mmol) and an indole derivative (2 mmol) were dissolved in
an appropriate solvent (e.g., CH2Cl2, acetone or ethyl acetate) and
activated silica (429 mg, 0.040-0.063 mm) was added. The solvent
was removed under reduced pressure and the solid mixture was
heated under argon at 70 °C overnight (∼12-16 h). Purification
by column chromatography (silica gel 70-230 mesh, CH2Cl2 to
CH2Cl2:MeOH 10:1 as the gradient eluent) yielded the crude
product. It was then washed or recrystallized as described below
and in the Supporting Information.
N-(5-(1H-Indol-3-yl)-1-oxo-1,2,3,4,5,10-hexahydroazepino[3,4-
b]indol-4-yl)tosylamide ((()-11a). A crude product was obtained
following general procedure A. It was dissolved in CH2Cl2;
n-hexane was added dropwise until some precipitate was formed.
Then the solution was cooled to 4 °C and finally filtered to yield
a white solid product (90 mg, 93%). Rf 0.12 (CH2Cl2:MeOH 20:
1). Mp 145-146 °C (CH2Cl2:n-hexane, dec). 1H NMR (300 MHz,
DMSO-d6) δ (ppm) 11.34 (1H, br s), 10.73 (1H, br s), 8.06-7.96
(2H, m), 7.61 (2H, d, J ) 8.1 Hz), 7.38 (1H, d, J ) 8.1 Hz), 7.27-
7.20 (3H, m), 7.08 (1H, unresolved ddd), 7.04-6.96 (1H, m), 6.92
(1H, d, J ) 8.1 Hz), 6.80-6.71 (3H, m), 4.69 (1H, d, J ) 4.3 Hz),
3.64-3.56 (1H, m), 3.51-3.47 (1H, m), 3.19-3.06 (1H, m), 2.37
(3H, s). 13C NMR (75 MHz, DMSO-d6) δ (ppm) 164.0, 142.4,
137.6, 136.3, 136.2, 129.4, 127.5, 126.6, 125.1, 124.7, 123.7, 120.9,
120.6, 118.7, 118.4, 117.5, 117.4, 116.8, 115.4, 112.1, 111.7, 54.6,
41.6, 25.0, 21.1. IR (KBr) ν (cm-1) 3361 s, 3057 m, 2923 m, 2863
m, 1926 w, 1644 s, 1547 m, 1481 s, 1455 s, 1338 s, 1291 m, 1244
w, 1222 w, 1185 w, 1158 s, 1088 s, 1006 w, 989 w, 943 w, 883 w,
814 m, 744 s, 661 m, 578 m, 552 m, 531 m, 428 w. MS (CI) m/z
(rel. intensity) 485 (12), 484 (39), 329 (35), 314 (19), 313 (100),
312 (21), 301 (15), 300 (82), 272 (19), 271 (29), 270 (11), 243
(24), 242 (15), 216 (12), 212 (20), 185 (20), 145 (86), 91 (15).
HRMS (ESI) calcd for C27H25N4O3S (M + H+) 485.1642, found
485.1639.
N-(5-(1H-Indol-3-yl)-1-oxo-1,2,3,4,5,10-hexahydroazepino[3,4-
b]indol-4-yl)benzenesulfonamide ((()-13a). A crude product was
obtained following general procedure A. It was recrystallized from
CH2Cl2 to yield a white solid product (61 mg, 66%). Rf 0.37
(CH2Cl2:MeOH 10:1) mp 189 °C (CH2Cl2). 1H NMR (300 MHz,
DMSO-d6) δ (ppm) 11.33 (1H, br s), 10.73 (1H, d, J ) 2.2 Hz),
8.10 (1H, d, J ) 5.9 Hz), 7.98 (1H, dd, J ) 6.3, 3.2 Hz), 7.80-
7.74 (2H, m), 7.60 (1H, unresolved dddd), 7.52-7.42 (2H, m), 7.39
(1H, d, J ) 8.3 Hz), 7.25 (1H, d, J ) 8.1 Hz), 7.09 (1H, unresolved
ddd), 7.04-6.97 (1H, m), 6.91 (1H, d, J ) 8.1 Hz), 6.83-6.78
(2H, m), 6.75 (1H, unresolved ddd), 6.62 (1H, d, J ) 2.2 Hz),
4.71 (1H, d, J ) 4.2 Hz), 3.65 (1H, dd, J ) 10.8, 6.1 Hz). 13C
NMR (75 MHz, DMSO-d6) δ (ppm) 164.0, 140.7, 136.3, 126.2,
132.3, 129.0, 127.6, 127.5, 126.5, 125.1, 124.7, 123.7, 121.0, 120.6,
118.7, 118.5, 117.4, 117.0, 115.3, 112.1, 111.7, 54.9, 54.4, 41.3.
IR (KBr) ν (cm-1) 3411 s, 3313 s, 3063 m, 2874 m, 1640 s, 1550
m, 1480 s, 1454 m, 1419 m, 1338 s, 1294 sh, 1265 sh, 1245 m,
1220 m, 1161 s, 1088 s, 1011 w, 989 w, 950 m, 879 w, 812 w,
739 s, 688 s, 585 s, 528 m, 488 m, 451 m, 426 m. MS (EI) m/z
(rel. intensity) 470 (22), 329 (23), 314 (11), 313 (49), 312 (13),
301 (11), 300 (51), 272 (14), 271 (24), 270 (11), 243 (28), 242
(17), 216 (18), 212 (17), 207 (13), 185 (19), 145 (91), 77 (22), 69
(12), 45 (11), 44 (100), 43 (21), 41 (10). HRMS (EI) calcd for
C26H22N4O3S (M+) 470.1407, found 470.1407.
N-(5-(1H-Indol-3-yl)-1-oxo-1,2,3,4,5,10-hexahydroazepino[3,4-
b]indol-4-yl)-5-methylpyridine-2-sulfonamide ((()-14a). A crude
product was obtained following general procedure A. It was washed
with diethyl ether and finally filtered to yield a white solid product
(89 mg, 92%). Rf 0.17 (CH2Cl2:MeOH 100:5). mp >300 °C (Et2O).
1H NMR (300 MHz, DMSO-d6) δ (ppm) 11.28 (1H, s), 10.67 (1H,
d, J ) 2.0 Hz), 8.25 (1H, br s), 8.02-8.06 (2H, m), 7.61 (2H, m),
7.34 (1H, d, J ) 8.2 Hz), 7.22 (1H, d, J ) 8.1 Hz), 7.17 (1H, d,
J ) 7.9 Hz), 6.96-7.08 (3H, m), 6.81-6.85 (1H, m), 6.71-6.76
(2H, m), 4.82 (1H, d, J ) 5.3 Hz), 4.03 (1H, dd, J ) 12.9, 6.6
Hz), 3.49 (1H, dd, J ) 14.0, 3.9 Hz), 3.17-3.26 (1H, m), 2.30
(3H, s). 13C NMR (75 MHz, DMSO-d6) δ (ppm) 164.3, 155.3,
149.9, 138.1, 136.8, 136.5, 136.4, 127.7, 127.5, 125.4, 124.8, 123.8,
121.0, 120.9, 120.8, 118.8, 118.5, 118.1, 116.9, 115.8, 112.2, 111.8,
55.8, 42.9, 40.1, 18.2. IR (KBr) ν (cm-1) 3411 s, 3359 s, 3191 sh,
3083 sh, 2871 m, 1930 w, 1648 s, 1556 m 1485 s, 1456 s, 1340 s,
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1307 s, 1247 w, 1223 m, 1202 w, 1163 s, 1131 w, 1109 m, 1094
s, 1051 w, 1028 w, 1003 m, 993 m, 960 m, 881 w, 835 w, 807 w,
747 s, 663 s, 636 m, 612 m, 575 m, 554 s, 530 m, 501 w, 427 w.
HRMS (CI) calcd for C26H22N5O3S (M-) 484.1449, found 484.1437.
General Procedure for the Reaction of 5-Hydroxy-2,3,4,5-
tetrahydroazepino[3,4-b]indol-1(10H)-one ((()-6) with Indoles
(General Procedure B). Alcohol (()-6 (100 mg, 0.462 mmol) and
an indole derivative (4.62 mmol) were dissolved in the heat with
an appropriate solvent (acetone or dichloromethane and ethyl
acetate) and activated silica (800 mg, 0.040-0.063 mm) was added.
The solvent was removed under reduced pressure and the mixture
was heated to 70 °C overnight (∼12-16 h). Purification by column
chromatography (silica gel 70-230 mesh, CH2Cl2 to CH2Cl2:MeOH
20:1 as the gradient eluent) yielded the crude product. It was then
washed or recrystallized as described below and in the Supporting
Information.
5-(1H-Indol-3-yl)-2,3,4,5-tetrahydroazepino[3,4-b]indol-1(10H)-
one ((()-15a). A crude product was obtained following general
procedure B. After recrystallization from hot MeOH a white solid
(133 mg, yield: 91%) was obtained at 4 °C. Rf 0.23 (CH2Cl2:MeOH
20:1). Mp 271 °C (MeOH, dec). 1H NMR (300 MHz, DMSO-d6)
δ (ppm) 11.24 (1H, br s), 10.76 (1H, d, J ) 1.9 Hz), 8.11 (1H, dd,
J ) 5.7, 4.0 Hz), 7.52 (1H, d, J ) 7.7 Hz), 7.38 (1H, d, J ) 8.1
Hz), 7.32 (1H, d, J ) 8.1 Hz), 7.12-7.01 (3H, m), 6.94 (1H,
unresolved ddd), 6.79-6.70 (2H, m), 4.95 (1H, dd, J ) 5.3, 5.1
Hz), 3.36-3.25 (1H, m), 3.22-3.08 (1H, m), 2.34-2.23 (2H, m).
13C NMR (75 MHz, DMSO-d6) δ (ppm) 164.1, 136.4, 136.0, 127.8,
127.4, 125.8, 123.8, 123.6, 121.0, 120.9, 119.3, 119.0, 118.6, 118.3,
118.3, 112.1, 111.6, 37.7, 34.8, 33.4. IR (KBr) ν (cm-1) 3351 s,
3306 s, 3055 m, 2951 m, 2930 m, 2865 m, 1895 w, 1780 w, 1623
s, 1575 m, 1542 s, 1482 s, 1455 m, 1447 m, 1420 m, 1402 m,
1369 m, 1335 s, 1310 m, 1293 m, 1246 m, 1223 m, 1190 w, 1158
m, 1112 w, 1095 m, 1054 m, 1039 w, 1010 m, 991 w, 973 w, 946
w, 913 w, 880 w, 819 w, 776 m, 765 sh, 752 s, 745 s, 713 m, 678
m, 653 m, 631 w, 605 m, 585 m, 528 w, 505 m, 473 w, 446 w,
424 w, 408 w. MS (EI) m/z (rel. intensity) 316 (21), 315 (100),
298 (39), 297 (12), 286 (22), 285 (30), 272 (15), 271 (20), 269
(13), 258 (23), 257 (35), 256 (15), 243 (12), 198 (45), 128 (10), 44
(13). HRMS (EI) calcd for C20H17N3O (M+) 315.1366, found
315.1366.
Di-tert-butyl 4-(4-Methylphenylsulfonamido)-1-oxo-4,5-dihy-
droazepino[3,4-b]indole-2,10(1H, 3H)-dicarboxylate ((()-16a).
Aziridine (()-8a (200 mg, 0.352 mmol) and ammonium formate
(33 mg, 0.528 mmol) were dissolved in absolute MeOH (10 mL).
After addition of Pd/C (10 mg, 5%(w/w)) the reaction was heated
to reflux for 1.5 h. After cooling to room temperature the reaction
mixture was filtered and the solvent was removed in vacuo.
Purification by column chromatography (silica gel 70-230 mesh,
n-hexane:ethyl acetate 6:1) yielded an off-white solid (155 mg,
76%). Rf 0.58 (n-hexane:ethyl acetate 1:1). mp 71 °C (ethyl acetate:
n-hexane). 1H NMR (400 MHz, DMSO-d6) δ (ppm) 7.97 (1H, d,
J ) 8.6 Hz), 7.84 (1H, d, J ) 7.1 Hz), 7.73 (1H, d, J ) 8.3 Hz),
7.51 (1H, unresolved ddd), 7.50-7.44 (3H, m), 7.33 (1H, unre-
solved ddd), 4.00-3.84 (2H, m), 3.54 (1H, dd, J ) 14.7, 8.3 Hz),
2.99 (1H, dd, J ) 15.7, 3.2 Hz), 2.88 (1H, dd, J ) 15.7, 6.6 Hz),
2.44 (3H, s), 1.53 (9H, s), 1.45 (9H, s). 13C NMR (100 MHz,
DMSO-d6) δ (ppm) 161.1, 150.6, 148.5, 143.0, 138.4, 137.4, 130.2,
129.8, 127.8, 127.4, 126.5, 123.3, 123.1, 120.8, 114.0, 84.4, 82.6,
52.3, 47.8, 27.5, 27.2, 26.0, 21.0. IR (KBr) ν (cm-1) 3439 m, 3267
sh, 2978 m, 2927 m, 2856 sh, 1742 s, 1599 w, 1553 w, 1450 m,
1415 m, 1395 m, 1370 s, 1326 m, 1236 m, 1158 s, 1122 sh, 1092
m, 1064 m, 1022 w, 992 m, 956 w, 893 w, 852 w, 816 w, 764 m,
750 m, 707 w, 664 m, 590 w, 552 w, 524 w. MS (EI) m/z (rel.
intensity) 569 (1), 383 (9), 369 (7)339 (12), 275 (6), 199 (14), 198
(100), 197 (19), 185 (33), 184 (18), 91 (8), 56 (42), 55 (14). HRMS
(ESI) calcd for C29H35N3NaO7S (M + Na+) 592.2088, found
592.2091.
4-Methyl-N-(1-oxo-1,2,3,4,5,10-hexahydroazepino[3,4-b]indol-
4-yl)benzenesulfonamide ((()-16b). Compound (()-16a (90 mg,
0.158 mmol) was dissolved in 7:1 CH2Cl2:TFA and the mixture
was stirred for 2 h at room temperature. Then saturated NaHCO3-
(aq) (30 mL) was added slowly and the mixture was extracted with
CH2Cl2 (4 × 30 mL). The combined organic layers were dried over
MgSO4. After filtration the solvent was removed under reduced
pressure to yield a green oil. Purification by column chromatography
(silica gel 70-230 mesh, ethyl acetate) yielded a white solid (56
mg, 96%). Rf 0.46 (n-hexane:ethyl acetate 1:1). Mp 206 °C (ethyl
acetate). 1H NMR (400 MHz, DMSO-d6) δ (ppm) 11.27 (1H, s),
8.00 (1H, d, J ) 6.2 Hz), 7.97 (1H, unresolved dd), 7.76 (2H, d,
J ) 8.3 Hz), 7.43-7.32 (4H, m), 7.19 (1H, ddd, J ) 8.2, 7.0, 1.0
Hz), 7.00 (1H, unresolved ddd), 3.58-3.46 (1H, m), 3.32-3.27
(2H, m), 3.00 (1H, dd, J ) 17.1, 5.4 Hz), 2.91 (1H, dd, J ) 16.9,
8.7 Hz), 2.38 (3H, s). 13C NMR (100 MHz, DMSO-d6) δ (ppm)
163.9, 142.7, 138.2, 136.0, 129.7, 127.1, 126.9, 126.5, 124.1, 119.5,
119.2, 112.8, 112.1, 51.9, 46.7, 31.4, 21.0. IR (KBr) ν (cm-1) 3297
s, 3247 s, 3061 sh, 2918 m, 1615 s, 1550 m, 1478 s, 1452 s, 1414
m, 1325 s, 1284 s, 1269 m, 1228 w, 1185 w, 1154 s, 1117 w, 1092
m, 1061 w, 1005 w, 957 w, 916 w, 889 m, 943 w, 832 w, 812 m,
787 w, 761 m, 741 m, 662 m, 590 w, 570 w, 550 m, 522 m, 431
w. MS (EI) m/z (rel. intensity) 369 (11), 199 (29), 198 (100), 185
(31), 169 (17), 167 (13), 158 (11), 157 (12), 155 (10), 130 (19),
129 (19), 128 (13), 91 (19), 44 (11). HRMS (EI) calcd for
C19H20N3O3S (M + H+) 370.1220, found 370.1228.
5-(Octyloxy)-2,3,4,5-tetrahydroazepino[3,4-b]indol-1(10H)-
one ((()-17). Alcohol (()-6 (100 mg, 0.462 mmol) and n-octanol
(602 mg, 4.62 mmol) were dissolved in acetone and activated silica
(800 mg, 0.040-0.063 mm) was added. The solvent was removed
under reduced pressure and the mixture was heated to 70 °C for
15 h. Purification by column chromatography (silica gel 70-230
mesh, ethyl acetate) yielded 23 mg (15%) of a colorless solid. Rf
0.31 (ethyl acetate). 1H NMR (300 MHz, DMSO-d6) δ (ppm) 11.38
(1H, br s), 8.18 (1H, dd, J ) 6.2, 3.0 Hz), 7.63 (1H, d, J ) 8.1
Hz), 7.42 (1H, d, J ) 8.3 Hz), 7.20 (1H, ddd, J ) 8.3, 7.0, 1.1
Hz), 7.04 (1H, ddd, J ) 7.9, 7.0, 0.9 Hz), 4.88 (1H, unresolved
dd), 3.68-3.50 (2H, m), 3.49-3.37 (1H, m), 3.22-3.09 (1H, m),
2.46-2.32 (1H, m), 1.98-1.84 (1H, m), 1.57-1.43 (2H, m), 1.39-
1.14 (10H, m), 0.84 (3H, t, J ) 6.9 Hz). 13C NMR (75 MHz,
DMSO-d6) δ (ppm) 163.4, 135.7, 127.7, 127.6, 123.9, 120.8, 119.4,
117.1, 112.2, 71.7, 67.4, 35.5, 31.2, 30.8, 29.8, 28.8, 28.7, 25.9,
22.1, 14.0. HRMS (ESI) calcd for C20H28N2NaO2 (M + Na+)
351.2043, found 351.2046.
Di-tert-butyl 5-Methoxy-4-(4-methylphenylsulfonamido)-1-
oxo-4,5-dihydroazepino[3,4-b]indole-2,10(1H,3H)-dicarboxy-
late ((()-18a). Aziridine (()-8a (284 mg, 0.50 mmol) was
suspended in absolute MeOH (5 mL) and ceric ammonium nitrate
(CAN) (27 mg, 0.05 mmol) was added. The reaction was stirred at
room temperature for 9 h until no further changes were observed
by TLC. The solvent was removed in vacuo. Purification by column
chromatography (silica gel 70-230 mesh, n-hexane:ethyl acetate
3:1) yielded the starting material (150 mg) and a white solid product
(141 mg, 47%, 99% based on recycled starting material). Rf 0.21
(n-hexane:ethyl acetate 3:1). Mp 79-80 °C (n-hexane:ethyl acetate).
1H NMR (400 MHz, DMSO-d6) δ (ppm) 8.00 (1H, d, J ) 8.6 Hz),
7.82 (1H, d, J ) 8.3 Hz), 7.73 (2H, d, J ) 8.1 Hz), 7.60 (1H, d,
J ) 7.8 Hz), 7.55 (1H, ddd, J ) 8.4, 7.2, 1.2 Hz), 7.47 (2H, d, J
) 7.8 Hz), 7.39 (1H, unresolved ddd), 4.70 (1H, br s), 4.07-3.96
(1H, m), 3.83 (1H, dd, J ) 14.9, 5.6 Hz), 3.43 (1H, dd, J ) 14.8,
10.4 Hz), 2.99 (3H, s), 2.44 (3H, s), 1.54 (9H, s), 1.38 (9H, s). 13C
NMR (75 MHz, DMSO-d6) δ (ppm) 160.4, 150.1, 148.4, 143.2,
138.3, 136.7, 130.7, 130.0, 127.8, 127.7, 126.5, 123.8, 122.4, 120.1,
114.1, 85.0, 82.2, 76.1, 56.5, 55.0, 46.7, 27.5, 27.2, 21.0. IR (KBr)
ν (cm-1) 3438 m, 3278 m, 2981 m, 2933 m, 2821 w, 1753 s, 1679
w, 1665 w, 1649 w, 1599, 1548 w, 1477 sh, 1449 s, 1416 m, 1394
sh, 1372 s, 1350 s, 1325 s, 1288 s, 1261 m, 1228 m, 1213 m, 1160
s, 1093 s, 1078 sh, 1043 w, 1025 m, 994 s, 958 w, 892 m, 862 m,
833 m, 815 w, 785 m, 772 m, 753 m, 707 w, 664 m, 596 w, 553
s, 538 sh, 472 w. MS (EI) m/z (rel. intensity) 599 (1), 499 (4), 399
(13), 339 (11), 338 (15), 288 (33), 274 (17), 244 (29), 228 (11),
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215 (15), 214 (13), 213 (26), 212 (100), 198 (12), 187 (14), 186
(28), 185 (92), 184 (31), 183 (19), 169 (12), 156 (17), 155 (20),
130 (24), 129 (16), 128 (14), 92 (13), 91 (36), 60 (15), 57 (12), 56
(51), 55 (14), 44 (72), 41 (79). HRMS (EI) calcd for C30H37N3O8S
(M+) 599.2296, found 599.2296.
N-(5-Methoxy-1-oxo-1,2,3,4,5,10-hexahydroazepino[3,4-b]in-
dol-4-yl)-4-methylbenzenesulfonamide ((()-18b). Sulfonamide
(()-18a (128 mg, 0.213 mmol) was dissolved in CH2Cl2 and
activated silica (600 mg, 0.040-0.063 mm) was added. The solvent
was removed in vacuo and the residue was heated to 70 °C for 13
h. Purification by column chromatography (silica gel 70-230 mesh,
n-hexane:ethyl acetate 1:2) yielded a white solid (63 mg, 74%). Rf
0.31 (n-hexane:ethyl acetate). Mp 170 °C (n-hexane:ethyl acetate).
1H NMR (400 MHz, DMSO-d6) δ (ppm) 11.54 (1H, br s), 8.01-
7.92 (2H, m), 7.77 (2H, unresolved ddd), 7.46-7.37 (4H, m), 7.21
(1H, ddd, J ) 8.3, 6.9, 1.0 Hz), 7.04 (1H, ddd, J ) 8.3, 6.9, 1.0
Hz), 4.42 (1H, d, J ) 3.9 Hz), 3.76-3.69 (1H, m), 3.46-3.38 (1H,
m), 3.19-3.10 (1H, m), 3.06 (3H, s), 2.40 (3H, s). 13C NMR (75
MHz, DMSO-d6) δ (ppm) 163.4, 142.7, 138.5, 135.8, 129.6, 128.0,
127.9, 126.6, 124.0, 120.2, 119.7, 112.8, 112.3, 76.5, 55.3, 51.6,
40.9, 21.0. IR (KBr) ν (cm-1) 3349 s, 3284 m, 3199 m, 2927 m,
2823 sh, 1733 w, 1651 s, 1597 w, 1578 w, 1549 m, 1480 s, 1445
m, 1341 s, 1291 m, 1248 w, 1211 w, 1185 sh, 1158 s, 1116 m,
1091 s, 1020 m, 996 m, 960 m, 884 m, 839 w, 815 m, 781 w,
740 m, 663 m, 615 w, 538 m, 430 w. HRMS (EI) calcd for
C20H21N3NaO4S (M + Na+) 422.1145, found 422.1145.
2,3,4,5-Tetrahydro-5-(1H-pyrazol-1-yl)-4-(tosylamino)azepino-
[3,4-b]indol-1(10H)-one ((()-19a). Aziridine (()-8a (113 mg, 0.2
mmol) and 1H-pyrazole (136 mg, 2.0 mmol) were dissolved in an
CH2Cl2 and activated silica (429 mg, 0.040-0.063 mm) was added.
The solvent was removed under reduced pressure and the solid
mixture was heated under argon at 70 °C for 16 h. Purification by
column chromatography (silica gel 70-230 mesh, CH2Cl2 to CH2-
Cl2:MeOH 50:1 as the gradient eluent) yielded the crude product.
This was dissolved in CH2Cl2 and n-hexane was added dropwise.
After cooling to 4 °C a white solid (51 mg, 59%) was collected by
filtration. Rf 0.34 (CH2Cl2:MeOH 10:1). Mp 206 °C (CH2Cl2:n-
hexane). 1H NMR (400 MHz, DMSO-d6) δ (ppm) 11.67 (1H, s),
8.23 (1H, d, J ) 5.1 Hz), 8.20 (1H, d, J ) 3.9 Hz), 7.53 (2H,
unresolved ddd), 7.46 (1H, d, J ) 2.2 Hz), 7.41 (1H, unresolved
ddd), 7.31-7.26 (3H, m), 7.18-7.12 (1H, m), 6.89-6.84 (2H, m),
6.05 (1H, unresolved dd), 5.79 (1H, d, J ) 6.1 Hz), 3.96 (1H,
unresolved ddd), 3.31-3.26 (1H, m), 2.37 (3H, s) 13C NMR (100
MHz, DMSO-d6) δ (ppm) 163.2, 142.5, 139.0, 138.0, 135.9, 129.7,
129.6, 128.3, 126.9, 126.3, 124.1, 119.8, 119.4, 112.4, 110.4, 105.0,
61.6, 56.4, 42.4, 21.0. IR (KBr) ν (cm-1) 3321 w, 3060 m, 2921
m, 1645 s, 1599 m, 1580 w, 1554 m, 1479 s, 1454 m, 1397 m,
1338 s, 1288 s, 1248 w, 1221 w, 1185 m, 1160 s, 1091 s, 1046 m,
1020 w, 1007 w, 992 w, 944 w, 882 w, 837 w, 814 m, 747 s, 705
m, 662 m, 579 m, 552 m, 534 m, 433 w. MS (EI) m/z (rel. intensity)
435 (4), 265 (12), 264 (71), 222 (13), 213 (23), 212 (100), 198
(19), 197 (19), 196 (12), 185 (74), 184 (23), 183 (11), 169 (18),
156 (16), 155 (19), 97 (10), 91 (30), 83 (12), 71 (15), 68 (33), 57
(24), 55 (17). HRMS (EI) calcd for C22H21N5O3S (M+) 435.1360,
found 435.1360.
General Procedure for Ring-Opening Reactions of Aziridines
with Secondary Amines (Procedure C). Aziridine (()-8a (142
mg, 0.25 mmol) was dissolved in absolute 1,4-dioxane (5 mL) under
argon in a Schlenk tube with a Teflon screwed stopper. After
addition of the appropriate amine (1.25 mmol) the sealed reaction
vessel was heated to 80 °C for 5 d. Then it was cooled to room
temperature and the solvent was removed in vacuo. Purification
by column chromatography (silicagel 70-230 mesh, CH2Cl2 to
CH2Cl2:MeOH 30:1 as a gradient eluent) yielded an oily, pale-
yellow product. This was washed or recrystallized from hot diethyl
ether as described below and in the Supporting Information.
4-Methyl-N-(1-oxo-5-(pyrrolidin-1-yl)-1,2,3,4,5,10-hexahy-
droazepino[3,4-b]indol-4-yl)benzenesulfonamide ((()-20a). A
crude product was obtained following general procedure C.
Recrystallization from boiling diethyl ether yielded a white solid
(86 mg, 78%). Rf 0.37 (CH2Cl2:MeOH 10:1). Mp 185 °C (Et2O).
1H NMR (300 MHz, DMSO-d6) δ (ppm) 11.49 (1H, br s), 7.89-
7.76 (2H, m), 7.72 (2H, d, J ) 8.3 Hz), 7.44-7.33 (4H, m), 7.18
(1H, unresolved ddd), 7.01 (1H, unresolved ddd), 3.94 (1H, d, J )
3.4 Hz), 3.81-3.69 (1H, m), 3.52-3.40 (1H, m), 3.11-2.97 (1H,
m), 2.40 (3H, s), 2.38-2.26 (2H, m), 2.16-2.01 (2H, m), 1.54-
1.35 (4H, br s). 13C NMR (75 MHz, DMSO-d6) δ (ppm) 164.1,
142.5, 138.9, 135.7, 129.5, 128.6, 128.5, 126.6, 123.5, 120.5, 119.1,
113.1, 112.1, 61.0, 54.0, 50.0, 42.8, 22.8, 21.0. IR (KBr) ν (cm-1)
3337 s, 3204 s, 3061 sh, 2964 m, 2873 m, 2803 m, 1918 w, 1739
w, 1645 s, 1577 w, 1547 s, 1484 s, 1444 s, 1337 s, 1305 m, 1289
m, 1246 m, 1214 m, 1186 w, 1156 s, 1092 s, 1042 w, 1007 w, 991
m, 948 m, 877 w, 835 w, 814 m, 776 m, 741 s, 660 s, 579 m, 550
s, 536 s, 436 m. MS (EI) m/z (rel. intensity) 438 (5), 367 (44), 283
(13), 213 (60), 212 (100), 199 (10), 198 (72), 197 (17), 185 (67),
169 (12), 167 (14), 156 (19), 155 (24), 129 (11), 128 (16), 92 (12),
91 (29), 71 (51), 70 (68). HRMS (EI) calcd for C23H26N4O3S (M+)
438.1720, found 438.1721.
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A silica gel-promoted regioselective ring-opening reaction of epoxides with indoles and pyrrole under
mild and solvent-free conditions is described. This reaction provides a synthetic pathway for a diverse
class of novel hymenialdisine analogues.
 2008 Elsevier Ltd. All rights reserved.
1. Introduction
Epoxides are versatile building blocks for novel biologically ac-
tive compounds since they can be readily opened with different
nucleophiles giving a variety of functionalized diverse products.1
Nucleophilic epoxide opening reactions play a key role especially in
the construction of carbon–carbon and carbon–oxygen bonds,
essential components of organic compounds.1,2 These reactions are
generally performed with acid or base catalysts. In the absence of
such catalysts, the reaction is moderately slow.3
More specifically, it has been reported that epoxide ring-open-
ing reactions with indoles and pyrroles can be carried out under
acid catalysts4 or high pressure conditions.5 In addition, Lewis acid
catalysts such as lanthanide triflates,6 nano-crystalline titanium(IV)
oxide,7 RuCl3$nH2O,
8 HBF4/SiO2
9 and InCl3/silica
10 have been also
reported for such transformations. Some of these known methods
require comparably long reaction time, high temperature or pres-
sure conditions, expensive reagents and gave unsatisfactory yields.
Thus, the development of clean, efficient and mild conditions for
the ring opening of epoxides with indoles and pyrroles is desirable.
Small molecule kinase inhibitors are of significant actual
interest, both as potential therapeutics and as experimental tools
for understanding the physiological role of these enzymes.11 Pro-
tein kinases act pivotally in signal transduction as well as in cellular
proliferation, differentiation and various regulatory mechanisms.12
Kinase inhibitors have emerged as promising therapeutic mole-
cules for treatment of a number of diseases including cancer and
asthma.12,13 In recent years, intense effort has been devoted
towards the development and identification of such small molecule
inhibitors associated with diseases; currently 20–30% of pharma-
ceutical discovery programmes are focused on kinase functions.11,12
Staurosporine (1), a bisindole alkaloid has been found as one of
the first kinase inhibitors in nanomolar concentrations (Fig. 1).14
Several kinase inhibitors have progressed to human clinical tri-
als.12,15,16 Among them, hymenialdisine (HMD) (2), a natural
product, exhibited promising results in inhibiting various kinases.16
We were intrigued by the fascinating structure and highly signifi-
cant kinase inhibiting activity exhibited by staurosporine (1) and
hymenialdisine (2). As a part of our ongoing efforts to apply cata-
lytic oxidation methodology18 to synthesize potential bio-active
compounds,19,20 we became interested in preparing a small library
of novel bisindoles as hybrid analogues (3) of staurosporine and
hymenialdisine.16 It has been reported that the kinase inhibiting
activity of HMDs vary much if other heterocycles instead of imid-
azoles are introduced in its core structure.17 Therefore, we decided
to introduce indoles on annulated HMD scaffold to evaluate their
biological activity. Our initial efforts in this field culminated
recently in the establishment of a novel strategy for annulated
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O
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Figure 1. Structures of staurosporine (1), hymenialdisine (2) and hybrid analogues (3).
* Corresponding author. Tel.: þ49 381 1281 193; fax: þ49 381 1281 51193.
E-mail address: man-kin.tse@catalysis.de (M.K. Tse).
Contents lists available at ScienceDirect
Tetrahedron
journal homepage: www.elsevier .com/locate/ tet
0040-4020/$ – see front matter  2008 Elsevier Ltd. All rights reserved.
doi:10.1016/j.tet.2008.05.092
Tetrahedron 64 (2008) 7171–7177
HMD-type bisindoles using aziridines and hydroxyl precursors as
starting materials.20 Here, we disclose another amenable, di-
versified strategy using silica gel as solid support for ring opening of
epoxide ()-5a under mild and solvent-free reaction conditions to
give novel bisindole-type hymenialdisine analogues ()-8 with
a free hydroxyl group.
2. Results and discussion
We initiated a synthetic effort that began with the large scale
preparation of the Boc-protected olefin 4a from commercially
available indole-2-carboxylic acid following a previous protocol
reported by us.20 Initial efforts for the epoxidation of 4a to produce
()-5a utilizing methods such as m-CPBA21 or MTO22 were un-
successful. To our delight, we found that the reaction proceeded
smoothly to give epoxide ()-5a in 83% yield with in situ generated
dimethyloxirane using Oxone (2KHSO5$KHSO4$K2SO4) as the
terminal oxidant (Scheme 1).23 The structure of the epoxide ()-5a
was confirmed by X-ray crystal structural analysis (Fig. 2). However,
when the same reaction conditions were applied to the un-
protected olefin 4b, the formation of the desired epoxide ()-5b
was not observed. Transformations of ()-5a into ()-5b have not
been performed to avoid unwanted epoxide ring-opening reactions
employing the typical Boc-deprotection conditions (HCl/MeOH,
TFA/CH2Cl2, heat, Na2CO3/MeOH, etc.). With the key building block
()-5a in hand, we envisioned to explore silica gel-promoted21
epoxide ring opening under easily manageable solvent-free
conditions to produce hymenialdisine analogues.
N
N
O
R
R
4a (R = Boc)
4b (R = H)
N
N
O
O
R
(±)-5a (R = Boc) (83%)
(±)-5b (R = H) (0%)
Oxone®
NaHCO3
acetone : H2O
(2:1)
R
Scheme 1. Selective epoxidation of 5a.
Initial attempts to open epoxide ()-5a with indoles and
deprotection of both Boc groups in situ following our previous
protocol20 at 70 C resulted in the desired ring opened product in
moderate to good yields (39–60%). However, the reaction mixture
was complicated with concomitant formation of several side
products, which in our hands could not be separated and charac-
terized. We hypothesized that the epoxide ring-opening reaction
proceeds much faster than the deprotection of the Boc groups. This
enforced us to turn our focus in searching milder conditions to
achieve higher selectivity. Fortunately, the reaction proceeded
smoothly at room temperature and went to completion with
preservation of both Boc groups to give ()-6a in 74% yield.
Next, we applied this protocol to prepare unsymmetrical
bisindoles starting from epoxide ()-5a (Table 1). Most of the re-
actions proceeded at room temperature to give ()-6a–e in mod-
erate to good yields (55–74%). Functional groups on the indole ring
such as alkyl, halide, alkoxy and ester groups were tolerated under
these mild reaction conditions (Table 1, entries 2–5). However, we
were unable to isolate the desired product with 2-methyl indole
(Table 1, entry 6). The ring-opening reaction of the very reactive
epoxide on silica possibly proceeds much faster than the nucleo-
philic attack of the sterically hindered 2-methyl indole. It is note-
worthy to mention that the regioselectivity in all other reactions
was excellent. As expected, only one diastereomer is obtained
during ring-opening reaction. It takes place at the benzylic position
of the ()-5a and at the 3-position of the attached indole, which is
in full agreement with an electrophilic substitution mechanism.10
Pyrrole opens ()-5a under the same conditions (Scheme 2).
The reaction was also regioselective at benzylic position of the
substrate affording the corresponding product ()-7a as the major
product along with a minor amount of ()-7b.9
Standard procedure using TFA to deprotect the Boc groups of
()-6a at room temperature24 resulted in decomposition of the
substrate. As we noticed formation of the desired deprotected
compound in the initial screening using our previous protocol,20 we
assumed that the Boc groups can be removed at higher tempera-
ture using activated silica as solid support.
Figure 2. Molecular structure of epoxide ()-5a. The thermal ellipsoids correspond to
30% probability.
Table 1
Ring-opening reactions of ()-5aa
activated silica,
   rt, 90 min
(±)-6a-f
N
N
O
O
Boc
Boc
(±)-5a
N
H
N
N
O
OHHN
Boc
Boc
R
R
Entry Substrate Product Yieldb (%)
1 N
H
()-6a 74
2 N
H
CH3
()-6b 64
3
N
H
Br
()-6c 72
4
N
H
H3CO2C
()-6d 55c
5
N
H
BnO
()-6e 56
6 N
H
CH3 ()-6f 0
a Reaction conditions: epoxide ()-5a (300 mg, 0.72 mmol), indole derivative
(7.2 mmol), activated silica (0.040–0.063 mm, 1.56 g), argon, rt, 90 min.
b Isolated yield.
c Reaction time: 10 h.
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Thus, compound ()-6awas adsorbed on activated silica gel and
heated at 100 C for overnight to give the desired product ()-8a.
This is in agreement with our hypothesis that the epoxide ring-
opening reaction proceedsmuch faster than the deprotection of the
Boc-protecting groups. Structure of ()-8awas confirmed again by
X-ray crystal structural analysis (Fig. 3). This method was success-
fully employed to all the other epoxide ring opened products to give
the desired products in 56–75% yield (Table 2, entries 2–6).
The selective epoxidation and subsequent ring opening
prompted us to explore a synthetic route to prepare the enantio-
merically pure epoxide of the Boc-protected olefin 4a. For this
purpose, we tested Shi’s catalyst25 using Oxone (2KHSO5$KH-
SO4$K2SO4) as the oxidant. But with our substrate, the conversion
was negligible. Next, we checked the feasibility of Jacobson’s
protocol26 for the epoxidation of olefin 4a, for its simple work up
procedure.26b When 4a was treated with 4 mol % Jacobson’s cata-
lyst using NaOCl as the oxidant, the desired epoxide was yielded in
66% with 74% ee. The product was recrystallized using a mixture of
hexane/ethyl acetate (9:1). After two consecutive recrystallizations,
(þ)-5a was obtained in >99% ee from the mother liquor in 34%
yield. Subsequently, this enantiopure epoxide was subjected to the
ring-opening reaction with indole. Indeed, the desired bisindole
(þ)-6a was obtained with 99% ee and 67% yield (Scheme 3).
3. Conclusions
In conclusion, we developed a convenient method for the
opening of epoxide with indoles and pyrrole on solid support to
synthesize novel unsymmetrical bisindoles. The advantages of the
present protocol are the easeofworkup, solvent-free conditions and
the high selectivity. This method can also be extended to synthesize
enantiomerically pure bisindole-type hymenialdisine analogues.
4. Experimental section
4.1. General
All solvents and chemicals were obtained commercially and
were used as-received. NMR spectra were measured using a Bruker
activated
silica, rt, 
90 min
(±)-7a (69%)
(±)-5a
N
H
N
N
O
OH
HN
Boc
Boc
N
N
O
OHHN
Boc
Boc
+
(±)-7b (15%)
Scheme 2. Epoxide opening reaction with pyrrole.
Figure 3. Molecular structure of ()-8a. Only one molecule of the asymmetric unit is
depicted. The thermal ellipsoids correspond to 30% probability.
Table 2
Deprotection of Boc groups of ()-6a
activated silica
100 °C
overnightN
N
O
OH
(±)-6a-e & 7a
Boc
Boc
R
N
H
NH
O
OH
(±)-8a-e & 9a
R
Entry R Product Yieldb (%)
1
N
H
()-8a 75
2
N
H
CH3
()-8b 66
3
N
H
Br
()-8c 65
4
N
H
H3CO2C
()-8d 71
5
N
H
BnO
()-8e 56
6 N
H
()-9a 65
a Reaction conditions: ()-6a–e and 7a (0.415 mmol), activated silica (0.040–
0.063 mm, 0.92 g), argon, 100 C, overnight.
b Isolated yield.
N
N
O
HN
(+)-6a (67%)
>99% ee
activated silica,
rt, 90 min
N
H
N
N
O
O
Boc
Boc
Boc
Boc
(+)-5a (66%, 74% ee)
>99% ee from mother liquor
after two consecutive
recrystallizations
OH
4a
Jacobson´s cat. (4 mol%)
NaOCl
0 °C-rt, 2 h
Scheme 3. Synthesis of enantiomerically pure bisindoles.
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ARX 300 or ARX 400 spectrometer at 300 or 400 MHz (1H) and 75
or 100 MHz (13C). All spectra were recorded in DMSO-d6 or CDCl3
and chemical shifts (d) are reported in parts per million relative to
tetramethylsilane referenced to the residual solvent peaks. Spectra
were recorded at room temperature unless otherwise stated. Mass
spectra were in general recorded on an AMD 402/3 or an HP 5989A
mass selective detector. In each case characteristic fragments with
their relative intensities in percentages are shown. Infrared spectra
were recorded on a Nicolet 6700 spectrometer using KBr plates or
on the same machine equipped with a smart endurance (Thermo
Electron Corporation) for ATR-IR. Wave numbers (n) are reported in
cm1. HPLC analysis was performed on an HP 1090 machine with
DAD detector. Melting points were measured with a Stuart melting
point apparatus (SMP3) and are not corrected. Activated silica gel
was obtained by heating silica gel (0.040–0.063 mm) at 140 C in
vacuum overnight.
4.2. X-ray diffraction
Diffraction data were collected with an STOE-IPDS diffracto-
meter using graphite-monochromated Mo Ka radiation. The struc-
tures were solved by direct methods27 and refined by full-matrix
least-squares techniques on F2.28 XP (BRUKER AXS) was used for
graphical representations. Crystallographic data for the structures
in this paper have been deposited with the Cambridge Crystallo-
graphic Data Centre as supplementary publication numbers CCDC
681249 [()-5a] and CCDC 682863 [()-8a]. Copies of the data can
be obtained free of charge from www.ccdc.cam.ac.uk or from the
Cambridge Crystallographic Data Centre,12 Union Road, Cambridge
CB2 1EZ, UK; fax: þ44 1223 336033; or deposit@ccdc.cam.ac.uk.
4.2.1. Crystal data for ()-5a
Space group P1, triclinic, a¼7.791(2), b¼9.354(2), c¼14.997(3) Å,
a¼96.86(3), b¼102.25(3), g¼98.00(3), V¼1045.1(4) Å3, Z¼2,
rcalcd¼1.317 g cm3, 15,688 reflections measured, 4551 were in-
dependent of symmetry, of which 3120 were observed (I>2s(I)),
R1¼0.042, wR2 (all data)¼0.113, 271 parameters.
4.2.2. Crystal data for ()-8a
Space group P1, triclinic, a¼12.1668(7), b¼13.1234(7), c¼
14.0402(9) Å, a¼70.049(5), b¼84.851(5), g¼64.600(4), V¼
1899.3(2) Å3, Z¼4, rcalcd¼1.327 g cm3, 29,081 reflections mea-
sured, 8062 were independent of symmetry, of which 4604 were
observed (I>2s(I)), R1¼0.051,wR2 (all data)¼0.131, 539 parameters.
4.3. Synthesis
4.3.1. Epoxidation of (Z)-di-tert-butyl 1-oxoazepino[3,4-b]indole-
2,10(1H,3H)-dicarboxylate ()-5a
To a vigorously stirred mixture of olefin 4a (0.80 g, 2.0 mmol)
and NaHCO3 (1.68 g, 20.0 mmol) in acetone (200 mL) at 0 C was
added dropwise a solution of Oxone (3.71 g, 6.0 mmol) in H2O
(120 mL) over a period of 30 min. The ice bath was removed and the
reaction mixture was stirred at room temperature for 3 h. The re-
action mixture was filtered, the solid residue was washed with
acetone and the filtrate was concentrated in vacuum. The aqueous
layer was extracted with ethyl acetate (350 mL). The combined
organic extracts were washed with brine (50 mL), dried over
MgSO4 and concentrated in vacuum. The crude compound was
purified by column chromatography (silica gel 70–230 mesh, n-
hexane/ethyl acetate 9:1) to yield awhite fluffy solid (692 mg, 83%).
Crystals suitable for X-ray analysis were obtained by recrystallizing
with ethyl acetate.Mp Rf¼0.27 (n-hexane/ethyl acetate 8:2). Mp:
164 C (ethyl acetate). HPLC analysis: column, Chiralcel OD-H;
solvent, heptane/ethanol 97:3; flow¼1.0 mL/min, tR¼10.11,
13.97 min. 1H NMR (400 MHz, CDCl3): d (ppm)¼8.09 (1H, d, J¼
8.5 Hz), 7.75 (1H, d, J¼7.8 Hz), 7.48 (1H, unresolved dd), 7.34 (1H,
unresolved dd), 4.46–4.23 (1H, m), 4.18 (1H, unresolved d), 4.06–
3.90 (1H, m), 3.90–3.79 (1H, m), 1.59 (18H, m). 13C NMR (100 MHz,
CDCl3): d (ppm)¼160.0, 152.0, 148.9, 137.8, 129.6, 127.6, 127.3, 123.6,
120.0, 119.0, 114.6, 85.1, 84.0, 47.1, 28.0, 27.6. 1H NMR (400 MHz,
323 K, CDCl3): d (ppm)¼8.14–8.07 (1H, m), 7.78–7.72 (1H, m), 7.46
(1H, unresolved ddd), 7.33 (1H, unresolved ddd), 4.30 (1H, un-
resolved d), 4.16 (1H, d, J¼3.9 Hz), 4.02–3.91 (1H,m), 3.87–3.81 (1H,
m), 1.6 (18H, m). 13C NMR (100 MHz, 323 K, CDCl3): d (ppm)¼159.9,
152.2, 149.0, 138.0, 129.9, 127.5, 127.5, 123.6, 119.9, 119.0, 114.9, 85.1,
83.9, 54.6, 47.2, 45.5, 28.1, 27.7. ATR-IR (cm1)¼3057w, 2980w,
2935w, 1768m, 1720s, 1559m, 1477w, 1448m, 1368s, 1322s, 1290m,
1258w, 1226w, 1206m, 1145s, 1119m, 1079s, 1024w, 985m, 944m,
894w, 851s, 780s, 746s. MS (EI): m/z (rel int.) 69 (20), 70 (18), 71
(22), 83 (19), 84 (24), 85 (11), 86 (10), 97 (14), 102 (12), 112 (10),
128(16), 129 (91), 130 (11), 157 (51), 158 (10), 169 (31), 170 (11), 185
(28), 186 (22), 197 (23), 198 (52), 214 (100), 215 (12), 414 (6). HRMS
(EI): calcd for C22H26N2O6 (M
þ) 414.1785, found 414.1782.
4.3.2. Asymmetric epoxidation of (Z)-di-tert-butyl 1-
oxoazepino[3,4-b]indole-2,10(1H,3H)-dicarboxylate (þ)-5a
A solution of 0.05 M Na2HPO4 (5 mL) was added to a 6 mL
aqueous solution of bleach (w14% NaOCl). The pH value of the
resulting buffered solution (w1 M in NaOCl) was w12.0 and was
adjusted to pH 11.5 by addition of a few drops of 5% HCl solution.
The solution was cooled to 0 C from which 8.7 mL were added at
once to a 0 C solution of 4a (1.0 g, 2.5 mmol) and Jacobson’s
catalyst (64.0 mg, 0.10 mmol) in 4 mL of dichloromethane. The
reaction mixture was stirred at room temperature for 2 h. Ethyl
acetate (20 mL) was added to the mixture, the organic phase was
separated, dried over MgSO4 and concentrated in vacuum. The
crude product was purified by column chromatography (silica gel
70–230 mesh, n-hexane/ethyl acetate 9:1) to afford a white fluffy
solid (671 mg, 66%, 74% ee). The product was recrystallized with
hexane. White solid precipitated out with 33% ee and the enan-
tiomerically enriched compound with 82% ee was obtained after
drying the mother liquor. It was again recrystallized using hexane/
ethyl acetate mixture (9:1) to produce (þ)-5a in >99% ee from
mother liquor with 34% yield as a fluffy solid. Mp: 78 C (ethyl
acetate/hexane). HPLC analysis: >99% ee (Chiralcel OD-H, solvent:
heptane/ethanol 97:3, flow¼1.0 mL/min); tR¼13.97 min (major).
[a]D
22 þ4.65 (c 1.0, CHCl3).
4.4. General procedure for the ring-opening reaction of the
epoxide (±)-5a with indoles (general procedure A)
Epoxide ()-5a (300 mg, 0.72 mmol) and an indole derivative
(7.2 mmol) were dissolved in dichloromethane and activated silica
(1.56 g, 0.040–0.063 mm) was added. The solvent was removed
under reduced pressure at room temperature and the solid mixture
was kept under argon for 90 min. Purification by column chroma-
tography (silica gel 70–230 mesh, n-hexane/ethyl acetate 9:1 to n-
hexane/ethyl acetate 8:2 as the gradient eluent) yielded the pure
product. It was then washed or recrystallized as described below.
4.4.1. Di-tert-butyl 4-hydroxy-5-(1H-indol-3-yl)-1-oxo-4,5-
dihydroazepino[3,4-b]indole-2,10(1H,3H)-dicarboxylate ()-6a
The desired product was obtained following general procedure
A (287 mg, 74%). This was recrystallized from ethyl acetate/hexane
to yield pure analytical sample as an off-white solid. Mp Rf¼0.35
(ethyl acetate/hexane 4:6). Mp: 190 C (ethyl acetate/hexane). 1H
NMR (300 MHz, CDCl3): d (ppm)¼8.21 (1H, br s), 8.13 (1H, d,
J¼9.1 Hz), 7.71–7.68 (1H, m), 7.43 (1H, unresolved ddd), 7.38–7.32
(2H, m), 7.23–7.20 (2H, m), 7.14–7.09 (1H, m), 6.71 (1H, unresolved
d), 5.19–5.13 (1H, m), 4.98–4.95 (1H, m), 4.76 (1H, d, J¼3.6 Hz),
3.68–3.60 (1H, m), 2.96–2.87 (1H, m), 1.69 (9H, s), 1.43 (9H, s). 13C
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NMR (75 MHz, CDCl3): d (ppm)¼157.6, 156.1, 149.2, 139.9, 136.1,
135.6, 129.0, 126.7, 124.3, 123.9, 123.5, 123.4, 122.6, 121.2, 120.5,
118.3, 115.3, 111.6, 109.1, 85.1, 80.6, 79.8, 42.7, 32.5, 28.4, 27.9. ATR-IR
(cm1)¼3369br, 2978w, 2931w, 1711s, 1611w, 1506m, 1444m,
1415m, 1392w, 1354s, 1315m, 1280m, 1250m, 1152s, 1083s, 1015m,
964w, 942w, 907w, 854w, 836m, 740s. MS (EI): m/z (rel int.) 41
(100), 43 (30), 44 (99), 55 (43), 56 (74), 57 (25), 60 (10), 69 (18), 71
(10), 83 (15), 97 (12), 272 (26), 531 (1). HRMS (EI): calcd for
C30H33N3O6 (M
þ) 531.2364, found 531.2368. HPLC analysis:
column, Chiralcel OD-H; solvent, heptane/isopropanol 90:10;
flow¼1.0 mL/min; tR¼7.81, 9.95 min.
4.4.2. Di-tert-butyl 4-hydroxy-5-(1H-indol-3-yl)-1-oxo-4,5-
dihydroazepino[3,4-b]indole-2,10(1H,3H)-dicarboxylate (þ)-6a
Enantiomerically pure (þ)-6awas obtained as awhite solid from
(þ)-5a following the same procedure as described for ()-6a
(258 mg, 67%). Mp: 136 C (ethyl acetate/hexane). HPLC analysis:
>99% ee; column, chiracel OD-H; solvent, heptane/ethanol 90:10;
flow¼1.0 mL/min; tR¼9.54 minmajor. [a]D22þ409.5 (c 0.097, CHCl3).
4.4.3. Di-tert-butyl 4-hydroxy-5-(7-methyl-1H-indol-3-yl)-1-oxo-
4,5-dihydroazepino[3,4-b]indole-2,10(1H,3H)-dicarboxylate ()-6b
The desired product was obtained as a white solid following
general procedure A (252 mg, 64%).Mp Rf¼0.51 (ethyl acetate/hex-
ane 2:3) Mp: 154 C (ethyl acetate/hexane).. 1H NMR (300 MHz,
CDCl3): d (ppm)¼8.07–8.04 (2H, m), 7.49 (1H, d, J¼8.1 Hz), 7.36 (1H,
unresolved ddd), 7.26 (1H, d, J¼7.9 Hz), 7.11–6.93 (3H, m), 6.62 (1H,
unresolved d), 5.11–5.06 (1H, m), 4.89–4.85 (1H, m), 4.68 (1H, d,
J¼3.5 Hz), 3.59–3.49 (1H, m), 2.88–2.78 (1H, m), 2.38 (3H, s), 1.62
(9H, s), 1.36 (9H, s). 13C NMR (75 MHz, CDCl3): d (ppm)¼157.6, 156.0,
149.1,139.8,135.7,135.7,129.0,126.3,124.3,123.5,123.5,123.3,123.0,
121.2,120.8,120.6,116.0,115.2,109.5, 85.0, 80.5, 79.7, 42.7, 32.5, 28.3,
27.8, 16.5. ATR-IR (cm1)¼3342br, 3054w, 2976w, 2930w, 1711s,
1612w, 1505m, 1444m, 1416w, 1392w, 1365s, 1354s, 1315m, 1280m,
1245m,1153s,1088s,1016w, 967w, 943w, 928w, 906w, 853w, 835m,
785m, 768m, 744s, 633w. MS (EI): m/z (rel int.) 41 (94), 43 (14), 44
(100), 55 (31), 56 (77), 57 (13), 286 (36), 545 (3). HRMS (ESIþ): calcd
for C31H35N3O6þNaþ (MþNaþ) 568.2418, found 568.2416.
4.4.4. Di-tert-butyl 5-(5-bromo-1H-indol-3-yl)-4-hydroxy-1-oxo-
4,5-dihydroazepino[3,4-b]indole-2,10(1H,3H)-dicarboxylate ()-6c
The desired product was obtained following general procedure A
(318 mg, 72%). This was recrystallized from ethyl acetate/hexane to
yield pure analytical sample as a white solid. Rf¼0.44 (ethyl acetate/
hexane 2:3). Mp: 207 C (ethyl acetate/hexane). 1H NMR (300 MHz,
CDCl3): d (ppm)¼8.35 (1H, br s), 8.13 (1H, d, J¼8.5 Hz), 7.87 (1H,
unresolved d), 7.45 (1H, ddd, J¼8.5, 7.2, 1.3 Hz), 7.34–7.22 (3H, m),
7.17–7.12 (1H, m), 6.69 (1H, unresolved d), 5.20–5.14 (1H, m), 4.96–
4.92 (1H,m), 4.68 (1H, d, J¼3.4 Hz), 3.60–3.51 (1H,m), 2.96–2.86 (1H,
m),1.68 (9H, s),1.44 (9H, s).13CNMR(75 MHz, CDCl3): d (ppm)¼157.5,
155.9,149.0,139.9,135.4, 134.6,129.1, 128.5,125.5,125.1, 124.1, 123.6,
123.2, 121.1, 120.6, 115.3, 113.8, 113.1, 85.1, 80.2, 79.9, 42.5, 32.0, 28.1,
27.8. ATR-IR (cm1)¼3424s, 2978w, 2925w, 1742w, 1727s, 1689m,
1561w, 1508w, 1458m, 1446m, 1417w, 1393w, 1368s, 1354m,1316m,
1280m, 1256w, 1195m, 1157s, 1100s, 1056w, 1016w, 945w, 905w,
886w, 835w, 797w, 770w, 750m, 626w, 472w, 424w. HRMS (EI):
calcd for C30H32Br1N3O6 (M
þ) 609.1469, found 609.1477.
4.4.5. Di-tert-butyl 4-hydroxy-5-(5-(methoxycarbonyl)-1H-indol-
3-yl)-1-oxo-4,5-dihydroazepino[3,4-b]indole-2,10(1H,3H)-
dicarboxylate ()-6d
The desired product was obtained following general procedure
A (235 mg, 55%). This was recrystallized from methanol to yield
pure analytical sample as a white solid.Mp Rf¼0.23 (ethyl acetate/
hexane 4:6). Mp: 205 C (methanol). 1H NMR (300 MHz, DMSO-d6):
d (ppm)¼11.50 (1H, unresolved d), 8.40 (1H, br s), 8.00 (1H, d,
J¼8.5 Hz), 7.73 (1H, dd, J¼8.5, 1.5 Hz), 7.56–7.51 (1H, m), 7.46–7.30
(2H, m), 7.23–7.18 (1H, m), 7.11 (1H, unresolved dd), 6.99 (1H, m),
5.23 (1H, d, J¼3.4 Hz), 5.11–5.06 (1H, m), 3.85 (3H, s), 3.30–3.21 (1H,
m), 2.83–2.71 (1H, m), 1.62 (9H, s), 1.34 (9H, s). 13C NMR (75 MHz,
DMSO-d6): d (ppm)¼167.2, 156.8, 155.5, 148.6, 139.1, 138.8, 135.9,
129.1, 126.5, 126.3, 124.1, 123.6, 123.2, 122.2, 121.6, 121.3, 120.8,
114.5, 111.8, 109.5, 84.6, 79.5, 78.0, 51.7, 42.4, 31.3, 28.1, 27.3 ATR-IR
(cm1)¼3340br, 2978w, 2931w, 1708s, 1619m, 1508m, 1442m,
1416w, 1392w, 1355s, 1314m, 1279m, 1241s, 1189w, 1153s, 1090s,
1016w, 964w, 905m, 835m, 767w, 746s. HRMS (ESIþ): calcd for
C32H35N3O8þNaþ (MþNaþ) 612.2317, found 612.2316.
4.4.6. Di-tert-butyl 5-(5-(benzyloxy)-1H-indol-3-yl)-4-hydroxy-1-
oxo-4,5-dihydroazepino[3,4-b]indole-2,10(1H,3H)-dicarboxylate
()-6e
The desired productwas obtained following general procedure A
(258 mg, 56%). This was recrystallized from ethyl acetate/hexane to
yield pure analytical sample as an off-white solid. Rf¼0.32 (ethyl
acetate/hexane 4:6). Mp: 142 C (hexane/ethyl acetate) 1H NMR
(300 MHz, CDCl3): d (ppm)¼8.13 (1H, d, J¼8.5 Hz), 8.10 (1H, br s),
7.55–7.48 (2H, m), 7.47–7.36 (3H, m), 7.35–7.21 (2H, m), 7.20–7.08
(3H, m), 6.97 (1H, dd, J¼8.7, 2.3 Hz), 6.77–6.67 (1H, m), 5.20 (3H, br
s), 5.02–4.91 (1H,m), 4.70 (1H, d, J¼3.4 Hz), 3.62–3.50 (1H,m), 3.04–
2.92 (1H, m), 1.70 (9H, s), 1.44 (9H, s). 13C NMR (75 MHz, CDCl3):
d (ppm)¼156.0, 153.8, 149.2, 140.0, 137.5, 135.7, 131.4, 129.0, 128.6,
127.9, 127.7, 127.1, 124.6, 124.4, 123.6, 123.4, 121.2, 115.3, 113.6, 112.4,
108.9, 101.5, 85.1, 80.4, 79.8, 70.8, 32.5, 28.4, 27.9. ATR-IR (cm1)¼
3367br, 2975w, 2928w, 2857w,1713s,1624w,1581w,1499w,1483w,
1446m, 1415w, 1392w, 1365s, 1315m, 1280m, 1249w, 1153s, 1092s,
1016w, 966w, 938w, 907w, 836m, 744s, 696s. HRMS (ESIþ): calcd for
C37H39N3O7þNaþ (MþNaþ) 660.2680, found 660.2676.
4.4.7. Di-tert-butyl 4-hydroxy-1-oxo-5-(1H-pyrrol-2-yl)-4,5-
dihydroazepino[3,4-b]indole-2,10(1H,3H)-dicarboxylate ()-7a
The desired product was obtained following general procedure
A (240 mg, 69%). This was recrystallized from ethyl acetate/hexane
to yield pure analytical sample as an off-white solid. Rf¼0.60 (ethyl
acetate/hexane 2:3). Mp: 175 C (ethyl acetate/hexane). 1H NMR
(400 MHz, CDCl3): d (ppm)¼8.58 (1H, br s), 8.15–8.13 (1H, m), 7.50–
7.45 (2H, m), 7.25–7.21 (1H, m), 6.67–6.66 (1H, m), 6.08 (1H, dd,
J¼5.6, 2.9 Hz), 6.01–5.95 (1H, m), 4.98–4.91 (2H, m), 4.55 (1H, d,
J¼3.6 Hz), 3.67–3.59 (1H, m), 3.14–3.07 (1H, m), 1.67 (9H, s), 1.45
(9H, s). 13C NMR (75 MHz, CDCl3): d (ppm)¼157.0, 156.3, 149.0,
139.8, 133.4, 129.2, 124.3, 123.8, 123.7, 123.5, 121.2, 118.9, 115.3,
109.1,108.6, 85.2, 80.3, 42.2, 34.8, 28.4, 27.8. ATR-IR (cm1)¼3342br,
2978w, 2931w, 1733s, 1611w, 1512m, 1445m, 1414w, 1392w, 1356s,
1314s, 1279m, 1248m, 1153s, 1089s, 1016w, 979w, 945w, 906w,
853w, 835m, 768w, 746m, 722m. MS (EI): m/z (rel int.) 41 (99), 43
(15), 44 (97), 55 (36), 56 (83), 57 (38), 192 (10), 193 (64), 194 (17),
207 (11), 220 (10), 221 (30), 222 (100), 223 (41), 263 (16), 264 (30),
280 (10), 281 (14), 325 (10), 481 (4). HRMS (EI): calcd for
C26H31N3O6 (M
þ) 481.2207, found 481.2222.
4.4.8. Di-tert-butyl 4-hydroxy-1-oxo-5-(1H-pyrrol-3-yl)-4,5-
dihydroazepino[3,4-b]indole-2,10(1H,3H)-dicarboxylate ()-7b
The desired product was obtained following general procedure
A (53 mg,15%). This was recrystallized from ethyl acetate/hexane to
yield pure analytical sample as an off-white solid. Rf¼0.40 (ethyl
acetate/hexane 2:3). Mp: 100 C. 1H NMR (300 MHz, CDCl3):
d (ppm)¼8.20 (1H, br s), 8.15–8.10 (1H, m), 7.52–7.42 (2H, m), 7.23
(1H, unresolved ddd), 6.66 (1H, dd, J¼4.7, 2.4 Hz), 6.46 (1H, un-
resolved dd), 6.03–5.98 (1H, m), 5.07–4.93 (2H, m), 4.37 (1H, d,
J¼3.6 Hz), 3.66–3.54 (1H, m), 3.16–3.03 (1H, m), 1.67 (9H, s), 1.45
(9H, s). 13C NMR (75 MHz, CDCl3): d (ppm)¼157.5, 156.1, 149.2,
139.9, 136.0, 128.7, 124.6, 123.5, 123.1, 121.2, 118.6, 116.7, 116.5, 115.3,
108.7, 85.0, 80.4, 79.8, 43.0, 34.5, 28.4, 27.9. MS (EI):m/z (rel int.) 41
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(93), 55 (26), 56 (73), 57 (25), 193 (32), 194 (14), 221 (26), 222 (100),
223 (37), 234 (13), 239 (24), 251 (5), 264 (19), 280 (20), 281 (14),
324 (13), 325 (13). 481 (1). ATR-IR (cm1)¼3322m, 2983w, 2935w,
1728s, 1685s, 1530s, 1478w, 1446m, 1409m, 1366m, 1350s, 1313m,
1275s, 1251s, 1227w, 1192w, 1154s, 1124w, 1087s, 1042m, 1008m,
976w, 944m, 902w, 871w, 854w, 838w, 829w, 805w, 784m, 767w,
752s, 739w, 694w. HRMS (ESIþ): calcd for C26H31N3O6þNaþ
(MþNaþ) 504.2110, found 504.2104.
4.5. General procedure for the deprotection of Boc groups
(general procedure B)
Compounds ()-6a–e and 7a (0.415 mmol) were dissolved in
dichloromethane, and activated silica (0.92 g, 0.040–0.063 mm)
was added. The solvent was removed under reduced pressure and
the solid mixture was heated at 100 C overnight. Purification by
column chromatography (silica gel 70–230 mesh, methanol/
dichloromethane 0.5:9.5 as the gradient eluent) yielded the pure
product. It was then washed or recrystallized as described below.
4.5.1. 4-Hydroxy-5-(1H-indol-3-yl)-2,3,4,5-tetrahydroazepino[3,4-
b]indol-1(10H)-one ()-8a
The desired product was obtained following general procedure B
(93 mg, 75%). This was recrystallized from methanol to yield pure
analytical sample as colourless crystals. Rf¼0.31 (methanol/
dichloromethane 0.5:9.5). Mp: 306 C (methanol, dec). 1H NMR
(300 MHz, DMSO-d6): d (ppm)¼11.24 (1H, br s), 10.80 (1H, un-
resolved d), 7.96 (1H, unresolved dd), 7.43(1H, d, J¼7.9 Hz), 7.36 (1H,
d, J¼8.1 Hz), 7.31 (1H, d, J¼8.1 Hz), 7.12–6.97 (3H, m), 6.93–6.88 (2H,
m), 6.74 (1H, unresolved dd), 5.22 (1H, d, J¼4.9 Hz), 4.73 (1H, d,
J¼5.1 Hz), 4.24–4.10 (1H, m), 3.29–3.20 (1H, m). 13C NMR (75 MHz,
DMSO-d6): d (ppm)¼164.3, 136.4, 136.2, 127.8, 127.2, 126.0, 124.0,
123.4, 120.8, 118.5, 118.3, 118.3, 117.6, 116.6, 112.0, 111.6, 71.4, 44.1,
42.6. ATR-IR (cm1)¼3281br, 2924w, 2851w, 1626s, 1548m, 1483m,
1454m, 1338m, 1069s, 1013m, 740s, 681m. MS (EI):m/z (rel int.) 44
(13),117 (15),128 (11),129 (24),130 (10),144 (27),188 (100),189 (16),
214 (10), 216 (14), 242 (15), 243 (37), 244 (11), 245 (12), 257 (18), 258
(15), 271(35), 272 (76), 273 (24), 286 (15), 313 (30), 331 (68), 332 (14).
HRMS (EI): calcd for C20H17N3O2 (M
þ) 331.1315, found 331.1315.
4.5.2. 4-Hydroxy-5-(7-methyl-1H-indol-3-yl)-2,3,4,5-
tetrahydroazepino[3,4-b]indol-1(10H)-one ()-8b
The desired product was obtained as a white solid following
general procedure B (83 mg, 66%). Rf¼0.26 (methanol/dichloro-
methane 0.5:9.5). Mp: 168 C (methanol/dichloromethane). 1H
NMR (300 MHz, DMSO-d6): d (ppm)¼11.23 (1H, br s), 10.76 (1H,
unresolved d), 7.95 (1H, unresolved dd), 7.36 (1H, d, J¼8.2 Hz),
7.30–7.25 (1H, m), 7.12–7.04 (2H, m), 6.86–6.80 (3H, m), 6.76 (1H,
unresolved dd), 5.20 (1H, d, J¼4.6 Hz), 4.72 (1H, d, J¼5.2 Hz), 4.18–
4.07 (1H, m), 3.27–3.18 (1H, m), 2.40 (3H, s). 13C NMR (75 MHz,
DMSO-d6): d (ppm)¼164.3, 136.2, 135.8, 127.8, 127.2, 125.7, 123.7,
123.4, 121.3, 120.8, 120.7, 118.5, 118.1, 116.6, 116.0, 112.0, 71.3, 44.0,
42.8, 16.7. ATR-IR (cm1)¼3375m, 3288s, 2973w, 2917w, 1633s,
1579w, 1537m, 1480s, 1452m, 1398w, 1375w, 1338s, 1286w, 1228m,
1181w, 1155w, 1129w, 1105m, 1076s, 1003m, 970m, 936w, 914w,
870m, 834w, 816w, 778w, 773w, 741s, 680m, 653w. MS (EI): m/z
(rel int.) 41 (14), 43 (30), 44 (81), 55 (12), 57 (11), 60 (10), 69 (17), 71
(15), 73 (18), 128 (16), 129 (10), 130 (12), 131 (22), 256 (11), 257 (26),
259 (12), 271 (25), 272 (16), 284 (10), 285 (33), 286 (94), 287 (23),
300 (15), 327 (33), 345 (100), 346 (18). HRMS (EI): calcd for
C21H19N3O2 (M
þ) 345.1472, found 345.1472.
4.5.3. 5-(5-Bromo-1H-indol-3-yl)-4-hydroxy-2,3,4,5-
tetrahydroazepino[3,4-b]indol-1(10H)-one ()-8c
The desired product was obtained following general procedure
B (87 mg, 65%). This was washed with diethyl ether and hexane to
yield pure analytical sample as an off-white solid. Rf¼0.26 (meth-
anol/dichloromethane 0.5:9.5). Mp: 234–238 C (ether/hexane,
dec). 1H NMR (300 MHz, DMSO-d6): d (ppm)¼11.28 (1H, br s), 11.02
(1H, unresolved d), 8.00 (1H, unresolved dd), 7.62 (1H, d, J¼1.9 Hz),
7.37 (1H, d, J¼8.4 Hz), 7.29 (1H, d, J¼8.5 Hz), 7.19–7.03 (3H, m), 6.91
(1H, d, J¼2.3 Hz), 6.77 (1H, unresolved dd), 5.28 (1H, d, J¼4.5 Hz),
4.69 (1H, d, J¼5.3 Hz), 4.14–4.01 (1H, m), 3.32–3.20 (1H, m). 13C
NMR (75 MHz, DMSO-d6): d (ppm)¼164.2, 136.2, 135.0, 128.0, 127.7,
127.2, 125.7, 123.5, 123.2, 120.7, 120.6, 118.7, 117.6, 116.1, 113.7, 112.0,
111.0, 71.7, 44.1, 42.5. ATR-IR (cm1)¼3401m, 3286w, 3054w,
2920w, 1630s, 1546s, 1478s, 1451s, 1408w, 1335s, 1286w, 1242w,
1154w, 1079s, 1003w, 971w, 931w, 909w, 883m, 791m, 768w, 740s,
660w. MS (EI): m/z (rel int.) 44 (18), 59 (10), 69 (12), 102 (12), 103
(19), 115 (10), 123 (19), 128 (15), 129 (44), 144 (77), 188 (100), 189
(46), 409 (5). HRMS (EI): calcd for C20H16Br1N3O2 (M
þ) 409.0420,
found 409.0412.
4.5.4. Methyl 3-(4-hydroxy-1-oxo-1,2,3,4,5,10-
hexahydroazepino[3,4-b]indol-5-yl)-1H-indole-5-carboxylate
()-8d
The desired product was obtained following general procedure
B (92 mg, 71%). This was recrystallized from methanol to yield
pure analytical sample as colourless crystals. Rf¼0.21 (methanol/
dichloromethane 0.5:9.5). Mp: 201 C (methanol). 1H NMR
(300 MHz, DMSO-d6): d (ppm)¼11.30 (1H, br s), 11.23 (1H, un-
resolved d), 8.32 (1H, unresolved d), 7.98 (1H, unresolved dd),
7.73 (1H, dd, J¼8.7, 1.7 Hz), 7.44–7.35 (2H, m), 7.11–6.98 (2H, m),
6.90 (1H, d, J¼2.3 Hz), 6.75 (1H, unresolved ddd), 5.34 (1H, d,
J¼4.7 Hz), 4.80 (1H, d, J¼5.3 Hz), 4.17–4.08 (1H, m), 3.83 (3H, s),
3.31–3.20 (1H, m). 13C NMR (75 MHz, DMSO-d6): d (ppm)¼167.3,
164.1, 138.9, 136.2, 127.6, 127.3, 125.9, 125.8, 123.5, 122.0, 121.2,
120.6, 120.0, 119.5, 118.6, 116.0, 112.0, 111.5, 71.4, 51.6, 43.8, 42.3.
ATR-IR (cm1)¼3296br, 3059w, 2924w, 2854w, 1691m, 1616s,
1546m, 1480m, 1435m, 1336m, 1282w, 1242s, 1214w, 1147w,
1102w, 1078w, 1003w, 972w, 932w, 870m, 768m, 742s, 668w,
661w. MS (EI): m/z (rel int.) 43 (11), 44 (35), 121 (22), 129 (13),
144 (17), 149 (13), 175 (16), 214 (21), 215 (15), 216 (12), 241 (18),
242 (31), 243 (31), 256 (15), 257 (10), 269 (12), 270 (14), 271 (65),
272 (86), 273 (17), 299 (11), 300 (15), 301 (23), 302 (10), 303 (16),
304 (13), 315 (20), 316 (13), 328 (16), 329 (38), 330 (100), 331
(39), 332 (10), 344 (20), 357 (13), 358 (24), 371 (70), 372 (14), 389
(97), 390 (31). HRMS (EI): calcd for C22H19N3O4 (M
þ) 389.1370,
found 389.1380.
4.5.5. 5-(5-(Benzyloxy)-1H-indol-3-yl)-4-hydroxy-2,3,4,5-
tetrahydroazepino[3,4-b]indol-1(10H)-one ()-8e
The desired product was obtained following general procedure
B (77 mg, 56%). This was recrystallized from ethyl acetate/hexane
to yield pure analytical sample as an off-white solid. Rf¼0.20
(methanol/dichloromethane 0.5:9.5). Mp: 203 C (ethyl acetate/
hexane, dec). 1H NMR (300 MHz, DMSO-d6): d (ppm)¼11.27 (1H,
br s), 10.63 (1H, unresolved d), 8.00 (1H, unresolved dd), 7.48–
7.27 (6H, m), 7.19 (1H, d, J¼8.9 Hz), 7.14–7.04 (3H, m), 6.83 (1H,
unresolved d), 6.81–6.71 (2H, m), 5.22 (1H, d, J¼4.7 Hz), 5.00 (2H,
s), 4.69 (1H, d, J¼4.9 Hz), 4.17–4.06 (1H, m), 3.30–3.17 (1H, m). 13C
NMR (75 MHz, DMSO-d6): 164.4, 151.7, 137.6, 136.2, 131.6, 128.4,
127.8, 127.7, 127.6, 127.5, 127.2, 126.3, 124.7, 123.4, 120.8, 118.5,
117.4, 116.6, 112.2, 112.0, 111.3, 102.0, 71.2, 69.7, 44.0, 42.6, 38.7.
ATR-IR (cm1)¼3292br, 3060w, 2956w, 2924w, 2855w, 1722m,
1622s, 1579w, 1545m, 1478s, 1451m, 1378w, 1335m, 1285s, 1219w,
1182m, 1154w, 1074m, 1044w, 1003w, 846w, 786m, 739s, 696m,
666w. MS (EI): m/z (rel int.) 71 (13), 73 (25), 91 (40),149 (11), 223
(10), 243 (11), 259 (30), 260 (11), 261 (31), 271 (10), 272 (18), 273
(9), 285 (13), 287 (33), 288 (12), 289 (11), 328 (17), 346 (32), 419
(25), 437 (100), 438 (28). HRMS (EI): calcd for C27H23N3O3 (M
þ)
437.1734, found 437.1733.
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4.5.6. 4-Hydroxy-5-(1H-pyrrol-2-yl)-2,3,4,5-
tetrahydroazepino[3,4-b]indol-1(10H)-one ()-9a
The desired product was obtained following general procedure
B (76 mg, 65%). This was recrystallized from ethyl acetate/hexane to
yield pure analytical sample as a brown solid. Rf¼0.33 (methanol/
dichloromethane 0.5:9.5). Mp: 209 C (hexane/ethyl acetate). 1H
NMR (300 MHz, DMSO-d6): d (ppm)¼11.24 (1H, br s), 10.55 (1H,
unresolved d), 7.91 (1H, unresolved dd), 7.38–7.33 (1H, m), 7.13–
7.06 (2H, m), 6.86–6.79 (1H, m), 6.53–6.51 (1H, m), 5.84 (dd, 1H,
J¼3.0, 2.6 Hz), 5.61–5.59 (1H, m), 5.16 (1H, d, J¼4.7 Hz), 4.48 (1H, d,
J¼5.8 Hz), 4.06–3.99 (1H, m), 3.29–3.16 (1H, m). 13C NMR (75 MHz,
DMSO-d6): d (ppm)¼164.1, 136.0, 134.0, 127.8, 127.3, 123.4, 120.7,
118.6, 116.3, 115.2, 111.9, 107.0, 105.8, 71.9, 44.4, 44.3. IR (KBr)
(cm1)¼3533w, 3321s, 2876w, 1619s, 1552s, 1483s, 1455m, 1412w,
1367w, 1334s, 1299m, 1250w, 1217m, 1196w, 1156w, 1131w, 1093w,
1069s,1027w,1012w,1003w, 977w, 930w, 913w, 875w, 846w, 802s,
785w, 768m, 745w, 733s, 633m, 612m, 550m, 481w, 449w, 432w.
MS (EI): m/z (rel int.) 44 (32), 166 (11), 192 (17), 193 (63), 194 (17),
195 (17), 207 (19), 208 (10), 220 (22), 221 (36), 222 (98), 223 (24),
262 (11), 263 (100), 264 (15), 281 (39). HRMS (EI): calcd for
C16H15N3O2 (M
þ) 281.1159, found 281.1161.
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Abstract—The selective CH-functionalization of 2-substituted indoles is presented. Using bis(pinacolato)diboron (2) in the presence
of iridium complexes, a novel catalytic mono-borylation is observed preferentially at the 7-position of the indole. This allows for an
efficient synthesis of various 2,7-di- and 2,4,7-trisubstituted indoles, which are otherwise difficult to access. The scope and limitation
of the method is demonstrated.
 2006 Elsevier Ltd. All rights reserved.
Indoles are an important class of heterocycles not only
because they are among the most ubiquitous com-
pounds in nature, but also because they have a wide
range of biological activities.1,2 Hence, it is not surpris-
ing that indoles act as lead compounds and are key
building blocks in numerous pharmaceuticals.3 In the
past, a multitude of synthetic methods for indoles have
been developed since its first chemical synthesis.3,4 Now-
adays, the choice of the synthetic method for a desired
indole derivative depends highly on the availability of
the starting materials and the functional group tole-
rance. Despite all known procedures, the synthesis of
indoles with non-conventional substitution patterns
remains a challenging task. In fact, such unusually
substituted indoles are highly interesting for the prepa-
ration of new biologically active compounds.
We have been interested in the application of catalytic
reactions for the synthesis of potential pharmaceuticals
for some time.5 In this regard, recently metal-catalyzed
borylation on aromatic C–H bonds has drawn our
attention.6 In general, this method is complimentary to
traditional electrophilic aromatic substitution and has
been used to synthesize otherwise not easily accessible
phenols7 and anilines.8
In addition, aromatic and heteroaromatic boronates are
valuable intermediates for Suzuki-Miyaura cross-coup-
ling reactions,10,11 for Cu-catalyzed C–N and C–O
bond-forming reactions,12 and for other reactions.13
Clearly, the direct C–H bond activation and functional-
ization provides a straightforward synthetic route to
access these arylboronates and avoid the use of halide
substrates and lithium or Grignard reagents in conven-
tional boronic acid synthesis.
Noteworthy, as potential pharmaceuticals, boronic
acids exhibit various biological activities.9 For example,
some of them have been used in boron neutron capture
therapy (BNCT) (Scheme 1).
In light with these issues, here we report a regioselective
borylation reaction towards 2,7-di- and 2,4,7-trisubsti-
tuted indoles, which are otherwise difficult to obtain.
As a proto-typical reaction, ethyl indole-2-carboxylate
(1a) is borylated in an inert solvent with 0.75 mol % of
[Ir(COD)OMe]2 and 1.5 mol % 4,4
0-di-tert-butyl-2,2 0-
bipyridine as the catalyst (Table 1).14 Only trace of
product is observed by GC–MS at room temperature
both in n-heptane and 1,4-dioxane (Table 1, entries 1
and 3). However, by increasing the temperature to
50 C, a good yield (67%) of the mono-borylated prod-
uct is obtained. Further optimization of the ratio of 1a
to 2 gave 3a in excellent yield (92%). It should be noted
that this reaction works better in n-heptane than in
0040-4039/$ - see front matter  2006 Elsevier Ltd. All rights reserved.
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Keywords: Iridium; Borylation; CH-activation; Indole.
* Corresponding author. Tel.: +49 381 1281193; fax: +49 381
128151193; e-mail: man-kin.tse@catalysis.de
Tetrahedron Letters 48 (2007) 371–375
1,4-dioxane (Table 1, entries 2 and 4). However, at higher
reaction temperature (100 C) both solvents gave com-
parative results. Hence, 1,4-dioxane can be used for less
soluble substrates instead.
As two C–H bonds are not hindered in 1a, non-selective
borylation was initially expected. Different from our
expectation, a single regioisomer 3a was obtained, the
structure of which was assigned based on 2D-1H
NMR and further confirmed by X-ray crystallography
(Fig. 1).
To demonstrate the scope and limitation of this reac-
tion, various 2-substituted indoles were subjected to
the typical reaction conditions,16 which, to our delight,
provided 2,7-disubstituted indole products in moderate
to excellent yields (Table 2, entries 1–7). Various func-
tional groups, such as halogen, ester, mono- and di-N-
substituted amides, as well as aromatic rings (phenyl)
are tolerated. From the GC–MS analysis of the crude
reaction mixture, the mono-borylated product usually
has >97% selectivity at the 7-position. Lower product
yields obtained were due to isolation problems and sub-
sequent diborylation. In fact, the diborylated com-
pounds can be obtained as major products when more
B2Pin2 (2) is employed (Table 2, entries 8 and 9). It is
noteworthy that the second catalytic borylation reaction
proceeds also with high regioselectivity (>85%). 1H
NMR of the isolated regioisomers showed that the
major diborylated product contains a 2,4,7-substitution
pattern.
We surmise that the high selectivity towards the 7-posi-
tion is due to an ortho-directing effect. Although the reg-
ioselectivity of the borylation process for arenes is
mainly controlled by steric effects,6 a few examples
showed the involvement of an electronic or coordination
effect.6b,17 For unprotected pyrrole and indole it is
known that borylation occurs preferentially at the
B
HO
HO CO2H
H2N
para-BPA Hoechst 33258
N N NH
N N
H
N
B
OH
OH
Scheme 1. Selected boron neutron capture therapy agents (BNCT).9
Table 1. Influence of stoichiometry of ethyl indole-2-carboxylate (1a) to bis(pinacolato)diboron (2), B2Pin2, temperature and solvent to the
borylation reaction
N
H
OEt
O
+ B2Pin2
[Ir(COD)OMe]2
dtbpy, solvent, temp.
1a
N
H
OEt
O
PinB
2
3a
Entry 1a:2a Solvent Temp (C) Yieldb (%)
1 1:0.5 n-Heptane rt Trace
2 1:0.5 n-Heptane 50 67
3 1:0.5 1,4-Dioxane rt No reaction
4 1:0.5 1,4-Dioxane 50 Trace
5 1:0.5 1,4-Dioxane 100 59
6 1:0.7 n-Heptane 50 92
Standard reaction conditions: 1a (0.50 mmol), 2 (0.25–0.35 mmol), [Ir(COD)OMe]2 (0.0038 mmol) and 4,4
0-di-tert-butyl-2,20-bipyridine
(0.0075 mmol) were charged into a schlenk tube with Teflon screwed stopper under Ar. Freshly distilled solvent (1.5 mL) and dodecane (GC internal
standard, 432 lL) were added. The reaction mixture was then heated for 16 h at rt–100 C.
aMolar ratio of 1a to 2.
b GC yield.
Figure 1. Molecular structure of 3a. The thermal ellipsoids correspond
to 30% probability.15
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Table 2. [Ir(COD)OMe]2/dtbpy-catalyzed borylation of various 2-substituted indoles
14
N
H
R1 +
[Ir(COD)OMe]2
dtbpy,
n-heptane or 1,4-dioxane,
50-100 oC, overnight
N
H
R1
BPin
R2 R2
N
H
R1
BPin
R2
B2Pin2 +
BPin
1a-h
2
3a-h 4a-h
Entry Substrate Product 1:2a Temp (C) Solvent Yieldb (%)
1 N
H
OEt
O
1a
N
H
OEt
O
BPin
3a
1:0.7 50 n-Heptane 83 (92)c
2 N
H
OEt
O
Cl
1b
N
H
OEt
O
BPin
Cl
3b
1:0.6 100 1,4-Dioxane 45
3
N
H
N
O
1c
N
H
N
O
BPin
3c
1:0.7 100 1,4-Dioxane 93
4
N
H
N
O
O
1d
N
H
N
O
BPin
O
3d
1:0.7 100 1,4-Dioxane 99d
5 N
H
HN
O
1e
N
H
HN
O
BPin
3e
1:0.7 100 1,4-Dioxane 50c
6 N
H
1f 
N
H
BPin
3f
1:0.7 50 n-Heptane 54
7 N
H
1g
N
H
BPin
3g
1:0.7 50 n-Heptane 58
8 N
H
OEt
O
1a
N
H
OEt
O
BPin
BPin
4a
1:2.5 50 n-Heptane 75c,e
9 N
H
OEt
O
F
1h
N
H
OEt
O
BPin
F
BPin
4h
1:1.2 50 n-Heptane 48
Standard reaction conditions: 1a (0.50 mmol), 2 (0.30–1.25 mmol), [Ir(COD)OMe]2 (0.0038 mmol) and 4,4
0-di-tert-butyl-2,20-bipyridine
(0.0075 mmol) were charged into a schlenk tube with Teflon screwed stopper under Ar. Freshly distilled solvent (1.5 mL) and dodecane (GC internal
standard, 432 lL) were added. The reaction mixture was then heated for 16 h at 50 C for n-heptane and 100 C for 1,4-dioxane.
aMolar ratio of 1a to 2.
b Isolated yield.
c GC yield.
d NMR yield.
e The ratio of 4,7-diborylated product to 5,7-diborylated product is 85:15 determined by 1H NMR.
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2-position,6,18 while borylation of N-methylindole gave
a mixture of 2- and 3-borylated products in a ratio of
56:44.18a Thus, it is likely that the indole N–H group
is a directing group for the borylation reaction.
In most of the reported borylation procedures, the are-
nes are usually used in excess with respect to 2 when
more than one unhindered C–H bond exists in order
to obtain the mono-boronate in good yield.6,18 How-
ever, 2-substituted indoles gave full conversion with high
selectivity towards 7-borylated indoles in the presence of
an equimolar or a slight excess amount of 2 (Table 2, en-
tries 1, 3 and 4). This is an important advantage because
more expensive starting materials may also be further
functionalized through the boronate using our protocol.
It is noteworthy that in principle both boronate groups
in bis(pinacolate)diborane (2) are effective to the bory-
lation reaction and generate only hydrogen as by-product
(Tables 1 and 2). Hence this reaction is a clean, atom
efficient and direct method towards 2,7-disubstituted
indoles.
As a demonstration for the use of the borylated indoles,
the Suzuki-Miyaura cross-coupling reaction was per-
formed with 3a and PhI, which yielded the phenyl-
substituted product 5 in 73% yield under microwave
conditions (Scheme 2).6a
Since 2-substituted phenylhydrazines are less accessible,
relatively few examples for the synthesis of 2,7-disubsti-
tuted indoles are known via the most commonly used
Fischer indole synthesis.19
Clearly, the method presented here provides a more gen-
eral access to this substitution pattern and may contrib-
ute to medicinal chemistry and pharmaceutical industry
in the future.
In conclusion, we have shown the application of the irid-
ium-catalyzed borylation reaction to 2-substituted
indoles. Excellent regioselectivity towards 7-borylated
indoles was observed. In the presence of an excess of
the borylation reagent, 2,4,7-trisubstituted indoles are
obtained preferentially. The scope and limitation of
the catalytic system are demonstrated on indoles with
various functional groups with moderate to excellent
yields. Further functionalization of the 7-borylated
indoles to potentially bioactive compounds is in progress
in our group.
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Palladium-Mediated Fluorination of Arylboronic Acids**
Takeru Furuya, Hanns Martin Kaiser, and Tobias Ritter*
Fluorinated organic molecules have become increasingly
important as pharmaceuticals[1] and tracers for positron-
emission tomography (PET), a powerful technology for
noninvasive molecular imaging.[2] The nucleus of choice for
PET is fluorine-18 (18F), which is typically introduced into
PET tracers through the formation of carbon–fluorine bonds
using nucleophilic fluoride (18F) under harsh reaction con-
ditions.[3] The short half-life of 18F (109 minutes) requires that
carbon-fluorine bond formation occurs at a late stage in the
PET tracer synthesis, ideally as the last step. Many promising
PET tracers for imaging are currently inaccessible owing to
the lack of suitable chemistry for the general, late-stage
introduction of fluorine into complex, functionalized mole-
cules.[3,4] Herein, we present a new strategy for carbon–
fluorine bond formation that relies on the fluorination of
arylboronic acids using palladium complexes [Eq. (1)]. The
reaction permits a general, regiospecific late-stage formation
of carbon–fluorine bonds in the presence of a large variety of
functional groups found in biologically active molecules.
Ultimately, we anticipate our new fluorination reaction will
provide a chemical solution for the synthesis of currently
inaccessible PET tracers to increase both knowledge and
understanding of basic, biomedical, and pharmaceutical
research through molecular imaging.[5–8]
Carbon–fluorine bond formation is a challenging chemical
transformation, and no general, functional-group-tolerant
fluorination reaction of arenes is currently available for the
synthesis of complex molecules. Simple fluoroarenes are
typically synthesized by pyrolysis of diazonium tetrafluoro-
borates,[9] direct fluorination using highly reactive elemental
fluorine,[10] or nucleophilic aromatic substitution reactions of
electron-poor aromatic molecules.[11,12] Common aromatic
organometallic compounds, such as aryl lithium and aryl
Grignard reagents, can afford arylfluorides if using electro-
philic fluorine sources; however, neither aryl lithium nor aryl
Grignard reagents can be used for the late-stage fluorination
of arenes bearing electrophiles, such as aldehydes, or protic
functionalities, such as alcohols, limiting their general util-
ity.[13] Organometallic compounds with lower basicity, such as
aryl zinc halides, aryl silanes, aryl stannanes, and aryl boronic
acids, afford fluorobenzenes in less than 10% yield (see the
Supporting Information). The electrophilic fluorination of
specific carbon–hydrogen bonds of phenylpyridine deriva-
tives and related structures was reported in 2006 by Sanford
et al. , and uses catalytic palladium (II) acetate and N-
fluoropyridinium salts.[14] The reaction takes advantage of a
covalently attached pyridine directing group and affords
fluorinated aryl pyridine derivatives using microwave irradi-
ation (100–150 8C, 1–4 h, 33–75% yield). A different
approach, the reductive elimination of aryl fluorides from
palladium(II) fluoride complexes, would obviate the use of
directing groups, and has been investigated over the past
decade by Grushin and Yandulov.[15,16] Carbon–fluorine bond
formation to form aryl fluorides by reductive elimination
from a palladium(II) fluoride complex has not yet been
substantiated.[16,17] In general, all methods mentioned above
cannot be employed for late-stage fluorination of structurally
complex molecules owing to either harsh reaction conditions
or limited substrate scope.
We have sought a new regiospecific, late-stage fluorina-
tion reaction of arenes that encompasses a larger substrate
scope than is currently accessible, tolerates the presence of a
variety of functional groups, is not limited to a particular class
of arenes, and is not dependent on a directing group. Our
strategy is illustrated in Equation (1), and consists of the
synthesis of new aryl palladium complexes that react with the
electrophilic fluorination reagent selectfluor[18] to afford
fluoroarenes.
Our initial investigations for the design of transition-metal
complexes that afford efficient fluorination was guided by the
observation that palladium has been successfully employed in
several carbon–heteroatom bond formations,[19,20] including
carbon–fluorine bonds for specific substrates.[14,21] Addition-
ally, the development of our methodology was directed by the
[*] T. Furuya, H. M. Kaiser, Prof. T. Ritter
Department of Chemistry and Chemical Biology
Harvard University, 12 Oxford Street, Cambridge, MA 02138 (USA)
Fax: (+1)617-496-4591
E-mail: ritter@chemistry.harvard.edu
Homepage: http://www.chem.harvard.edu/groups/ritter/
index.html
[**] We thank Merck& Co. and Amgen Inc. for unrestricted support, Eli
Lilly & Co. for a Graduate Fellowship for T.F., and the Degussa
Foundation for a fellowship for H.M.K. We thank Dr. Douglas M. Ho
for X-ray crystallographic analysis.
Supporting information for this article is available on the WWW
under http://dx.doi.org/10.1002/anie.200802164.
Angewandte
Chemie
5993Angew. Chem. Int. Ed. 2008, 47, 5993 –5996  2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
necessity to predict and control the exact location of
fluorination and the need to introduce fluorine at any desired
aromatic position. Therefore, the target molecules for fluo-
rination are pre-functionalized with boronic acids at the
position at which fluorine is desired. Boronic acids are readily
accessible, compatible with a variety of functional groups
present in PET tracers, competent nucleophiles for trans-
metallation to palladium, and can be introduced into complex
molecules.[22]
Several aryl palladium complexes based on ligands that
are commonly used for palladium chemistry did not lead to
carbon–fluorine bond formation when evaluated for fluori-
nation. We therefore designed new aryl palladium complexes
that are derived from a bidentate ligand that contains a
neutral and an anionic nitrogen donor atom for coordination
to palladium. Our design was based on the assumptions that
nitrogenous ligands resist oxidation by electrophilic fluorina-
tion reagents, can support high-valent aryl palladium fluo-
rides for subsequent carbon–fluorine reductive elimination,
and do not induce competing nitrogen–fluorine reductive
elimination. We prepared the new palladium acetate complex
1 by known sulfonamide insertion[23] into the palladium–
carbon bond of benzoquinoline-derived palladacycle 3,[24]
followed by chloride–acetate ligand exchange [Eq. (2)]. The
aryl palladium complexes 4a–m were prepared by trans-
metallation using twelve different arylboronic acids (Table 1).
Transmetallation proceeded at 23 8C in a basic methanol/
benzene solution and afforded the palladium complexes as
moisture- and air-stable yellow solids in 65–91% yield on a
400 mg scale after purification by chromatography on silica
gel. The aryl palladium complexes derived from 1 are tolerant
toward the presence of a variety of functional groups found in
biologically active compounds, including alcohols, an indole,
and a primary amide. The phenyl palladium sulfonamide 4a
(R=H) crystallized in a square-planar geometry with the aryl
group trans to the k1-sulfonamide ligand (Figure 1). The trans
relationship may be crucial to prevent undesired carbon–
nitrogen bond formation through reductive elimination of the
aryl and sulfonamide substituents.[25]
Fluorination of the aryl palladium complexes 4a–m using
the electrophilic reagent selectfluor (2) afforded the aryl-
fluorides 5a–m regiospecifically in 31–82% isolated yield
(Table 2). The fluorination reaction tolerates the presence of
a variety of functional groups, most notably protic function-
alities that are not typically compatible with nucleophilic
aromatic substitution methods owing to the high basicity of
fluoride ion in anhydrous solvents suitable for nucleophilic
displacement.[10] Additionally, electron-rich fluoroarenes (5b,
5g, 5h), which cannot be synthesized through late-stage
fluorination using nucleophilic displacement, are accessible
regiospecifically. The scope of the reaction was further
extended to electron-poor (5e, 5 l), heterocyclic (5m), and
ortho-substituted arenes (5k). Fluorination proceeds in 30
minutes when performed in acetonitrile or acetone at 50 8C.
Although fluorination was observed at 23 8C, the highest
Table 1: Transmetallation to form aryl palladium(II) complexes.
Boronic acid Yield
[%]
Boronic acid Yield
[%]
4a 76 4g 70
4b 85 4h 79
4c 91 4 i 65
4d 80 4k 90
4e 71 4 l 88
4 f 73 4m[a] 76
[a] Boc= tert-butyloxycarbonyl.
Figure 1. ORTEP diagrams of 1 and 4a, with thermal ellipsoids set at
50% probability, showing the trans relationship of the sulfonamide
nitrogen atom to the acetate and to the aryl ligands.
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yields were obtained at a reaction temperature of 50 8C.
Yields of isolated products were identical when the fluorina-
tion reactions were performed under rigorous exclusion of air
and moisture or open to the atmosphere.
The fate of the palladium moiety after fluorination was
determined to be cationic palladium complex 6, which was
independently synthesized by treatment of palladium chlo-
ride 7 with silver tetrafluoroborate in acetonitrile (Scheme 1).
Subsequent reaction of 6 with one equivalent of pyridine
afforded the stable palladium tetrafluoroborate salt 8, which
was isolated and characterized. Addition of pyridine after
termination of the reaction shown in Table 2 also afforded 8,
which suggests that the pyridyl sulfonamide ligand remained
coordinated to palladium throughout the reaction. The
stability of the ligand–metal complex is advantageous for a
prospective catalytic version of the presented fluorination
reaction.
Transition-metal catalysis for carbon–fluorine bond for-
mations is a valuable goal in itself. However, for the synthesis
of PET tracers, a fluorination reaction using stoichiometric
amounts of transition metal is advantageous, as stoichiometric
reactions are faster than the corresponding catalyzed reac-
tions, and time is the most important factor for the efficient
preparation of PET tracers owing to the short half-life of 18F.
Moreover, price and toxicity of palladium are of lesser
importance for applications in molecular imaging because
PET tracers are used in picomolar quantities and are purified
by HPLC before injection in vivo.
Two possible mechanisms for the fluorination reaction
presented herein are electrophilic palladium–carbon bond
cleavage and carbon–fluorine reductive elimination from a
discrete, high-valent palladium fluoride.[21] The redox activity
of palladium (II) may play a crucial role for fluorination,
which suggests a high-valent, discrete palladium fluoride
complex as an intermediate before carbon–fluorine reductive
elimination.[26]
In conclusion, we report a fluorination reaction of aryl
boronic acids mediated by palladium, in which carbon–
fluorine bond formation is the final synthetic step. The
functional group tolerance, broad substrate scope, and
regiospecificity of the reaction provide a general method for
the late-stage fluorination of functionalized arenes. This new
chemistry may become the basis for the development of a
general solution for the synthesis of PET tracers for
biomedical applications. Electrophilic 18F sources are avail-
able, but from a biomedical perspective nucleophilic 18F is
the preferred source of fluorine for PET imaging because it
can be prepared in high specific activity.[3] A subsequent goal
is therefore the development of an electrophilic fluorine
source originating from nucleophilic fluoride (18F). Further
development of the transformation presented herein, in
combination with known or new electrophilic fluorine
sources, may deliver promising PET tracers to impact
biomedical research in the fields of cancer, neurodegener-
ative diseases, gene therapy, and drug development.
Experimental Section
Representative fluorination (4-fluorobiphenyl, 5c): Aryl palladium
complex 4c was added as a solid (143 mg, 0.200 mmol, 1.00 equiv) in
10 portions over 10 min to a solution of selectfluor (2 ; 85.0 mg,
0.240 mmol, 1.20 equiv) in acetonitrile (6.0 mL) at 50 8C. The reaction
mixture was subsequently stirred at 50 8C for 20 min. After cooling to
23 8C, pyridine was added to the reaction mixture (8.1 mL, 0.10 mmol,
1.0 equiv), and the reaction mixture filtered through a plug of celite.
The filtrate was concentrated in vacuo and the residue purified by
chromatography on silica gel, eluting with hexane/ethyl acetate 99:1
(v/v) to afford 24.8 mg of 5c as a white solid (72% yield).
CCDC-675999 (1) and CCDC-676000 (4a) contain the supple-
mentary crystallographic data for this paper. These data can be
obtained free of charge from The Cambridge Crystallographic Data
Centre via www.ccdc.cam.ac.uk/data_request/cif.
Received: May 8, 2008
Published online: July 4, 2008
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Table 2: Electrophilic fluorination with aryl palladium complexes.
4 Product Yield
[%]
4 Product Yield
[%]
4a 5a[a] 81 4g 5g[b] 31
4b 5b[a] 79 4h 5h[b] 46
4c 5c 72 4 i 5 i 73
4d 5d 70 4k 5k 82
4e 5e 61 4 l 5 l[a] 54
4 f 5 f 74 4m 5m[b] 60
[a] Yield for this entry determined by 19F NMR analysis because of low
boiling point of product. [b] Acetone used as solvent.
Scheme 1. Independent synthesis of palladium byproduct 6.
p-Ns=para-nitrobenzenesulfonyl.
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ABSTRACT
A general copper-catalyzed method for the sulfonylation of arylboronic acids with sulfinate salts is described. A variety of alkyl−aryl, diaryl,
and alkyl−heteroaryl sulfones were synthesized in good yield.
The synthesis of sulfones has drawn much attention over
the years since they constitute useful building blocks in
organic chemistry as well as in medicinal chemistry. Because
of their chemical properties1 and promising biological
activities,2 especially, aryl and diaryl sulfones have emerged
as important synthetic targets in recent years. As an example,
aryl sulfones are the main constituent of many drugs, such
as the selective COX-2 inhibitor Vioxx3 (1) and the pros-
taglandin D2 (DP) antagonist MK-0524 (2),4 whereas the
diaryl sulfones 3 have been shown to inhibit the HIV-1
reverse transcriptase and represent an emerging class of
substances able to address the toxicity and resistance
problems of nucleoside inhibitors (Figure 1).5
Known procedures for aryl sulfone preparation are based
on the oxidation of the corresponding sulfides,6 the electro-
† Leibniz-Institut fu¨r Katalyse e.V. an der Universita¨t Rostock.
‡ University of Rostock, Center for Life Science Automation (CELISCA).
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philic aromatic substitution of arenes with arenesulfonic acids
in the presence of strong acids7 or with arenesulfonyl
halides,8 the reaction of carbon electrophiles with sulfinate
salts,9 and the reaction of organomagnesium halides10 or
organolithium compounds11 with sulfonate esters. All these
simple and attractive procedures have their own drawbacks,
mainly due to the incompatibility with numerous functional
groups such as amines, olefins, and some nitrogen hetero-
cycles. Over the past decade, there has been a significant
improvement in metal-mediated coupling of sulfinic acid salts
with aryl halides and triflates12 as well as arylboronic acids
with sulfonyl chlorides13 as alternatives to these conventional
methods. However, the scope is limited to aryl bromides/
iodides or triflates, and the use of air- or moisture-sensitive
reagents is sometimes not avoidable. Recently, a copper-
mediated oxidative coupling reaction of arylboronic acid with
sulfinic acid salt was described.14 However, an excess of
copper acetate (with respect to the arylboronic acid) was
required. Hence, improved methods for the preparation of
diaryl sulfones are therefore highly desirable. In recent years,
we have applied catalytic reactions to the synthesis of new
pharmacologically interesting compounds.15 On the basis of
our previous work on copper-catalyzed reactions,16 we
thought that the use of an appropriate ligand or additive
would enable us to realize a catalytic version of the
sulfonylation of boronic acids to synthesize aryl sulfones
(Scheme 1). With the wide variety of commercially available
boronic acids and esters as well as the metal-catalyzed direct
C-H bond functionalization to the not easily accessible
boronates,17 catalytic sulfonylation of these boron-containing
compounds should be very versatile for the preparation of
sulfones. In light with these issues, here we report the first
copper-catalyzed oxidative coupling of arylboronic acids with
sulfinic acid salts. In our prototypical reaction, phenylboronic
acid and sodium methanesulfinate were reacted at 60 °C in
anhydrous DMSO in air in the presence of Cu(OAc)2, a
ligand, and K2CO3 as base. The initial screening of the(6) Oae, S. Organic Sulfur Chemistry; CRC Press: Boca Raton, FL, 1992;Chapter 6.
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Chem. 2001, 66, 8616. (c) Frost, C. G.; Hartley, J. P.; Whittle, A. J. Synlett
2001, 830. (d) Bandgar, B. P.; Kasture, S. P. Synth. Commun. 2001, 31,
1065.
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Figure 1. Structures of Vioxx (1), MK-0524 (2), and diaryl
sulfones 3.3-5
Scheme 1. Catalytic Sulfonylation with Different Ligands
(GC Yield)a
a Reaction conditions: see Supporting Information.
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ligands clearly showed that the reaction can be performed
catalytically with 20 mol % of Cu(OAc)2. We have tested
different ligand types in our model reaction. Among these
ligands, tetradentate and bidentate N ligands gave poor results
irrespective of their donor atom and capacity. We realized
that only monodentate ligands can stabilize the generated
copper species for the required transformation, and indeed,
N-protected imidazoles were found to be the most suitable
ligands for this reaction with a loading of 20 mol % with
respect to the substrate.
In fact, when the ligand loading was increased to 40 mol
%, a substantial amount of conversion was observed and the
corresponding methyl sulfone was isolated in 64% yield
(Table 1). Following a previously reported protocol using a
stoichiometric amount of copper at room temperature,12 the
same substrate gave only 59% of the desired product. These
results indicate that our catalytic system is even slightly more
efficient than the reported stoichiometric conditions. Reac-
tions with different additives, such as (CH3)4NBr, CsF,
chloramine-T, and 1,4-benzoquinone, were also performed
in the presence or absence of ligand; however, none of them
were able to improve the yield significantly. Further opti-
mization showed the best catalytic system was defined as
follows: 0.5 mmol of boronic acid, 1.5 equiv of sulfinic acid
salt, 20 mol % of Cu(OAc)2, 40 mol % of 1-benzylimidazole,
2 equiv of K2CO3, and 1.25 g of molecular sieves (4 Å) at
60 °C in anhydrous DMSO in a flask equipped with an air
drying tube. To the best of our knowledge, this is the first
example of copper-catalyzed sulfonylation of an arylboronic
acid.
A variety of aryl sulfones have been prepared employing
these reaction conditions, as shown in Table 2. This cross-
coupling reaction is quite general and can be easily applied
to a wide range of arylboronic acids. Both electron-rich and
electron-deficient substrates reacted with almost similar ease,
and the substrate variety indicates that the substitution pattern
in the aromatic ring does not have significant influence in
the reaction outcome. Bromo and chloro substituents on the
boronic acid part are also tolerated under the reaction
conditions, which could extend the scope of further func-
tionalization on the aromatic ring. The reaction also pro-
ceeded with pinacol boronate ester with good yield (Table
2, entry 6). Reaction of the 2-trifluoromethylphenylboronic
acid is noteworthy. In spite of the presence of a strong
Table 1. Cross-Coupling Reaction between Arylboronic Acid
and Sodium Methanesulfinatea
entry Cu(OAc)2 1-benzylimidazole temp
GC yield
(%)
1 1.1 equiv - rt 59
2 20 mol % 20 mol % 60 °C 47
3 20 mol % 40 mol % 60 °C 64
a Reaction conditions: see Supporting Information.
Table 2. Catalytic Sulfonylation of Boronic Acidsa
a Reaction conditions: see Supporting Information.
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electron-withdrawing group at the ortho position, it reacted
smoothly to provide the corresponding sulfone (Table 2, entry
9). Of particular interest is the reaction with 4-vinylphenyl-
boronic acid to the corresponding methyl sulfone. Although
the starting material polymerized, we were able to obtain a
moderate product yield (Table 2, entry 11). Under the same
reaction conditions, we were able to couple 4-hydroxyphe-
nylboronic acid to the corresponding methyl sulfone, but only
with moderate yield, most probably because of the reduction
of the in situ generated arylcopper species (Table 2, entry
10).18
The same method can also be extended to synthesize diaryl
or heteroaryl substrates, which are of particular interest for
potential drug applications. Arylsulfinate salts were ef-
ficiently coupled with arylboronic acids to provide diaryl
sulfones in good yields following the same reaction proce-
dure (Table 2, entries 13 and 14). Similarly, this reaction
was also possible with heterocyclic substrates, such as
thiophene-3-boronic acid and pyridine-4-boronic acid, though
the yields were somewhat lower (Table 2, entries 15 and
16). This method is also applicable to a vinyl sulfone. As
an example, phenylvinylboronic acid was coupled success-
fully to give the corresponding vinyl methyl sulfone in good
yield (Table 2, entry 17).
In summary, we have developed an efficient and general
method for a copper-catalyzed synthesis of methyl-aryl,
aryl-aryl, and heteroaryl sulfones with various functional
groups, which can also be extended to the preparation of
vinyl sulfones. Further studies to increase the catalytic
activity are currently underway in our laboratory.
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Abstract: A self-catalyzed selective oxidation of
sulfides to sulfoxides has been developed. The
scope of the protocol is demonstrated in the selec-
tive oxidation of 17 different substrates. High yields
and chemoselectivity (in general >90%) are achiev-
ed in most cases.
Keywords: green chemistry; selective oxidation;
self-catalyzed; solvent free; sulfoxide
For the sustainable development of our economy, the
further use of green chemistry is an important issue.
In this respect preventing waste, but not treating or
cleaning it up, is a basic requirement.[1] In a given
chemical process, reducing the use of toxic chemicals
and waste remitting with high atom-efficiency are key
points. One of the major challenges of organic synthe-
sis is undoubtedly to develop more environmentally
friendly oxidation processes.[2] As an example, herein
we report an efficient oxidation of sulfides to sulfox-
ides.
The selective oxidation to give sulfoxides has at-
tracted much attention over the years since sulfoxides
constitute useful building blocks in organic synthesis
for the preparation of biologically active compounds
and activation of enzymes.[3] Traditionally, the synthe-
sis is performed with a stoichiometric amount of or-
ganic or inorganic oxidant and a large amount of
toxic waste is produced.[4] In order to run this trans-
formation in a “greener” manner, there are three fac-
tors that can be improved: use of (i) environmentally
benign oxidants, (ii) less or even no organic solvent
and (iii) non-toxic catalysts. Hence, aqueous hydrogen
peroxide has been used as the terminal oxidant since
the beginning of the last century,[5] because it is
cheap, environmentally benign, readily available, of
high atom-efficiency (47%), and theoretically only
generates water as the by-product.[6] Different kinds
of catalysts including acids,[7] iron,[8] vanadium,[9] tung-
sten,[10] manganese,[11] copper,[12] titanium,[13] plati-
num,[14] and magnesium[15] based systems were used to
obtain good yields.
During our continuous investigation for selective
oxidation reactions using aqueous hydrogen peroxide
as the terminal oxidant,[16] we found serendipitously
that the sulfoxides themselves, produced during the
reaction, can be very effective catalysts for the selec-
tive oxidation of sulfide to sulfoxide (Scheme 1). This
is one of the relatively few cases of self-catalyzed re-
actions.[17] This process needs no additional catalysts,
solvents and proceeds highly selectively.
In our initial exploratory experiments applying thio-
anisole in the presence of different transition metal
catalysts under solvent-free conditions, all reactions
gave good yields of methylsulfinylbenzene after 12 h
at room temperature. To our surprise, the control ex-
periment without catalyst also showed high yield of
the corresponding sulfoxide (>98%, GC yield). At
70 8C, the oxidation of thioanisole to methylsulfinyl-
benzene with 1 equiv. 30 wt% H2O2 gave even full
conversion within 1 h! When the reaction was carried
out at room temperature, the yield to methylsulfinyl-
benzene was only 63% (GC yield) after 6 h. As
shown in Figure 1 the reaction started at a very low
rate. However, when a small amount of methylsulfi-
nylbenzene is produced, the reaction is accelerated
and became faster and faster. After the formation of
4.7% sulfoxide in the mixture (5 min), ~90% of thio-
anisole could be further converted into methylsulfi-
nylbenzene in the next 15 min. It is clear that the con-
centration of methylsulfinylbenzene, but not the con-
centration of thioanisole or hydrogen peroxide deter-
mined the initial reaction rate. In order to clarify this
Scheme 1. Selective oxidation of sulfides to sulfoxides.
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effect, methylsulfinylbenzene was further added to
the reaction mixture. 16% or 76% of thioanisole are
converted in 5 min with 5 or 20 mol% of added meth-
ylsulfinylbenzene. The reaction rates became similar
after 20 min, because much more sulfoxide than the
pre-added amount was produced. This is a direct evi-
dence for the acceleration of the sulfide oxidation by
the self-generating sulfoxide. Interestingly, both phos-
phine oxides and nitroxyl radicals decrease the rate of
the sulfide oxidation. Hence, the addition of 20 mol%
of trioctylphosphine oxide and 20 mol% TEMPO
gave a significantly lower yields (50–60% after
30 min) compared with the blank experiment (90%
after 30 min). Also the corresponding sulfone is not
the catalyst in the reaction system because up to
60 min, only ~1% of methylsulfonylbenzene is ob-
served by GC-FID and GC-MS. In fact, the reaction
in the presence of 20 mol% sulfone is much slower
than that with sulfoxide. The addition of dimethyl
sulfoxide exhibited comparable activity to methylsul-
fonylbenzene but it was much lower than with meth-
ylsulfinylbenzene, Figure 1 (h). Therefore, the struc-
ture of sulfoxide but not only the functional group
itself has a great effect on its activity.
In order to explore the generality for this protocol,
we further tested this selective oxidation with various
sulfides (Table 1). Typical sulfides, such as thioanisole,
methyl p-tolyl sulfide and ethyl phenyl sulfide gave
the corresponding sulfoxides in excellent yields, 92–
97% (Table 1, entries 1–3). It is noteworthy that only
1% sulfones formed in the oxidation of thioanisole
and methyl p-tolyl sulfide. This indicates that the
present protocol is very selective and easily controlla-
ble. Functional groups are also tolerated in this proce-
dure. Methyl phenyl sulfide derivatives with OMe,
Cl, CN, CH2Br and CH2CH2Cl substituents re-
Figure 1. Typical reaction conditions: 5.0 mmol (620 mg) thioanisole and 5.0 mmol (0.50 mL) 30 wt% H2O2 and the appro-
priate catalyst [no sulfoxide or sulfone was added for (a)–(c), 5 mol% methylsulfinylbenzene, 20 mol% methylsulfinylben-
zene, 20 mol% methylsulfonylbenzene, or 20 mol% dimethyl sulfoxide were initially present in (d), (e), (f) and (g) respec-
tively] were heated at 68–70 8C. (a) thioanisole (%) vs. reaction time; (b) methylsulfinylbenzene (%) vs. reaction time; (c)
methylsulfonylbenzene (%) vs. reaction time; (d), (e), (f) and (g) methylsulfinylbenzene (%) vs. reaction time.[18]
Table 1. Selective oxidation of sulfides to sulfoxides with hydrogen peroxide.[a]
Entry Substrate Product Sulfoxide:Sulfone[b] Yield[c] [%]
1 99:1 97
2 99:1 94
3 94:6 92
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Table 1. (Continued)
Entry Substrate Product Sulfoxide:Sulfone[b] Yield[c] [%]
4 99:1 98
5 97:3 91
6 98:2 88
7 91:9 52
8 94:6 90
9 91:1 90
10 99:1 90
11 99:1 87
12 88:12 69
13 99:1 93
14 96:4 87
15 96:4 81
16[d] 83:17 80
17[e] 86:14 84
[a] 2.0 mmol sulfide, 2.0 mmol H2O2 (30 wt% in water, 1 equiv., VWR), 70 8C (oil bath temperature), 1 h.
[b] Determined by GC-MS.
[c] Isolated yield for sulfoxide.
[d] 24.0 mmol H2O2, 12 h.
[e] 16.0 mmol H2O2, 2 h.
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sulted in excellent yields (Table 1, entries 4–8). With
2-(methoxyphenyl)methylsulfane, the isolated yield
reached 98% (Table 1, entry 4). However, a lower
yield (52%) is obtained with 4-(methylthio)benzyl
bromide. Here, GC-MS analysis showed that hydroly-
sis of the bromomethyl group to the corresponding 4-
methylthiobenzyl alcohol and oxidation of the benzyl
bromide group to 4-methylthiobenzylaldehyde are the
major side reactions.
The selective oxidation of compounds with two
functional groups within one molecule is always an in-
teresting topic in oxidation chemistry. Hence, sulfides
containing oxidizable NH2, CH2OH, CHO andC(O) groups were tested (Table 1, entries 9–13).
To our delight, for compounds containing amine and
alcohol groups, the oxidation occurred selectively on
the sulfur atom. Even with 4-methylthiobenzaldehyde,
a good isolated yield of 69%, was obtained.
Moreover, for the selective oxidation of aliphatic
sulfides, good yields are also achieved (Table 1, en-
tries 14 and 15). Methyl (methylthio)acetate was
easily oxidized into methyl methylacetate sulfoxide, a
synthetically useful reagent, in 81% yield.[19] Notably,
this protocol can be easily scaled up. As a demonstra-
tionof a 200-mmol scale reaction, 29.2 g of di-n-butyl
sulfide were oxidized to di-n-butyl sulfoxide. Merely
by extracting the reaction mixture was a quantitative
yield of product obtained with>93% purity.
The formation of sulfoxides from diphenyl sulfide
and benzyl phenyl sulfide are more difficult to ach-
ieve under the known standard oxidation procedures.
Even in the presence of highly active catalysts, much
more hydrogen peroxide and longer reaction times
were necessary in order to accomplish satisfactory re-
sults.[10b] In the presence of an excess of hydrogen per-
oxide, the yield for diphenyl sulfoxide reached 80%
(Table 1, entry 16) and the yield of benzyl phenyl sulf-
oxide reached 84% (Table 1, entry 17).
In conclusion, a self-catalyzed selective oxidation of
sulfides to sulfoxides has been developed for the first
time. The scope of the protocol is demonstrated in
the selective oxidation of 17 different substrates. High
yield and chemoselectivity (in general >90%) are
achieved in most cases. Compared with the previous
protocols, this system has the advantage that no or-
ganic solvents or any additional catalyst is necessary.
This makes the reaction environmentally benign,
more practical and easily manageable. The study of
the reaction mechanism and the development of a ste-
reoselective version of this reaction are now undergo-
ing in our laboratory.[20]
Experimental Section
General Procedure for the Self-Catalyzed Selective
Oxidation of Sulfide to Sulfoxide
All reactions were carried out in an oil bath (69–70 8C, oil
bath temperature). To a glass reactor (40 mL), 2.0 mmol
(0.292 g) di-n-butyl sulfide and 2.0 mmol H2O2 (30 wt% in
water, from VWR, 0.20 mL) were added, respectively. The
reaction was vigorously stirred (500–750 rpm) at 70 8C for
1 h. The mixture was then cooled to room temperature and
extracted by CH2Cl2 (20 mL3). After drying with anhy-
drous Na2SO4, the organic mixture was removed in vacuum
and a colorless liquid (0.301 g) was obtained. The sample
was analyzed by GC-MS, which indicated that the ratio be-
tween sulfoxide and sulfone was 96:4. 1H NMR analysis
showed that the ratio between sulfoxide and sulfone was
95:5.
Analytically pure dibutyl sulfoxide was obtained by
column chromatography (silica gel 60, 70–230 mesh) using
CH2Cl2 to ethyl acetate as the gradient eluent. After remov-
al of the solvent and drying under high vacuum for 2 h, a
white solid was obtained; yield: 282 mg (87%).
Example of a Scaling-Up for the Selective Oxidation
of Dibutyl Sulfide
To a round-bottom flask (250 mL), 200 mmol (29.2 g) of di-
n-butyl sulfide and 200 mmol H2O2 (30 wt% in water, from
VWR, 20 mL) were added respectively. The reaction mix-
ture was vigorously stirred (500–750 rpm) at 70 8C for 1 h.
During the reaction, the system should be open to air and
well cooled with a condenser.[21] The mixture was then
cooled to room temperature and extracted by ethyl acetate
(200 mL4). After drying with anhydrous Na2SO4, the or-
ganic mixture was removed in vacuum and a colorless liquid
(34.6 g) was obtained. The sample was analyzed by GC-MS,
which indicated that the ratio between sulfoxide and sulfone
was 93:7. 1H NMR analysis showed that the ratio between
sulfoxide and sulfone was 93:7. 1-(Butylsulfinyl)butane: Rf=
0.84 (ethyl acetate); colorless semi-solid; 1H NMR
(300.1 MHz, CDCl3): d=0.93 (6H, t, J=7.3 Hz), 1.35–1.54
(4H, m), 1.66–1.76 (4H, m), 2.54–2.70 (4H, m); 13C NMR
(75.5 MHz, CDCl3): d=13.7, 22.1, 24.6, 52.1; GC-MS (E.I. ,
70 eV): m/z (rel. int.)=162 (M+, 1), 106 (12), 89 (32), 63
(16), 57 (35), 56 (12), 55 (22), 41 (100), 39 (36).
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A gold-catalyzed mild and general oxidative homo-coupling of
arenes using PhI(OAc)2 as the oxidant is described (13
examples, 31–81% yield).
Biaryls constitute an important structural component in natural
products, pharmaceuticals, agrochemicals and materials.1 In recent
decades there have been rapid advances in C(sp2)–C(sp2) bond
formation reactions to construct biaryls. Traditionally, the arene
being coupled needs to be ‘pre-activated’, such as by halogenation,
prior to metal-mediated coupling reactions.2 Alternatively, halo-
genated arenes are converted to organometallic reagents and
homo- or hetero-coupling reactions are performed in the next step.
Transition metal-catalyzed cross-coupling reactions are undoubt-
edly the most versatile protocols to connect electrophilic reagents
(ArX) with nucleophilic organometallic derivatives (ArM).3 One
drawback of these reactions is the necessity for an activating group
on both the coupling partners. Though elegant C–H bond
functionalization methods to obtain the organometallic reagents
save one synthetic step,4 direct metal (e.g. Pd, Rh, Ru etc.)
catalyzed regioselective C–H bond activation with subsequent C–C
bond formation with ArX or ArM has a better atom efficiency.5
Very recently, significant advances have been made in the
development of arylation of arenes, such as indole, benzofuran
and naphthalene, with benzenes in metal-catalyzed reactions in the
presence of oxidants.6 Light mediated Ar–H substitution7 and
Lewis acid8 mediated oxidative coupling of arenes are also
impressive. However, these reactions typically take place under
an inert atmosphere or drastic conditions and have limited
substrate scope. Hence, the improvement of C–H bond transfor-
mations to biaryls through direct oxidation under practical and
mild conditions is highly desired.
Gold has been under the spotlight of the chemistry stage as a
catalyst in recent years.9 Both heterogeneous and homogeneous
gold catalysts showed excellent results in diversified reactivities.
With regard to homogeneous catalysis, on the one hand gold
shows reactivity as a ‘soft’ Lewis acid to perform C–C,10 C–N,11
C–O12 and C–F13 bond formation reactions with multiple bonds.
On the other hand redox-type reactions such as reduction,14
oxidation,15 diboration,16 homo-coupling of boronic acids,17
cross-coupling reactions18 and coupling of alkyl triflates with
electron-rich arenes19 have been demonstrated. Novel structures
have been made smoothly with gold catalysts via cascade
reactions.20
Notably, gold has a rich organometallic chemistry.21 Its aryl
complexes have been synthesized from Au(I)/(III) complexes.22
Alternatively, C–H bond activation of arenes with Au(III)
complexes to form gold aryl complexes is possible23 and these
gold aryl complexes can produce aryl acetylenes with concomitant
formation of Au(I) species.21a Though the catalytic version of this
interesting transformation has been attempted, it gave only the
hydroarylation of alkynes.24 Coupling of the ligands on gold
complexes was also reported.25 Thus, gold is a good candidate to
act as a catalyst for biaryl synthesis from arenes with a suitable
oxidant.26 Based on our experience with C–H functionalization
of arenes27 and oxidation reactions,28 here we report the first
general gold-catalyzed oxidative coupling of arenes to yield
biaryls.
Our screening started with a model reaction, using p-xylene to
form 2,29,5,59-tetramethylbiphenyl catalyzed by various catalysts
using PhI(OAc)2 as the oxidant. 2 mol% of catalyst was employed
in our primary investigations (eqn (1)). To our delight, HAuCl4
catalyzed the reaction smoothly to yield the biphenyl in 74% yield
at 55 uC (Table 1, entry 1). Other gold catalysts such as Au(OAc)3
and AuCl(PPh3) also showed significant activity (39 and 76% yield
respectively). Although Lewis acid mediated oxidative coupling of
electron-rich arenes in an overstoichiometric amount has been
reported, typical Lewis acids like FeCl3 and BF3?OEt2 did not
work under our catalytic reaction conditions. Further solvent
screening revealed that acetic acid is a good solvent for this
reaction. Non-coordinative solvents like 1,2-dichloroethane (42%
yield) and the substrate, p-xylene (58% yield), can also be used as
the reaction medium (see ESI{).
ð1Þ
Even though a slightly higher concentration (10 equiv. to the
oxidant) of arene is used to get an optimized yield, the excess
starting material can be recovered and reused. It should be noted
that strong acids [e.g. TFA (.1% yield)] gave inferior results,
possibly due to the formation of polymers. It is noteworthy that
our protocol can be easily managed in ambient conditions. It is not
necessary to use inert conditions and no pre-treatment of solvent
or substrate is needed. When acetic anhydride was used (71%
yield) instead of HOAc, no improvement was observed. This result
implies that water in the reaction mixture does not affect our
system very much. Among the several oxidants used (K2S2O8,
aLeibniz-Institut fu¨r Katalyse, Albert-Einstein-Str. 29a, D-18059
Rostock, Germany. E-mail: man-kin.tse@catalysis.de;
Fax: (+49) 381-128151193
bUniversita¨t Rostock, Center for Life Science Automation (CELISCA),
Friedrich-Barnewitz-Str. 8, D-18119 Rostock, Germany
{ Electronic supplementary information (ESI) available: Effect of solvent,
oxidant and catalyst in oxidative homo-coupling of p-xylene and spectral
data of compounds synthesized. See DOI: 10.1039/b714928j
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Oxone1, 35% CH3CO3H, Cu(OAc)2, see ESI{), PhI(OAc)2
proved to be the best oxidant for this reaction.
PhI(OCOCF3)2 is a suitable reagent for Lewis acid mediated
biaryl formation reactions, however it gives slightly lower
productivity in our model reaction (69% yield).
To test the effectiveness of the gold catalytic system, a range of
arenes was examined using the preliminary optimized reaction
conditions (Table 1). In general, the reaction shows a typical
electrophilic aromatic substitution pattern. Notably, a variety of
arenes work comparably well (Table 1). Even 4-nitroanisole, which
gave no product in Lewis acid mediated oxidative coupling,8g
furnished the corresponding biaryl in moderate yield (Table 1,
entry 11).
The reaction protocol tolerates a wide range of functional
groups. All halogens survive after the reaction. To the best of our
knowledge, neither palladium- nor Lewis acid-catalyzed reactions
can maintain the reactivity with tolerance to all halogens. Only a
few C–H functionalization reactions exhibit such high halogen
group preservation (Table 1, entries 7–10).4b–e Other functional
groups such as methoxide and esters work equally well in our
reaction conditions (Table 1, entries 12 and 13). It is worth
mentioning that electron-rich heterocycles, such as thiophene, also
gave the corresponding products in moderate yield.
Interestingly, a decrease of reactivity fromHAuCl4 to Au(OAc)3
was observed. It suggests that some chloride ions may still
coordinate to the catalytic center. As a trace amount of chlorinated
product was detected by GC-MS, it is likely that the gold reaction
center contains both acetate and chloride ions. Though arene
cationic radical has been observed in Lewis acid mediated
oxidative coupling reactions of electron-rich arenes at 278 uC,8e
no biaryl was observed with 2 mol% BF3?OEt2 in the present
system. Moreover, nitro-substituted anisole did not work in the
Lewis acid systems while it worked moderately in our case. Since
AuCl(PPh3) worked as well as HAuCl3 under our oxidative
conditions, Au(III) is suggested as the CH–functionalization
catalyst.29 The substrate with the weakest carbon–halogen bond
(C–I) coupled smoothly in our conditions (Table 1, entry 10). It
further implies that high valent Au(III) is the major catalyst.18,30 A
typical electrophilic aromatic substitution pattern has been
observed in our reaction conditions. Hence, participation of a free
cationic radical is not likely, but the possibility of an auration
reaction, a Friedel–Crafts type substitution or the participation of
a coordinated cationic radical cannot be ruled out.
In summary, a new general gold-catalyzed oxidative homo-
coupling of arenes is reported. It can be simply handled in air and
no pre-treatment of substrate and solvent is necessary.
Interestingly, our reaction protocol does not require any Ag salt
to enhance the reactivity.31 Remarkable functional group tolerance
has been shown in our reaction conditions. The results shown
represent the first successful example of Au-catalyzed oxidative
homo-coupling of simple arenes. In principle the double CH-
functionalization is the most efficient process for the synthesis of
biaryls. Improved systems for direct cross-coupling of arenes are
under investigation and mechanistic studies of this reaction are in
progress in our laboratory.
We thank the State of Mecklenburg-Western Pommerania and
the Federal Ministry of Education and Research (BMBF) for
financial support. Dr C. Fischer, Mrs C. Mewes, Mrs A.
Lehmann, Mrs S. Buchholz, Mrs M. Heyken (all LIKAT) and
Table 1 Au-catalyzed oxidative homo-coupling of arenesa
Entry ArH Major product Temp./uC Yield (%)b
1 55 74c
2d 55 81c
3d 95 71c
4 55 75e
5 95 62
6 95 68c
7c 55 63f
8 95 68
9 95 56
10 95 79g
11 95 38
12 95 74h
13 95 78
14 95 31
a Reaction conditions: oxidant (1.0 mmol), p-xylene (10.0 mmol),
dodecane (55 mL, internal standard) and HAuCl4 (0.02 mmol,
2.0 mol%) were heated in the appropriate solvent (1.0 mL) at 55 uC
in air for 17 h. b Isolated yields based on the oxidant used. c GC
yields; trimers were observed. d 2 mL of solvent were used. e An
isomer mixture was isolated; product ratio 5 89 : 11 by GC-FID.
f 54% of para–para coupled product and 9% of para–ortho coupled
product were isolated. g 69% of para–para coupled product and 10%
of para–ortho coupled product were isolated. h 74% of para–para
coupled product was isolated and the para–ortho coupled product
was observed.
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In recent decades, transition metal catalyzed coupling reactions to construct aromatic C-C 
and C-X (X = N, O, S) bonds have been gained great attention of the scientific community 
and presently reached a highly advanced status.1 The classical way to this type of 
transformation is the metal-mediated coupling reactions of the “pre-activated” compounds, 
such as halogenated arenes.2 The most simple and convenient method to connect the 
electrophilic reagents (ArX) with the nucleophilic counter part, such as organometallic 
derivatives (ArM), or amines, alcohols and thiols, is undoubtedly transition metal-catalyzed 
cross-coupling reactions.1,3 The major drawback of these reactions is the necessity of an 
activating group on both or at least one of the coupling partners, which may not be always 
easily available. Also this “pre-activation”, such as halogenation, sulfonate formation or 
preparation of organometallic reagents, usually refers to an extra step towards the final 
product. 
Biaryls as well as aromatic amines constitute important structural motifs in natural 
products, pharmaceuticals, agrochemicals and materials. Owing to the numerous appealing 
applications, many efforts have been devoted to providing direct and efficient processes for 
their preparation. Organometallic reagents from elegant C-H bond functionalization methods 
save one synthetic step4 and direct metal, such as Pd, Rh and Ru etc., catalyzed regioselective 
C-H bond activation with subsequent coupling reaction has better atom efficiency.5 However, 
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direct aromatic C-H functionalization has not been reached its optimum level because 
practical synthetic utility demands less expensive, highly efficient and environmentally 
friendly catalytic systems.  Recently, significant advances have been made in the development 
of arylation of arenes, such as indole, benzofuran and naphthlene, with benzenes in metal-
catalyzed reactions in the presence of oxidants.6 Light mediated Ar-H substitution7 and Lewis 
acid8 mediated oxidative coupling of arenes are also impressive. On the other hand, metal 
mediated direct aromatic C-H activation followed by coupling with amines9 or Lewis acid 
catalyzed amination of electron rich arenes with electrophilic nitrogen source to produce 
aromatic amines has been well documented in the literature.10 In general, use of inert 
atmosphere or drastic conditions and limited substrate scope often renders the practicability of 
industrial usage of these types of reactions. Therefore, the improvement of aromatic C-H bond 
transformations under practical and mild conditions is one of the priority tasks for modern 
organic chemists. 
In recent years, gold has emerged as a most discussed topic of the catalysis community.11 
Gold catalysts are known to produce extraordinary results both in the fields of heterogeneous 
and homogeneous catalysis. Although in the last few years, there is a significant increase in 
scientific publication using gold as homogeneous catalysts, especially as a “soft” Lewis acid 
to perform C-C,12 C-N,13 C-O14 and C-F15 bond formation reactions with multiple bonds, 
heterogeneous gold catalysts are still dominant. Gold catalysts also have been employed in 
redox-type reactions such as reduction,16 oxidation,17 diboration,18 homo-coupling of boronic 
acids,19 cross coupling reactions20 and coupling of alkyl triflates with electron-rich arenes.21 
They have been used fruitfully for multi-component and cascade reactions to generate 
complex structures.22 Mechanistically, there is still a concern associated with the role of 
proton in reactions catalyzed by gold and other Lewis acids.23 
Simple gold salts are known to react with arenes to produce stable aryl-gold complexes. In 
early landmark reports, these aryl complexes used to be synthesized from Au(I)/(III) 
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complexes with Grignard reagents or organo-mercury compounds.24 These Au(I) aryl 
complexes can be further oxidized to their Au(III) derivatives.24b,e C-H bond activation of 
arenes with Au(III) complexes to produce gold aryl complexes has also been reported in the 
literature, which is often stabilized by N-donating ligands.25 In stoichiometric reactions, this 
gold complex reacts with acetylenes to produce aryl acetylenes and Au(I) species.26 However, 
when this reaction was performed in catalytic amount of gold in the presence of various 
oxidants, only hydroarylation of alkynes was observed.27 It should be noted that C-H bond 
activation and homocoupling of the coordinating ligand itself was determined.28 On the basis 
of these observations it was thought for long times that switching between two distinct 
oxidation states of gold in catalytic reaction conditions will be fruitful to the chemical 
enterprise. Very recently, it has been demonstrated that with a suitable ligand system gold can 
also perform Suzuki-Miyaura29 as well as Cu-free Sonogashira20a coupling reactions. In our 
long term searching for efficient C-H functionalization of arenes30 and oxidation reaction 
systems,31 we thought that gold can be a good candidate to act as catalyst for biaryl synthesis 
from arenes with a suitable oxidant.32  
Herein we present more detailed studies of the homo- and hetero-coupling of nonactivated 
arenes on the basis of aromatic C-H bond functionalization catalyzed by gold,33 and some 
intial experiments on aromatic electrophilic amination reaction. These results give us some 
insights on the diverse reaction mechanism. 
We started investigating the oxidative homocoupling reaction of p-xylene to form 
2,2’,5,5’-tetramethylbiphenyl using PhI(OAc)2 as the oxidant (Table 1). Initially we started 
with 5 mol% of HAuCl4 as catalyst with respect to the oxidant employed. This reaction went 
smoothly to yield the biphenyl in 65% at 55 °C (Table 1, entry 2) but remained unreactive in 
the absence of the catalyst (Table 1, entry 1). As substantial amount of chlorination of p-
xylene also observed with 5 mol% of HAuCl4, reduction of the catalyst loading to 2 mol% 
slightly enhanced the product yield by decreasing the amount of chlorine source (Table 1, 
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entry 3). Further experiments show that catalyst loading can be reduced down to 1 mol% with 
a slight decrement in yield but with accretion in TON and TOF of the reaction (Table 1, entry 
4).  
 
Table 1. Catalyst screening of oxidative homo-coupling of p-xylene[a] 
 
Me
Me
+ PhI(OAc)2
catalyst
HOAc, 55 oC, 17 h
Me
Me Me
Me
1 2  
entry catalyst yield [%][b] TON[c] TOF [h-1][d] 
1 nil 0 0 0 
   2[e] HAuCl4 65 13 0.8 
3 HAuCl4 74 37 2.2 
   4[f] HAuCl4 57 57 3.4 
5 Au(OAc)3 39 20 1.1 
6 AuCN 0 0 0 
7 AuCl(PPh3) 76 38 2.2 
8 FeCl3 0 0 0 
9 NH4FeCl4 0 0 0 
10 AgNO3 0 0 0 
11 CuCl2 0 0 0 
12 BF3•OEt2 0 0 0 
[a] Reaction conditions: PhI(OAc)2 (1.0 mmol), p-xylene (10.0 mmol), dodecane (55 L, internal standard) and 
catalyst (0.02 mmol, 2.0 mol%) were heated in HOAc (1.0 mL) at 55 °C in air for 17 h.  [b] Calibrated GC yields 
were reported; % yield = (no. of moles of biaryl)/(no. of moles of oxidant) x 100%. [c] Turnover number (TON) 
= (no. of moles of biaryl produced)/(no. of moles of catalyst). [d] Turnover frequency (TOF) = (no. of moles of 
biaryl produced)/[(no. of moles of catalyst) x (reaction time in hour)]. [e] 5 mol% of catalyst used. [f] 1 mol% of 
catalyst used. 
 
With 2 mol% of the catalyst loading, other gold catalysts such as Au(OAc)3 and 
AuCl(PPh3) also showed moderate activity, whereas AuCN remained completely inactive 
(Table 1, entries 5,6 and 7). It suggests that catalytic activity depends not only on the 
oxidation state of the catalyst, but also on the counter anion employed. Though Lewis acid 
mediated oxidative coupling of electron rich arenes has been reported, low temperature 
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(-78 °C), inert gas (N2) and overstoichiometric amount of the Lewis acid (BF3·Et2O) are 
necessary.8 Typical Lewis acids like FeCl3 and BF3•OEt2 did not work under our catalytic 
reaction conditions (Table 1, entries 8 and 12). Catalysts like NH4FeCl4, AgNO3, CuCl2 also 
remained unreactive (Table 1, entries 9, 10 and 11). These results reveal that the reaction do 
not follow a simple electrophilic substitution reaction pathway through a non-stabilized 
cationic radical.8 
 
Table 2. Solvent screening of oxidative homo-coupling of p-xylene[a] 
 
Me
Me
+ PhI(OAc)2
2 mol% HAuCl4
Solvent, 55 oC, 17 h
Me
Me Me
Me
1 2  
entry solvent yield [%][b] TON[c] TOF [h-1][d] 
1 p-xylene 58 29 1.7 
2 CH3CN 0 0 0 
3 CH3NO2 12 6 0.4 
4 ClCH2CH2Cl 42 21 1.2 
5 MeOH 3 2 0.1 
6 TFA <1 <1 <0.1 
7 HOAc 74 37 2.2 
8 Ac2O 71 36 2.1 
[a] Reaction conditions: PhI(OAc)2 (1.0 mmol), p-xylene (10.0 mmol), dodecane (55 L, internal standard) and 
HAuCl4 (3.2 mg, 0.02 mmol, 2.0 mol%) were heated in an appropriate solvent (2.0 mL) at 55 °C in air for 17 h. 
[b] Calibrated GC yields were reported; % Yield = (no. of moles of biaryl)/(no. of moles of oxidant) x 100%. [c] 
Turnover number (TON) = (no. of moles of biaryl produced)/(no. of moles of catalyst).  [d] Turnover frequency 
(TOF) = (no. of moles of biaryl produced)/[(no. of moles of catalyst) x (reaction time in hour)]. 
 
Solvent shows pivotal effects to this reaction and acetic acid came out as the best solvent. 
Acids activate the gold catalyst. Only small amount of HOAc (56 L) provided sufficient 
activity (66%) for the reaction. For a more practical reaction protocol for solid substrates, 1-2 
mL of HOAc proved to be convenient. When strong acid (TFA) was used as the solvent, the 
reaction furnished rapidly but produced inferior results, possibly due to the formation of 
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polymers (Table 2, entries 6). Both acetic anhydride and HOAc produced the desired biaryl in 
comparable yields (Table 2, entry 7 and 8). These results imply that water in the reaction 
mixture does not affect our system very much. The reaction can also be carried out in the 
presence of non-coordinative solvents like 1,2-dichloroethane and the substrate, p-xylene 
itself but with comparatively lower yield (Table 2, entries 1 and 4). As HOAc was generated 
during the reaction, the reaction may activate itself. With strongly coordinative solvent like 
CH3CN and MeNO2 (Table 2, entries 2 and 3), either there was no reaction or the yield was 
very poor, suggesting that the reduced Lewis acidity may be the reason for this.  
Amongst the oxidant used, PhI(OAc)2 showed to be the best oxidant of this reaction (Table 
3, entries 1). PhI(OCOCF3)2, a suitable reagent for Lewis acid mediated biaryl formation 
reactions, gave slightly lower productivity in our model reaction (Table 3, entry 2). 
Hypervalent iodine seems participating in the reaction as well. Indeed only very low yield of 
product was detected, PhI with peracetic acid, a formal in-situ generation method for 
PhI(OAc)2, gave 3% of the biphenyl while peracetic acid alone did not produce any coupling 
product. Other conventional oxidant such as K2S2O8, Oxone® and Cu(OAc)2 did not work at 
all (Table 3, entries 2-6).  
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Table 3. Solvent screening of oxidative homo-coupling of p-xylene[a] 
 
Me
Me
+ Oxidant
2 mol% HAuCl4
HOAc, 55 oC, 17 h
Me
Me Me
Me
1 2  
entry oxidant yield [%][b] TON[c] TOF [h-1][d] 
1 PhI(OAc)2 74 37 2.2 
2 PhI(OCOCF3)2 69 35 2.1 
3 O
O
I
OH  
0 0 0 
4 45% IBX <1 <1 <0.1 
5 Dess-Martin 1 <1 <0.1 
6 35% CH3CO3H 0 0 0 
7 PhI + 35% CH3CO3H 3 2 <0.1 
8 DMSO 0 0 0 
9 K2S2O8 0 0 0 
10 Oxone® 0 0 0 
11 Cu(OAc)2 0 0 0 
[a] Reaction conditions: Oxidant (1.0 mmol), p-xylene (10.0 mmol), dodecane (55 L, internal standard) and 
HAuCl4 (3.2 mg, 0.02 mmol, 2.0 mol%) were heated in HOAc  (1.0 mL) at 55 °C in air for 17 h.  [b] Calibrated 
GC yields were reported; % yield = (no. of moles of biaryl)/(no. of moles of oxidant) x 100%. [c] Turnover 
number (TON) = (no. of moles of biaryl produced)/(no. of moles of catalyst).  [d] Turnover frequency (TOF) = 
(no. of moles of biaryl produced)/[(no. of moles of catalyst) x (reaction time in hour)]. 
 
To improve the effectiveness of the gold catalytic system, the concentration effect was 
examined using the preliminary optimized reaction conditions (Table 4). The reaction is 
dependent on the concentration of substrate, mainly because of the formation of undesired 
oligomers observed on GC-MS (Table 4, entries 1, 4-6). When the concentration of the 
substrate such as p-xylene and benzene was increased to 20 fold compared to the oxidant, the 
yield of the corresponding homo-coupled product was also increased substantially especially 
in the latter case (Table 4, entries 6 and 9). While temperature effect is insignificant to 
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electron-rich p-xylene (Table 4, entries 1-3), it is beneficial to non-activated benzene (Table 
4, entries 7 and 8). With these reaction conditions, various non-activated arenes were coupled 
to test the effectiveness of the gold catalytic system.  
Table 4. Concentration effects on Au-catalyzed oxidative homo-coupling of arenes[a] 
R
+ PhI(OAc)2
2 mol% HAuCl4
HOAc, temp., 17 h
R
R
R
R
R
R = H, Me  
entry ArH ArH:PhI(OAc)2:HOAc[b] major product temp. [°C] 
yield 
[%][c] 
1 
Me
Me
1 
10:1:17 
Me
Me Me
Me
2 
55 74 
2 1 10:1:17 2 75 74 
3 1 10:1:17 2 95 70 
4 1 10:1:3 2 55 31 
5 1 10:1:9 2 55 52 
6 1 20:1:17 2 55 81 
7 
3 
10:1:17 
4 
55 34 
8 3 10:1:17 4 95 54 
9 3 20:1:17 4 95 71 
[a] Reaction conditions: Oxidant (1.0 mmol), p-xylene (10.0 mmol), dodecane (55 L, internal standard) and 
HAuCl4 (0.02 mmol, 2.0 mol%) were heated in the appropriate solvent (1.0 mL) and temperature in air for 17 h. 
[b] Molar ratio. [c] GC yields.  
 
While electron-rich substrates work well at 55 °C, neutral or electron deficient substrates 
react at slightly higher temperature (95 °C). In general, the reaction works smoothly in good 
to excellent yield. Even though slightly higher concentration (10 equivalents to the oxidant) of 
arene is used to get optimized yield, the excess starting material can be recovered and reused. 
For example, 7.5 equivalents of 4-bromo-2-methylanisole with respect to PhI(OAc)2 were 
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recovered after the reaction (Table 5, entry 10). The regioselectivity of the reaction follows 
typical electrophilic aromatic substitution pattern. A range of arenes worked comparably well 
under our reaction conditions to give the corresponding biaryls in moderate to good yields 
(Table 5). Even difficult substrates such as 4-nitroanisole, which was reported to be 
unreactive in Lewis acid mediated oxidative coupling,34 produced the corresponding biaryl in 
moderate yield (Table 5, entry 12). Highly electron deficient substrates like 1,3-
dicholorobenzene also reacted at elevated temperature (Table 5, entry 16).  
 
Table 5. Au-catalyzed oxidative homo-coupling of arenes[a] 
R1
+ PhI(OAc)2
2 mol% HAuCl4
HOAc, temp., 17 h
R2 R3 R2
R3
R1
R2 R3
R1  
entry ArH major product temp. [°C] yield [%][b] 
   1[c] 
3 4
95    71[d] 
   2[c] 
Me
Me
1
Me
Me
Me
Me
2
55    81[d] 
3 
Me
Me
5
Me
Me
Me Me
6
55    75[e] 
4 
Me
tBu
7 
Me
MetBu
tBu
8 
95 62 
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5 
F
MeO
9
OMe
MeOF
F
10
95    68[d] 
6 MeO
F
11
MeO OMe
F
F
12
55    63[f] 
7 
F
MeO
13
F
MeO
F
OMe
14
95    63[g] 
8 
MeO
Cl
15
Cl
OMe
MeO
Cl
16
95 68 
9 
MeO
Br
17
Br
OMe
MeO
Br
18
95 56 
10 
MeO
Br
Me
19
Br
OMe
MeO
BrMe
Me
20
95    56[h] 
11 
MeO
I
21
MeO OMe
I
I
22
95    79[i] 
12 
MeO
NO2
23
O2N
OMe
MeO
NO2
24
95 38 
13 
MeO
O
MeO
25
MeO OMe
OMe
O
MeO
O
26
95    86[j] 
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14 
Me
O
OMe
27
OMe
O
MeO
OMe
Me
28
95 78 
15 S Me
30
S SMe Me
31
95 31 
16
Cl
Cl
32
Cl
Cl
Cl
Cl
33
95    15[k] 
17
N
Me
Me
34
- 95 0 
18 N
35
- 95 0 
19
HN
Me
O
36
- 95 0 
20
Me
O
37
- 95 0 
21
Me
Me
Me
38
- 95 0 
[a] Reaction conditions: Oxidant (1.0 mmol), arene (10.0 mmol), dodecane (55 L, internal standard) and 
HAuCl4 (0.02 mmol, 2.0 mol%) were heated in HOAc (1.0 mL) at 55 °C in air for 17 h. [b] Isolated yields based 
on the oxidant used. [c] GC yields. [d] 20.0 mmol of arene was used.  [e] An isomer mixture was isolated; 
product ratio = 89:11 on GC-FID. [f] 54% of para-para coupled product and 9% of para-ortho coupled product 
were isolated. [g] An isomer mixture was isolated; product ratio = 24:49:27 on GC-FID. [h] An isomer mixture 
was isolated; product ratio = 88:12 (1H NMR). [i] 69% of para-para coupled product and 10% of para-ortho 
coupled product were isolated. [j] 74% of para-para coupled product was isolated and 12% of para-ortho 
coupled product were observed. [k] An isomer mixture was isolated; product ratio = 94:6 on GC-FID. 
A wide range of functional groups has been tolerated by the present reaction protocol. All 
halogens survived and kept intact during the course of the reaction. To the best of our 
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knowledge, neither palladium- nor Lewis acid-catalyzed reactions can maintain the reactivity 
tolerating all halogens (Table 5, entries 5-11). Some C-H functionalization reactions exhibit 
such high halogen group preservation.4b-e Methoxide and ester groups also survived and 
worked equally well in our reaction conditions (Table 5, entries 13 and 14). The electron rich 
heterocycle, thiophene also coupled to the corresponding product in single regioisomeric form 
in moderate yield (Table 5, entry 15). One of the drawbacks for this protocol is the 
compatibility with strong coordinating groups. Substrates containing functionalization such as 
N,N-dimethylbenzyl amine, 2-phenyl pyridine, N-acetyl aniline, aliphatic aromatic ketones 
did not give any desired product. Electron rich mesitylene did not produce the desired homo-
coupled product possibly due to the increased steric bulk in the substrate. Nevertheless, the 
present protocol is very easy to handle. It can be managed in ambient conditions and is not 
necessary to protect the mixture under inert atmosphere or pre-treat the solvent or substrate.  
Exploration of oxidative hetero-coupling of arenes using our protocols showed interesting 
results. Concentration effect plays a crucial role in this reaction. With equal amounts of para-
haloanisole and benzene, nearly equal amount of the homo-coupling product of biphenyl and 
the hetero-coupling product of phenylanisole was observed, whereas the yield of bis-anisole 
was only in a few percent (Table 6, entries 3, 9, 15). Clearly it can be imagined that the 
activation of benzene occurs in the initial step and the reactive intermediate is then trapped by 
another arene. Hence the biphenyl to phenylanisole ratio is close to the concentration ratio of 
benzene and anisole. Increasing the amount of benzene from 1 to 10 equivalents to PhI(OAc)2 
caused increment of biphenyl, as expected (Table 6, entries 1-4).  
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Table 6. Au-catalyzed oxidative hetero-coupling of arenes[a] 
X
+ PhI(OAc)2
2 mol% HAuCl4
HOAc, 95 °C, 17 h
OMe
+
4
OMe
X
+
X = Cl 40, Br, 41, I 42
OMe
X
X = Cl 16, Br, 18, I 43
X
MeO
+
 
entry X 
halo-anisole 
:benzene[b] 
hetero-coupled 
product (40, 41 or 
42) [%][c] 
homo-coupled 
product (16, 18 or 
43) [%][c] 
biphenyl 
(4) [%][c] 
hetero: 
homo:4 
[%][d] 
1 Cl 5:1 23 17 4 49:40:11 
2 Cl 5:2 32 7 18 52:12:36 
3 Cl 5:5 30 3 32 41:5:53 
4 Cl 5:10 23 0 41 32:0:68 
5 Cl 10:4 43 10 19 56:15:29 
6 Cl 15:6 46 11 22 54:15:31 
7 Br 5:1 27 15 9 45:37:18 
8 Br 5:2 42 7 27 48:13:39 
9 Br 5:5 37 3 43 38:4:58 
10 Br 5:10 29 1 60 27:2:71 
11 Br 10:4 50 8 30 50:13:37 
12 Br 15:6 55 11 30 51:14:35 
13 I 5:1 15    nd[e] 3 48:40:12 
14 I 5:2 26 nd 16 51:16:33 
15 I 5:5 25 nd 29 41:7:52 
16 I 5:10 20 nd 54 25:2:73 
17 I 10:4 36 nd 17 53:21:26 
18 I 15:6 41 nd 15 48:13:39 
[a] Reaction conditions: Oxidant (1.0 mmol), appropriate amounts of arenes, dodecane (55 L, internal standard) 
and HAuCl4 (0.02 mmol, 2.0 mol%) were heated in HOAc (1.0 mL) at 95 °C in air for 17 h. [b] No. of moles of 
anisole:no. of moles of benzene. [c] Calibrated GC yields based on the oxidant used. [d] GC peak area ratio of 
corresponding products. [f] Not determined. 
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Higher concentration of arenes resulted in a better total yield. The best result was obtained 
when a ratio of 15:6:1 of para-bromoanisole:benzene:PhI(OAc)2 was performed, in which a 
total yield of 95% was attained with 55% of cross coupling product (Table 6, entry 12). On 
the other hand, in the case of para-iodoanisole, ortho-acetoxylated product with respect to the 
methoxy goup, which was the major product in homocouplig reaction conditions, was not at 
all observed (according to GS-MS spectra of the crude reaction mixtures). The formation of 
such acetoxylated product with hypervalent iodine salt and a Lewis acid was already reported 
in the literature,35 which supports our observation during the homo-coupling experiments with 
para-iodoanisole. But surprisingly, the same substrate in hetero-coupling conditions produced 
different amount of homo- and hetero-coupling product of para-iodoanisole together with the 
formation of biphenyl (4) but not the acetoxylated product. 
Gold catalysts can be extended to C-N bond formation. The same type of amination 
reaction of electronrich arenes was reported in the literature promoted mainly with 
stoichiometric amount of Lewis acids.10 In a model reaction amination of p-xylene catalyzed 
by gold catalysts using diisopropylazodicarboxylate (DIAD) as an amine source was 
performed (Table 7). To our delight, 5% HAuCl4 catalyzed the reaction smoothly to yield the 
major aminated product in 31% at 55 °C using MeNO2 as solvent (Table 7, entry 1).  
 
Table 7. Catalyst and solvent screening of electrophilic amination of p-xylene [a] 
 
44
Me
Me
N N
iPrO2C
CO2iPr
+
5 mol% Catalyst
Solvent, 55 °C, 17 h
Me
Me
N
NHCO2iPr
CO2iPr
 
entry catalyst solvent 
yield of major isomer 
[%][b] 
major:minor 
[%][c] 
1 HAuCl4 CH3NO2 31 85:15 
2 AuPPh3Cl  CH3NO2 0 0:0 
3 AuCl3  CH3NO2 30 85:15 
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4 Au(OAc)3  CH3NO2 0 0:0 
5 AuCN  CH3NO2 0 0:0 
6  HAuCl4 CH3CN 14 80:20 
7 HAuCl4 p-xylene 11 83:17 
8 HAuCl4 ClCH2CH2Cl 14 84:16 
9 HAuCl4 AcOH 22 84:16 
10 HAuCl4 MeOH 0 0:0 
11 BF3.OEt2 CH3NO2 31 85:15 
[a] Reaction conditions: DIAD (1.0 mmol), p-xylene (10.0 mmol), dodecane (55 L, internal standard) and catalyst (0.05 
mmol, 5.0 mol%) were heated in the appropriate solvent (1.0 mL) at 55 °C in air for 17 h.  [b] Calibrated GC yields. [c] GC 
peak area ratio of corresponding products. 
 
But in sharp contrast to the C-C bond formation reaction, amination did not proceed when 
Au(OAc)3, AuCl(PPh3) or AuCN were used as catalyst, whereas AuCl3 showed comparable 
reactivity (Table 1, entries 2, 3, 4 and 5). Further solvent screening revealed that, MeNO2 is 
the solvent of choice, whereas polar protic solvent like AcOH and MeOH, coordinative 
CH3CN, and non-polar aprotic 1,2-dichloroethane gave inferior results (Table 1, entries 6-10). 
However, using 5 mol% of BF3·Et2O instead of HAuCl4, a similar yield was given (Table 1, 
entry 11), which suggests the present aromatic amination passes through a Lewis acid 
catalyzed reaction mechanism. This type of gold catalyzed electrophilic aromatic C-H 
functionalization is mechanistically entirely different from the forementioned oxidative 
homocoupling of arenes. 
Some mechanistic insights can be drawn from this diverse reactivity of gold catalysts. We 
have observed that the reactivity of Au(OAc)3 was lower than that of HAuCl4 and AuCl3 in 
C-C bond formation. By close monitoring the reaction mixture by GC-MS, in the initial stage 
of the reaction, a substantial amount of chlorinated product was formed with a rate faster than 
the formation of homo-coupled product. This implies that some chloride ion remained 
attached to the catalytic center during the course of the reaction and the actual catalyst 
contains both acetate and chloride ions. Lewis acid mediated oxidative coupling reactions of 
electron rich arenes using hypervalent iodine salts was performed at as low temperature as 
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-78 °C and a cationic radical species has been proposed as the reaction intermediate.8e In the 
aromatic amination process both BF3·OEt2 and HAuCl4 worked equally well, establishing that 
it is likely a Lewis acid catalyzed process, while no biaryl was observed with 2 mol% 
BF3·OEt2 in the present oxidative homo-coupling system. Moreover, nitro-substituted anisole 
did not work in the Lewis acid systems while it worked moderately in our case. Hence, direct 
participation of cationic radicals is not very likely. But the regioselectiviy in the present 
homo-coupling reaction protocol strictly follows typical electrophilic aromatic substitution 
pattern. Moreover during the screening process of homo-coupling of p-xylene, a trace amount 
of an unidentified compound with a molecular mass of 212, which corresponds to the 
unoxidized intermediate to bixylyl was observed. Participation of gold stabilized cationic 
radical species or electrophilic metalation like conventional Pd(II) or Pt(II) cannot be entirely 
ruled out. It has been recently reported that oxidative addition of aryliodides is possible with 
Gold(I) complexes. But under our conditions, the substrate with the weakest carbon halogen 
bond (C-I) coupled smoothly with intact preservation of iodo-group in the product (Table 5, 
entry 11), which implies that high valent Au(III) is the major catalyst.20, 36 It should be noted 
that both AuCl(PPh3) and HAuCl3, worked with same efficacy under our oxidative conditions 
and this also further supports the fact that Au(III) may be the C-H functionalization catalyst.37 
Knowing the distinct difference of reactivity between the C-C bond formation and amination 
process, it strongly suggests that rather than a simple aromatic electrophilic substitution, it 
follows a complicated pathway. 
In summary, a new general gold-catalyzed oxidative coupling of arenes was reported. 
Hetero-coupling was shown for the first time possible. This reaction can be simply handled in 
air and no pre-treatment of substrate and solvent is necessary. Interestingly our reaction 
protocol activated by a suitable acidic solvent and does not require any Ag salt to enhance the 
reactivity.38 Remarkable functional groups tolerance has been shown in our reaction 
conditions. This double CH-functionalization reaction is in principle the most efficient 
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process for the synthesis of biaryls. From the reaction pattern showed by electrophilic 
amination of p-xylene, the mechanism of gold catalyzed CH-functionalization is still unclear 
and an interesting area. Studies of the reaction mechanism are undoubtedly a currently fruitful 
area for the next generation of gold catalysis. 
 
General Procedure for HAuCl4 Catalyzed Homo-coupling of Arenes: To a 10 mL vial 
arene (10 mmol), PhI(OAc)2 (1 mmol), HAuCl4 (0.02 mmol) and acetic acid (1 mL) were 
added. The mixture was stirred for 17 h at 55 ºC and then quenched with water (10 mL). The 
reaction mixture was extracted with EtOAc (3 x 10 mL) and the combined organic layer was 
washed with saturated NaHCO3 (2 x 20 mL), brine (10 ml), dried over Na2SO4, filtered and 
concentrated. The residue was purified by column chromatography to afford the desired 
product. 
 
General Procedure for HAuCl4 Catalyzed Hetero-coupling of Arenes with Benzene: To a 
10 mL vial arene (5-15 mmol), benzene (1-10 mmol), PhI(OAc)2 (1 mmol), HAuCl4 (0.02 
mmol) and acetic acid (1 mL) were added. The mixture was stirred for 17 h at 95 ºC and then 
quenched with water (10 mL). The reaction mixture was extracted with EtOAc (3 x 10 mL) 
and the combined organic layer was washed with saturated NaHCO3 (2 x 20 mL), brine (10 
ml), dried over Na2SO4, filtered and concentrated. The residue was purified by column 
chromatography to afford the desired product. Analytically pure sample was obtained by thin 
layer chromatography of the purified product. 
 
General Procedure for Catalytic amination of Arenes: To a 10 mL vial arene (10 mmol), 
diisopropylazodicarboxylate (1 mmol), catalyst (0.05 mmol) and appropriate solvent (1 mL) 
were added. The mixture was stirred for 17 h at 55 ºC, cooled and quenched with water (10 
mL). The reaction mixture was added dodacane (internal standard, 55 L), stirred for 15 
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minutes, extracted with EtOAc and the organic layer was to GC analysis to determine the 
yield. The analytically pure sample of 44 was prepared by known literature method39 to 
calibrate the GC machine.  
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Abstract 
 
i
Abstract 
 
This dissertation deals with the synthesis of novel bioactive derivatives of the natural 
occurring hymenialdisine. As a part of this project, a solvent-free, efficient, and easy to 
handle diversification strategy for annulated hymenialdisine-type bisindoles was 
developed. A C-C bond-formation reaction on activated silica under mild reaction 
conditions starting from aziridines, epoxides or hydroxyl compounds is the key 
technology. The versatility of different aziridines as key building blocks was demonstrated 
with H-, O-, and N-nucleophiles in a diversity oriented synthesis to build up a focused 
chemical library. Furthermore, novel transition metal mediated introduction and 
transformation of functional-groups for potential application in the synthesis of novel drug 
candidates were developed. 
 
Die vorliegende Dissertation beschäftigt sich mit der Synthese von neuartigen biologisch-
aktiven Derivaten des Naturstoffes Hymenialdisin. Dafür wurde eine lösungsmittelfreie, 
effiziente und einfach zu handhabende Diversifizierungsstrategie für die Synthese von 
Hymenialdisin-artigen Bisindolen entwickelt. Durch den Aufbau von C-C Bindungen auf 
aktiviertem Kieselgel unter milden Reaktionsbedingungen wurden die Zielprodukte 
ausgehend von Aziridinen, Epoxiden oder Alkoholen erhalten. Der flexible Einsatz 
verschiedener Aziridine als Schlüsselbausteine konnte durch Umsetzungen mit H-, O-, und 
N-Nukleophilen beim Aufbau einer fokussierten Substanzbibliothek gezeigt werden. Ein 
zweiter Schwerpunkt der Arbeit lag in der Entwicklung neuer Übergangsmetall-
vermittelter Reaktionen für die Einführung und Transformation von funktionellen Gruppen 
für deren potentielle Anwendung in der Synthese biologisch aktiven Verbindungen. 
